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Abstract 
Regulation of gene expression under stress conditions involves chromatin remodeling 
through post-translational modification of histones. One of these modifications, acetylation 
of lysine residues, regulates transcription initiation and is linked to a variety of essential 
cellular processes including cell cycle control, DNA repair, and importantly, activation of 
cellular stress response pathways. Dysregulation of histone acetylation has been observed in 
many stress-related diseases such as inflammatory diseases, cancer, neurodegenerative 
disorders, and fungal infections. Tra1 is the only essential component of both the highly 
conserved SAGA and NuA4 histone acetyltransferase (HAT) complexes that are responsible 
for acetylation of histones and other proteins. Tra1 has been shown to be involved in the 
regulation of stress response pathways; however, the underlying mechanisms remain unclear. 
Huntington’s disease (HD) is a neurodegenerative disease caused by the aberrantly expanded 
polyglutamine (polyQ) repeats within the gene encoding the Huntingtin protein (Htt), leading 
to misfolding and aggregation of the mutant Htt. Defect in misfolded protein stress responses 
is a hallmark of HD. Thus, I sought to investigate how Tra1 orchestrates the transcriptional 
responses to toxic misfolded polyQ expansions. First, I developed an optimized yeast model 
of HD to study the effects of Tra1 on polyQ toxicity. I found that polyQ expansions impair 
the assembly of the Tra1-containing SAGA HAT complex. This correlates with loss of 
Tra1/SAGA function that exacerbates polyQ toxicity. Furthermore, polyQ expansions lead to 
increased expression of TRA1, revealing a compensatory feedback mechanism. Interestingly, 
deletion of SFP1, a transcription regulator downstream of TORC1, abolished TRA1 
upregulation upon polyQ expression. Thus, I identified a novel link between Tra1 and 
TORC1 signaling. Moreover, I showed that the increased sensitivity to heat stress in cells 
expressing expanded polyQ is rescued by an osmotic stabilizer sorbitol, suggesting that the 
defect can be traced back to the cell wall integrity. Considering that Tra1 is vital to maintain 
cell wall integrity and activation of the heat shock response, it appears that impaired 
Tra1/SAGA functions could underlie the dysregulation of these stress responses in the yeast 
model of HD. Finally, because of its essential role in cell wall maintenance and calcium 
homeostasis (two targets of antifungal drugs), Tra1 emerges as a rational target for 
pathological yeast infections. Indeed, I found that cells expressing a mutant tra1 allele 
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showed increased sensitivity to antifungal drugs. Overall, my graduate work helps 
characterize the global role of Tra1 in protein homeostasis and define its potential as a 
therapeutic target for stress-related human diseases.           
 
Keywords 
Stress response, histone acetyltransferase complex, Huntington’s disease, polyglutamine, 
fluorescent proteins, aggregation, heat shock response, cell wall integrity, calcineurin 
pathway, antifungal resistance, Tra1, TORC1, Sfp1. 
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Summary for lay audience 
Cells respond to environmental insults by remodeling their genome. Cells require critical 
transcriptional machinery to regulate the expression of specific genes in response to different 
stressors. Impaired cellular stress response pathways can lead to accumulation of toxic 
misfolded proteins and major cellular dysfunctions, which are hallmarks of several human 
disorders from neurodegeneration to our ability to fight fungal infections. Hyperactivation of 
cellular stress responses, on the other hand, can cause drug resistance in cancer therapy and 
lead to emergence of drug resistant microorganisms. Therefore, it is crucial to investigate the 
regulation of cellular stress responses and their implication in stress-related diseases. Using 
the budding yeast as an experimental model, my thesis explores how cells respond to stress in 
two major health problems: Huntington’s Disease and yeast resistance to antifungal drugs. 
While these two issues appear quite distinct, my work established that a single protein, Tra1, 
plays a pivotal role in controlling how cells modulate gene expressions under stress 
conditions linked to these pathologies. Therefore, understanding the crucial role of Tra1 in 
cellular stress responses will provide better insights into the pathogenesis and therapies of 
stress-related disorders.  
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Chapter 1  
1 Introduction 
In the first chapter, I will review literature pertinent to the subject of my thesis project. 
Specifically, I will focus on studies that define the role of Tra1 in gene expression, 
transcriptional regulation, and histone modification. Then, I will provide background 
information on cellular stress response pathways including TORC1 signaling, the heat 
shock response (HSR), the cell wall integrity (CWI) pathway, and the calcineurin 
pathway. Furthermore, I will emphasize the importance of the dysregulation of these 
cellular stress responses in human diseases, especially in Huntington’s disease (HD) and 
fungal infections. 
1.1 Cellular stress responses and stress-induced gene 
transcription 
A key aspect of cellular physiology is maintaining homeostasis, a dynamic state of 
equilibrium of the physiological and chemical conditions within our cells and our body 
(Keener and Sneyd, 2009). Many extracellular and intracellular factors, such as 
temperature and pH changes, hypoxia, genetic mutations, and protein misfolding can 
perturb protein homeostasis (or proteostasis) and cause cell stress. To cope with different 
environmental and genetic insults and restore homeostasis, cells adjust the expression of 
specific genes encoding stress response proteins through activation of multiple stress 
response pathways (Fulda et al., 2010). These stress response pathways include the 
unfolded protein response (UPR), the HSR, several MAPK pathways, the TORC1 
pathway, and the calcineurin pathway. The transcriptional regulation of stress-induced 
genes is critical for stress response activation. When increasing yeast incubation 
temperature from 25 to 38 °C, 52 proteins were induced in response to heat shock (Boy-
Marcotte et al., 1999). Upregulation of at least 115 genes was identified during H202 
treatment in response to oxidative stress (Godon et al., 1998). During osmotic stress, the 
mRNA level of 186 genes raised over 3-fold (Rep et al., 2000). Dysregulation of cellular 
stress responses has been found in various diseases including inflammatory diseases, 
cancer, and neurodegenerative disorders (Chen and Xie, 2018; Leak, 2014; Lindholm et 
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al., 2006). Understanding the regulation of gene transcription under specific disease 
conditions provides insights into the fundamental mechanisms of stress-related diseases. 
My thesis focuses on using the budding yeast Saccharomyces cerevisiae as a model 
organism to study transcriptional regulation in cellular stress responses in two distinct 
major health problems, HD, an inherited neurodegenerative disease, and pathological 
yeast infection and antifungal drug resistance.  
Stress-induced genes have specific sequences within their respective promoter that can be 
recognized by specific transcription factors. An example of such elements is the stress 
responsive element (STRE) which has a core sequence AGGGG (Ruis and Schüller, 
1995). STRE is the binding site of transcription factors Msn2/4 (Görner et al., 1998; 
Martínez-Pastor et al., 1996). A computer search in the yeast genome predicted that 186 
genes are potentially regulated through STRE (Moskvina et al., 1998). Other examples of 
stress response elements within gene promoters include the heat shock element (HSE), 
which is recognized by heat shock factors, the unfolded protein response element (UPRE), 
which is the binding sequence of Hac1/Xbp1 during ER stress, and the calcineurin 
dependent reporter element (CDRE), which is controlled by Crz1 to maintain calcium 
homeostasis (Morimoto and Westerheide, 2010; Stathopoulos and Cyert, 1997; 
Takayanagi et al., 2013). Importantly, some genes may contain both STRE and other 
stress response elements that can be induced by different stress-response transcription 
factors, such as HSP104 which encodes a heat shock protein, and an essential osmotic 
stress response gene GPD1 (Rep et al., 1999).  
Transcription initiation requires the binding of transcription factors and co-activators to 
the DNA regulatory regions. In eukaryotes, DNA is packed with histones to form 
nucleosomes, the fundamental subunit of chromatin (Kornberg and Lorch, 1999). The 
condensed chromatin structure and interaction between DNA and histones inhibit the 
binding of the transcriptional machinery (Grunstein, 1990). Specific enzymes can change 
the state of chromatin to start gene transcription. A major class of these histone-
modifying enzymes is the histone acetyltransferases (HAT) and associated complexes 
(Sterner and Berger, 2000). By transferring an acetyl group to certain lysine sites within 
histones in chromatin, HAT complexes weaken the interaction between DNA and 
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histones and/or change the chromatin to a more relaxed structure that allows the binding 
of transcription factors (Norton et al., 1989). Therefore, histone acetylation plays a vital 
role in gene transcription. Furthermore, many proteins of the HAT complexes have been 
reported as transcription co-activators (Bonnet et al., 2014). How HAT complexes 
regulate specific stress-induced gene transcriptions and their roles in cellular stress 
responses need further investigation. My thesis focuses on the role of Tra1, an essential 
component of two highly conserved HAT complexes, in cellular stress responses and its 
implication for stress-related diseases.  
1.2 Tra1 and transcription initiation 
Two major HAT complexes, which are highly conserved from yeast to humans, are the 
SAGA (Spt-Ada-Gcn5-Acetyltransferase) and NuA4 (Nucleosome acetyltransferase of 
H4) complexes. They respectively contain the Gcn5 and Esa1 lysine acetyltransferases, 
both of which have histones as a major substrate (Allard et al., 1999; Auger et al., 2008; 
Grant et al., 1997) (Figure 1.1A). In addition, SAGA and NuA4 have a number of non-
histone target proteins with roles likely unrelated to chromatin and gene regulation  
(Choudhary et al., 2009; Downey et al., 2015; Henriksen et al., 2012; Mitchell et al., 
2013). The SAGA complex also possesses a ubiquitin protease activity specific for 
monoubiquitinated histone H2B that is involved in the regulation of gene expression 
(Henry et al., 2003). A genome-wide microarray study first showed that SAGA 
contributes to the expression of about 10% of all yeast genes. Interestingly, a large 
amount of SAGA dependent transcripts are involved in cellular stress responses 
(Huisinga and Pugh, 2004). Furthermore, subsequent studies identified SAGA as a global 
transcription regulator that maps to the promoters of most genes (Baptista et al., 2018).  
The transcription-associated protein 1 (Tra1) is homologous to the mammalian TRRAP 
(McMahon et al., 1998) and was first identified within the purified SAGA complex 
(Grant et al., 1998). Tra1 is also an essential component of the NuA4 complex (Allard et 
al., 1999). It is a member of the phosphoinositide-3-kinase-related kinase (PIKK) family 
that also includes Tor1, DNA-PKcs, ATM, ATR and SMG-1 (Lovejoy and Cortez, 2009). 
The PIKK proteins play multiple vital roles in maintaining cell viability, especially stress-
induced signaling pathways such as DNA repair, ribosome biogenesis, and apoptosis 
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(Abraham, 2004). Recent structural studies using cryo-electron microscopy revealed the 
structure of Tra1 strikingly resembles another PIKK, DNA-PKcs, thus arguing in favor of 
a role for Tra1 in DNA repair (Díaz-Santín et al., 2017). As opposed to other PIKK 
proteins such as ATM and mTOR, Tra1 is not found to have catalytic activity due to the 
lack of signature motifs of kinases within the PI3K domain (Mutiu et al., 2007). The 
function of different Tra1 domains (Figure 1.1B) was investigated in a sequence-based 
study (Knutson and Hahn, 2011). Similar to other PIKK family proteins, there are five 
different domains in Tra1 and all are essential for viability. The long N-terminal HEAT 
(Huntingtin, elongation factor 3, PR65/A, and TOR) domain represents about 70% of the 
length of Tra1, which interact with transcription activators and other subunits of the HAT 
complexes, followed by the FAT (FRAP, ATM, and TRRAP) and FRB (FKBP12 
rapamycin binding) domains. After the PI3K domain, PIKK proteins have a small FAT 
C-terminal domain which is vital for the integrity of PIKK-containing complexes (Jiang 
et al., 2006). The authors reported the critical role of Tra1 in associating other subunits 
and contributing to the acetylation activity of the HAT complexes (Knutson and Hahn, 
2011). Previous studies identified Tra1 as a transcription co-activator that can recruit co-
activator complexes and directly interact with transcription activators during transcription 
initiation (Brown et al., 2001). Studies also showed that Tra1 has multiple transactivation 
domain binding sites within its HEAT region which allow its interaction with activators 
including yeast Gal4, Gcn4 or human c-myc (Lin et al., 2012; Park et al., 2001). Like 
Tra1 in S. cerevisiae, TRRAP in mice is essential for viability (Herceg et al., 2001). 
However, there are two paralogous proteins in S. pombe, Tra1 and Tra2 (Hayashi et al., 
2007). Tra1 in S. pombe is not essential and associates with SAGA, while Tra2 is 
essential and associates with NuA4 (Helmlinger et al. 2011). The fact that only S. pombe 
Tra2 is essential suggests that, in other organisms, NuA4 associated function of Tra1 is 
essential for viability (Helmlinger et al., 2011). Thus, it may not be a coincidence that 
depletion of Tra1 using the anchor-away system in S. cerevisiae recapitulates with higher 
fidelity the transcriptional profile of esa1Δ cells (a NuA4 component) and not gcn5Δ cells 
(a SAGA component) (Bruzzone et al., 2018). The requirement for Tra1, therefore, 
appears different for SAGA and NuA4 functions. 
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Figure 1.1 Tra1 is an essential component of both the SAGA and NuA4 HAT 
complexes. 
(A) Subunits of the SAGA and NuA4 HAT complexes. SAGA contains four modules, 
the HAT module, TAF module, deubiquitination (DUB) module, and TATA binding 
protein (TBP) module. The catalytic subunit of SAGA is Gcn5, whereas the 
acetyltransferase in NuA4 is Esa1. (B) The modular structure of Tra1 protein. Tra1 is 
a PIKK family protein which consists of five domains. Figure B adapted from Wang 
et al., 2018. 
 
Tra1
ADA1
TAFs
Spt3
Spt8
TBP
module
Ubp8
Sgf73 Sgf11
Sus1
DUB module
Spt7
Spt20
Gcn5
Ada2 Ada3
Sgf29HAT 
module
Ngg1
SAGA
Eaf1
Tra1
Esa1
Epl1
Yng2 Eaf6
Eaf5
Eaf7
Eaf3
HAT 
module
Act1 Swc4
Arp4 Yaf9NuA4
N-lobe C-lobe
FATCHEAT FAT FRB PI3K
1 2630 3204 3332 3462 3716 3744
A
B
6 
 
1.3 Yeast as a model organism 
Since first used in the early 1900s, the budding yeast S. cerevisiae has become a 
compelling model organism to build the fundamental understanding of eukaryotic cell 
biology (Mortimer and Johnston, 1986). The advantages of employing yeast include its 
short life cycle, simple growth requirements, and stable expression of plasmids. Yeast 
also allows the possibility of extensive and relatively easy genetic manipulations (Duina 
et al., 2014). Since the exciting publication of the first fully sequenced eukaryotic 
genome database came out in 1996, S. cerevisiae continues to offer new information on 
eukaryotic genome organization, basic cellular mechanisms, and evolution (Goffeau et al., 
1996). Numerous screening tools have been established including yeast genome-wide 
libraries carrying deletions of all non-essential genes and genomic plasmid banks for 
overexpression screen (Gelperin et al., 2005; Rose et al., 1987; Winzeler et al., 1999). 
These tools allow researchers to conduct high-throughput analysis of genetic interactions 
and protein functions. One example is the synthetic genetic array where a query mutation 
is crossed with the yeast deletion library. Spore inviability or growth defect of the double 
mutant indicates a genetic interaction between the two genes (Tong et al., 2001). More 
than 30% of all yeast genes have clear homologs in mammals (Botstein et al., 1997). 
Benefitting from the ease and rapidity of genetic screening, the yeast model is 
particularly amenable for genome-wide study on gene expression and signaling cascades. 
Most of the basic cellular mechanisms, such as the TORC1 signaling, the HSR, the 
MAPK pathways, and the calcineurin pathway, that I will discuss in subsequent sections, 
are conserved in human and widely studied in yeast. 
Due to the relatively short generation time, yeast is also used for aging research (Gershon 
and Gershon, 2000; Kaeberlein et al., 2007). The replicative as well as chronological life 
span allows researchers to investigate the aging processes of proliferating and 
nonproliferating cells respectively. Furthermore, yeast also provides an excellent platform 
for assessing cellular functions affected by disease-causing proteins (Smith and Snyder, 
2006). Making human point mutations in yeast orthologs, expressing human proteins in 
yeast, or humanizing yeast, i.e. replacing the yeast gene with its human homolog, 
successfully mimic human diseases’ phenotypes in S. cerevisiae (Laurent et al., 2016).  
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The yeast model has helped scientists gain a better understanding of different disease 
mechanisms such as neurodegenerations and cancer (Guaragnella et al., 2014; Miller-
Fleming et al., 2008). Researchers also exploit the yeast model for large-scale drug tests. 
Yeast has become a powerful in vivo tool for high throughput screens to identify drug 
targets and demonstrate the mechanisms of action (Couplan et al., 2011; Ohnuki et al., 
2010). 
Similarly to other model organisms, the yeast model is not perfect. Higher eukaryotes 
have more complex mechanisms that are difficult to study in yeast. Because yeast is a 
single cell organism, tissue studies and behavioral approaches are not feasible. 
Nevertheless, the use of this simple organism has become widespread, especially in 
combination with tools available in other model organisms such as C.elegans, Drosophila, 
rodents, and tissue culture cell lines established from patient samples. The simple yeast 
model not only enables a better understanding of the fundamental mechanisms of cellular 
functions but also contributes to accelerating the development of therapeutic agents for 
human diseases. In my thesis, I used S. cerevisiae to investigate the role of Tra1 in 
cellular stress responses and implications for Huntington’s disease and fungal infections. 
In the following sections, I will review the major stress responses pathways pertinent to 
my thesis project.  
1.4 TORC1 signaling pathway 
The Target of Rapamycin (TOR) is a widely conserved serine/threonine kinase that 
functions in two different complexes named TORC1 and TORC2, each of which plays 
vital roles in various aspects of eukaryote cell growth (Loewith and Hall, 2011). TORC1 
is activated under many stress conditions i.e. nutrient starvation and well studied for its 
role in regulating ribosome biogenesis, cell cycle, autophagy, and promoting cell growth 
during stress conditions (Barbet et al., 1996; Kawai et al., 2001; Noda and Ohsumi, 1998; 
Urban et al., 2007). TORC2, meanwhile, controls cell growth by regulating the 
polarization of the actin cytoskeleton (Schmidt et al., 1996). TORC2 has also been shown 
to regulate endocytosis and sphingolipid biosynthesis; however, the underlying 
mechanisms have yet to be elucidated (Tabuchi et al., 2006). 
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S. cerevisiae has two TOR genes encoding Tor1 and Tor2, which redundantly regulate 
growth (Loewith et al., 2002). Tor proteins are PIKK family proteins which contain a 
HEAT domain, binding targets for subunits of the TOR complexes; a core FAT domain, 
clamping onto the kinase domain and required for partners binding; an FRB domain, 
which contains the rapamycin binding region; and a PI3K kinase domain and FATC 
domain, which play critical roles in regulating protein kinase activity (Adami et al., 2007; 
Yang et al., 2013). The yeast TORC1 complex is formed by the proteins Kog1, Lst8, 
Tco89, and TOR1 or TOR2 (Loewith et al., 2002). Through fluorescence microscopy and 
fractionation experiments, TORC1 was found to localize to the vacuolar membrane 
(Reinke et al., 2004; Sturgill et al., 2008). Besides its known inhibition by rapamycin, 
many factors have been found to regulate TORC1 signaling including nutrient starvation, 
oxidative stress, heat shock, and cell wall stress (Beck and Hall, 1999; Gasch and 
Werner-Washburne, 2002). A yeast global protein kinase and phosphatase interaction 
network study identified downstream targets of TORC1 (Figure 1.2), revealing the 
critical role of the TORC1 signaling as described below (Breitkreutz et al., 2010). 
Ribosomes play a pivotal role in protein translation and cell growth. Actively dividing 
yeast cells allocate up to 85% of their transcriptional activity to ribosome biogenesis 
(Warner, 1999). TORC1 is a vital regulator of ribosome biogenesis through 
phosphorylation of the transcription factors Sch9 and Sfp1 (Lempiäinen and Shore, 2009). 
TORC1 directly binds and phosphorylates Sch9. Sch9 supports ribosome biogenesis and 
ribosomal protein gene transcription by inhibiting transcriptional repressor Dot6 and its 
homolog Tod6 (Huber et al., 2011; Lippman and Broach, 2009). Importantly, this 
phosphorylation is abolished during stress conditions (Urban et al., 2007). The activation 
of Sch9 also leads to the inhibition of Maf1, an RNA polymerase III repressor (Vannini et 
al., 2010). The phosphorylation of Sfp1 by TORC1 promotes Sfp1 binding to the 
promoters of genes encoding ribosomal proteins and thus regulates transcription 
activation (Fingerman et al., 2003). Mrs6, a protein involved in ER to Golgi trafficking, 
directly binds Sfp1 and regulates its cellular localization. Under stress conditions, Sfp1 
re-localizes from the nucleus to the cytoplasm that causes downregulation of ribosome 
biogenesis (Lempiäinen et al., 2009; Marion et al., 2004). Furthermore, Sfp1 or Sch9 
deletion leads to reduced cell size (Jorgensen et al., 2004), suggesting that ribosome 
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biogenesis regulated by the TORC1 signaling pathway is critical for cell size 
determination. 
TORC1 is essential for cell cycle regulation and growth. Treating yeast cells with 
rapamycin causes G1 arrest (Barbet et al., 1996). Previous literature showed that TORC1 
activates G1 cyclin-dependent protein kinases (CDKs) through destabilizing the CDK 
inhibitor Sic1 (Moreno-Torres et al., 2015). Furthermore, TORC1 is also involved in the 
G2/M transition through the interaction between Kog1 and a polo-like kinase Cdc5 
(Nakashima et al., 2008). Under stress or starvation conditions, cells undergo autophagy 
to degrade damaged proteins and organelles in order to generate biomaterials and ATP 
for essential protein synthesis (Reggiori and Klionsky, 2013). TORC1 has been shown to 
negatively regulate autophagy through the phosphorylation of autophagy-related genes 
(ATGs). Atg13 phosphorylation by TORC1 prevents its binding to Atg1 in yeast. The 
dephosphorylation and disassociation of the Atg1 mammalian homolog Ulk1 from 
mTORC1 increases its activity during starvation (Kamada et al., 2010; Noda, 2017; 
Yorimitsu et al., 2009).  
The TORC1 pathway has been linked to other cellular stress response pathways. 
mTORC1 is crucial for HSF1 activation in HeLa cells (Chou et al., 2012). Yeast cells 
carrying an Hsp90 mutation, which leads to overactivation of HSF1, are more sensitive to 
rapamycin, suggesting that inhibition of TORC1 signaling is involved in the process 
(Chou et al., 2012; Millson and Piper, 2014). Rapamycin treatment has also been shown 
to activate the CWI pathway, suggesting the negative regulation by TORC1 on cell wall 
integrity (Torres et al., 2002). Therefore, it is crucial to understand the multifunctional 
TORC1 regulation during stress and its connection with other stress response pathways.  
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Figure 1.2 Model of the TORC1 signaling pathway in S. cerevisiae.  
TORC1 is regulated by nutrients and cell stress. TORC1 level is inhibited by 
rapamycin. TORC1 controls ribosome biogenesis (Ribi) through phosphorylation of 
Sfp1 and Sch9. TORC1 negatively regulates autophagy by phosphorylating Atg13 and 
prevents the formation of Atg1 complex. TORC1 is also involved in cell cycle 
regulation.  
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1.5 Heat shock response 
The HSR is a well-conserved transcriptional program activated when cells are exposed to 
stresses which induces the expression of many heat shock proteins (HSPs) (Lindquist, 
1986; Richter et al., 2010). Many factors can lead to cell stress and activate the HSR 
including temperature changes, nutrient starvation, hypoxia, aging, and genetic mutations 
(Kalmar and Greensmith, 2009; Marambio et al., 2010; Murshid et al., 2013). Under 
stress conditions, an increased amount of misfolded or unfolded proteins accumulate 
within the cell, requiring a consequential increase in protein folding and quality control 
capacity to maintain protein homeostasis (Gidalevitz et al., 2011). The majority of HSPs 
function as molecular chaperones to unfold aggregated proteins, refold misfolded proteins, 
and target damaged proteins for degradation processes (Feder and Hofmann, 1999). 
Physiological changes such as the osmolyte synthesis and import, cytoskeleton 
remodeling, and interruption of the cell cycle regulated by HSPs also contribute to 
cellular survival during stress (Helmbrecht et al., 2000; Wettstein et al., 2012). Much of 
what we know about the HSR in eukaryotic cells has been elucidated in S. cerevisiae 
(Figure 1.3), supporting its use for investigating the underlying mechanisms of 
transcriptional regulation and effects during misfolded protein stress in my thesis.  
The key regulators of the HSR are heat shock factors (Akerfelt et al., 2010). Although 
mammals have multiple heat shock factors providing redundancy and specialization of 
the stress signals, Heat shock factor 1 (HSF1) is the main heat shock factor and is well 
conserved from yeast to human (Morimoto, 1998). During stress, HSF1 binds to a 
specific domain (nGAAn) termed the heat shock element (HSE) within the promoter of 
its targets, thereby regulating downstream gene transcription. The initial activation of the 
HSR requires HSF1 trimerization, phosphorylation at specific sites, and other post-
translational modifications (Chu et al., 1996; Holmberg et al., 2001; Westerheide et al., 
2009). As previously mentioned, the transcriptional regulation of HSPs also depends on 
co-activators. Tra1 has been shown to be involved in HSP activations (Lebedeva et al., 
2005). In addition, two other transcription factors, Msn2 and Msn4, were also found to be 
activated by heat shock in S. cerevisiae, mainly targeting enzymes involved in carbon 
metabolism and anti-oxidants (Boy-Marcotte et al., 1999). 
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HSF1 regulates the activation of HSPs which are critical for protein quality control. Well-
characterized HSPs include Hsp70, Hsp90, Hsp104, and small heat shock proteins 
(sHSPs) family. Hsp70 chaperones support about 30% of proteins to maintain their 
correct folding by binding transiently to hydrophobic polypeptides of unfolded proteins 
to prevent non-specific interactions that may cause misfolding and aggregation (Sharma 
and Masison, 2009). Compared to Hsp70, Hsp90 tends to interact with its clients at later 
and more mature folding stages (Taipale et al., 2010). Targets of Hsp90 are mainly 
transcription factors and protein kinases (Karagöz and Rüdiger, 2015). The binding of 
Hsp70 and Hsp90 to Carboxyl terminus of Hsc70-interacting protein (CHIP) leads to 
unfolded protein degradation (Kundrat and Regan, 2010). Hsp104 promotes damaged 
protein refolding by solubilizing protein aggregates in cooperation with Hsp70 and Hsp40 
(Glover and Lindquist, 1998; Okuda et al., 2015). The sHSPs are usually 12-43kDa and 
are also essential for cell survival under stress due to their chaperone activity and anti-
apoptotic effects (Bakthisaran et al., 2015). HSP26 and HSP42 deletion strains can 
survive under heat shock but displayed a significant cell morphology change and cell wall 
damage (Haslbeck et al., 2004). Furthermore, HSPs, such as Hsp70 and Hsp90, can 
directly interact with HSF1 and repress its activation (Abravaya et al., 1992; Zou et al., 
1998). The feedback mechanism provides an autoregulatory system that controls the 
extent of the HSR.  In S. cerevisiae, HSF1 C-terminal domain deletion has been shown to 
increase cell sensitivity to high temperature. Notably, the growth defect at a high 
temperature can be rescued by treating the cells with an osmotic stabilizer, sorbitol. This 
phenotype is further linked to the interaction between Hsp90 and Slt2, the mitogen-
activated protein kinase (MAPK) required for cell integrity (Truman et al., 2007). 
Moreover, inhibiting Hsp90 led to increased sensitivity to cell wall stressor caspofungin 
in another yeast species Aspergillus fumigatus (Lamoth et al., 2012) These results 
demonstrate the crosstalk between the HSR and the cell wall integrity (CWI) pathway in 
regulating cell survival during stress. 
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Figure 1.3 Model of the heat shock response pathway in S. cerevisiae. 
The HSR is crucial for proteostasis. HSF1 is phosphorylated and forms a trimer 
during stress. Then HSF1 translocates into the nucleus and binds to the HSE of its 
downstream targets to activate transcription. HSPs assist with protein refolding or 
target damaged proteins for degradation through the interaction with CHIP ubiquitin 
ligase. Overexpression of HSPs inhibits HSF1 activation to reduce the level of HSR.   
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1.6 Cell wall integrity  
The yeast cell wall is a layered dynamic structure outside of the cell membrane which 
occupies more than 20% of a yeast cell’s dry weight (Orlean, 1997). The outer layer of 
the yeast cell wall is comprised of glycoproteins protecting the inner layer from wall-
degrading enzymes (Zlotnik et al., 1984), whereas the inner layer is mainly made of 
glucan polymers and chitin that regulate cell wall elasticity and remodeling (Smits et al., 
1999). In S. cerevisiae, the cell wall is critical for budding and cell division, response to 
environmental stress, and cell-cell contact (Cid et al., 1995; Hohmann, 2002; Reynolds 
and Fink, 2001). 
The CWI pathway is a MAPK signaling cascade that maintains cell shape and cell wall 
integrity during various cellular stresses (Levin, 2011). Briefly, cell surface sensor 
proteins transmit stress signals to the Rho1 GTPase, the master regulator of the CWI 
pathway. During stress, Rho1 interacts with Pkc1 and activates the MAPK cascade: Bck1 
(MEKK), Mkk1/2 (MEKs), and Slt2 (MAPK) (Figure 1.4). Deletion of any CWI kinase 
causes cell growth defects at 37 °C and also increases cell sensitivity to cell wall stressors 
and mating pheromone (Gustin et al., 1998; Kirchrath et al., 2000; Martín et al., 2000). 
These results indicate the essential role of the MAPK signaling in regulating cellular 
stress responses. 
Cell surface sensors Wsc1/2/3 and Mid2 located on the plasma membrane recruit Rom1/2, 
the guanine nucleotide exchange factor of Rho1, to activate its GTPase activity. The yeast 
Pkc1 is homologous to the mammalian protein kinase C (Levin et al., 1990). Deletion of 
PKC1 is lethal but cells can grow with the support of sorbitol. The cell walls were found 
to be thinner in the pkc1Δ strain (Roemer et al., 1994). When Pkc1 is activated by Rho1, 
it phosphorylates specific residues of Bck1, leading to the phosphorylation of Mkk1/2 
and Slt2, which is functionally homologous to human ERK5 (Truman et al., 2006). The 
ERK5 signaling is crucial for oxidative stress and environmental stress through regulation 
of the serum and glucocorticoid-induced kinase (SGK) (Chao et al., 1999; Wang and 
Tournier, 2006). Downstream targets of the MAPK cascade include transcription 
regulators Rlm1 and Swi4/6. Rlm1 target genes are involved in cell wall synthesis (Jung 
et al., 2002). Meanwhile, Swi4/6 mainly regulate transcription of genes required for cell 
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G1 to S phase (Harrington and Andrews, 1996). Swi4/6 are also found to activate FKS1/2 
transcription, which encode proteins regulating β-glucan and chitin synthesis (Roemer et 
al., 1994) 
The CWI pathway is shown to be activated during heat shock stress to regulate cell 
survival (Truman et al., 2007). Previous literature indicated that Tra1 is involved in the 
CWI activation. However, the underlying mechanisms are not fully understood (Hoke et 
al., 2008). Thus, it will be interesting to investigate how Tra1 regulates cellular stress 
response to high temperature. Furthermore, high calcium concentration can also activate 
Slt2 phosphorylation (Mizunuma et al., 1998). In parallel with the CWI pathway, Fks2 is 
also regulated by Crz1, a transcription activator controlled by the calcium-calcineurin 
signaling (Stathopoulos and Cyert, 1997). All evidence suggests a connection between 
the CWI pathway and regulation of calcium homeostasis. 
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Figure 1.4 Model of the cell wall integrity pathway in S. cerevisiae.  
The CWI pathway is a MAPK signaling pathway in response to cell wall stress. 
Sensors on the plasma membrane transmit the signal to Rho1 GTPase and activate the 
MAPK Slt2. Downstream targets of Slt2 are transcriptional regulators Swi4/6 and 
Rlm1 which activate the transcription of gene involved in cell wall synthesis and cell 
cycle. Figure modified from Levin, 2005. 
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1.7 Calcium-calcineurin pathway 
Calcium ions play a vital role in cell signal transduction pathways. The regulation of 
calcium is crucial for cell survival, membrane fusion, cytoskeleton organization, and cell 
polarization (Cao et al., 2012; Foskett and Spring, 1985; Portis et al., 1979; Shirayoshi et 
al., 1983). Under normal growth condition, the level of the yeast cytosolic Ca2+ is 
between 50 to 200 nM (Miseta et al., 1999) and maintained stably by pumping Ca2+  into 
vacuoles through a vacuolar calcium ATPase Pmc1. Part of the cytosolic Ca2+ is 
transported into ER and Golgi through Pmr1, a secretory pathway calcium ATPase, 
which also helps pump extra Ca2+ out of the cells (Cunningham and Fink, 1994). 
However, calcium concentration can be abnormally increased resulting from 
environmental changes as well as intracellular stresses such as cell wall stress or ER 
stress (Bonilla et al., 2002; Chen et al., 2012). To maintain calcium homeostasis, the 
calcium-calcineurin pathway is activated (Crabtree, 2001) (Figure 1.5). 
Calcineurin is a highly conserved protein phosphatase in eukaryotes (Aramburu et al., 
2000). Calcineurin is a heterodimeric protein containing a catalytic subunit calcineurin A 
together with a Ca2+ binding and regulatory subunit calcineurin B (Rusnak and Mertz, 
2000). In S. cerevisiae, CNA1 and CNA2 encode calcineurin A, whereas CNB1 encodes 
calcineurin B. Deletion of each component is viable but cells displayed growth defect 
under stress conditions. Double deletion of CNA1 and CNA2	 show increased cell 
sensitivity to mating pheromone (Cyert et al., 1991). Furthermore, deletion of CNB1 
leads to no detectable calcineurin activity, even though Cna1 and Cna2 protein levels 
remain unchanged, indicating that the essential role of subunit B on enzymatic activity 
(Cyert and Thorner, 1992). Under stress conditions, a rapid influx of Ca2+ into the cytosol 
through the high affinity Ca2+ influx system (HACS) and low affinity Ca2+ influx system 
of the plasma membrane is sensed by calmodulin (Muller et al., 2001). External calcium 
ions and calmodulin then bind to calcineurin and activates its phosphatase activity.  
Next, the critical target Crz1, a transcriptional regulator, gets dephosphorylated and 
translocates to the nucleus to activate the transcription of downstream targets including 
PMC1 and PMR1 (Cyert, 2003; Li et al., 2011). The localization of Crz1 is dependent on 
its phosphorylation state. Nuclear import of Crz1 requires binding to Nmd5p. Only 
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dephosphorylated Crz1 can bind to Nmd5p in vitro (Polizotto and Cyert, 2001). 
Moreover, the export to the cytoplasm is achieved by Msn5p that exclusively recognize 
phosphorylated proteins (Boustany and Cyert, 2002). Calcineurin is shown to bind Crz1 
in a PIISIQ sequence and regulates its dephosphorylation (Kim et al., 2003).  
When imported into the nucleus, Crz1 recognizes and binds to the calcineurin-dependent 
response elements (CDRE), a unique 24 bp sequence, within the target gene promoters 
and regulates transcription (Stathopoulos and Cyert, 1997). A genome-wide microarray 
has identified 163 genes which are directly regulated by Crz1, mainly involved in ion 
transport (e.g. PMC1), vesicle transport (e.g. CVT19), cell wall synthesis (e.g. FKS2), 
lipid synthesis (e.g. SUR1), protein degradation (e.g. APG5), and transcription (e.g. RCN1) 
(Cyert, 2003; Yoshimoto et al., 2002). These results suggest the cross-talk between the 
calcineurin signaling and other cellular processes such as plasma membrane synthesis, 
the CWI pathway, and autophagy besides modulating ion homeostasis.  
The calcineurin signaling has been studied as a new target for antifungal drugs through its 
essential role in regulating fungal cell survival and virulence (Karababa et al., 2006; 
Soriani et al., 2008). Thus, it is crucial to understand the cellular mechanisms that 
regulate the calcineurin pathway. Histone acetylation has been linked to the regulation of 
the calcineurin pathway in fungi. Researchers observed that the C. neoformans gcn5Δ 
mutant strain is more sensitive to calcineurin inhibitors (O’Meara et al., 2010). As 
mentioned previously, Tra1 is vital for histone acetylation. Accordingly, a synthetic 
genetic array showed that cells with tra1SRR3413 and cnb1Δ double mutation showed a slow 
growth phenotype (Hoke et al., 2008). Cells carrying a mutant Tra1 allele displayed a 
growth defect under conditions of high calcium, indicating that calcium homeostasis 
pathways are impaired (Berg et al., 2018). These results suggest that functional Tra1 is 
required for the calcium-calcineurin pathway activation. Chapter 6 of my thesis will study 
the role of Tra1 in regulating the calcineurin pathway and the effects on antifungal 
resistance. 
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Figure 1.5 Model of the calcium-calcineurin pathway in S. cerevisiae.  
Calcineurin is activated by the binding of calmodulin and Ca2+. Calcineurin 
dephosphorylates Crz1 which controls its nucleus localization. Crz1 binds to CDRE 
of its target genes and activates transcription of genes involved in the transport of 
calcium. Figure modified from Liu et al., 2015. 
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1.8 Tra1 and cellular stress responses 
The nature of the Tra1 protein and its critical role within the SAGA/NuA4 complexes 
indicate that Tra1 may be involved in the regulation of cellular stress responses. 
Systematic genetic array analysis of tra1SRR3413 identified 114 negative genetic 
interactions where 30 interacting genes directly play a role in stress responses, with some 
genes implicated in stress-related signaling pathways (Hoke et al., 2008). Moreover, Tra1 
incorporation into the SAGA complex requires Tti2, a subunit of the Triple T complex 
responsible for PIKK family protein stabilization (Elias-Villalobos et al., 2019; 
Genereaux et al., 2012). Loss of Tti2 function leads to defect in SAGA-dependent 
transcription that correlates with increased sensitivity to various stresses (Genereaux et al., 
2012; Hoffman et al., 2016). Interestingly, the addition of an osmotic stabilizer sorbitol 
ameliorates the growth defect, suggesting that Tra1 is involved in cell wall function. 
Indeed, proper SAGA function through Gcn5 is required for the cell wall integrity 
transcriptional program (Sanz et al., 2016) and Tra1 mutants are hypersensitive to cell 
wall perturbing agents such as caffeine and calcofluor white (Berg et al., 2018; 
Helmlinger et al., 2011; Hoke et al., 2008; Mutiu et al., 2007). Studies of Tra1 deletions 
in S. pombe showed that Tra1 recruits SAGA to a subset of promoters, mainly controlling 
genes involved in stress response (Helmlinger et al., 2011).  Also, NuA4 was shown to 
directly interact with the stress-induced transcription factors Msn4, supporting a role for 
the complex in the general stress response pathway (Mitchell et al., 2008). The link 
between Tra1 and cellular stress response pathways is summarized in Figure 1.6. 
One of the most characterized roles of Tra1 in the response to stress is its role in the 
activation of the HSR in response to heat shock. The HSR is an evolutionary conserved 
stress response pathway to maintain protein homeostasis. The transcription of genes 
encoding HSPs requires heat shock factor HSF1 as well as co-activators such as SAGA 
(Cotto and Morimoto, 1999; Lindquist, 1986; Vinayachandran et al., 2018; Zanton and 
Pugh, 2004). Acetylation and displacement of histone H3 is observed at the promoters of 
HSPs during heat stress (Erkina and Erkine, 2006). Moreover, a loss-of-function mutation 
within Tra1 leads to growth inhibition at high temperature and in the presence of the cell 
wall perturbing agent (Berg et al., 2018; Hoke et al., 2010; Mutiu et al., 2007).  These 
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phenotypes correlate with a defective activation of the HSR. Similar phenotypes are 
observed in cells carrying a mutant HSF1 (1-583) lacking the C-terminal domain 
(Truman et al., 2007).  In support of a role for Tra1 in Hsf1 function, a physical 
interaction between Hsf1 and Tra1 was observed by mass spectrometry (Breitkreutz et al., 
2010). Moreover, studies in Drosophila found that Hsp70 transcription requires the 
recruitment of Tra1 homolog Nipped-A to its promoter (Lebedeva et al., 2005). In 
mammals, HSP genes are downregulated in TRRAP deficient cells (Herceg et al., 2003). 
Collectively, these results indicate that Tra1 is involved in HSF1-dependent transcription 
of HSP genes across species.  
Dysregulation of Tra1 has been observed in many stress-related diseases which I will 
introduce in the following section. Our recent study reported elevated TRA1 mRNA and 
protein levels in a yeast model of HD (Jiang et al., 2019).  Increased TRRAP expression 
is also observed in a mammalian HD cell line (Kim et al., 2016). Furthermore, TRRAP 
has been described as a potential biomarker of Alzheimer’s disease (AD) and is 
upregulated in hippocampal tissues of AD patients (Ho Kim et al., 2015). TRRAP also 
plays a critical role in cancer. TRRAP was identified to interact with several cancer-
related proteins such as c-Myc, P53, E2F transcription factors, and viral oncoprotein E1A 
(Jethwa et al., 2018; Lang and Hearing, 2003; McMahon et al., 1998). Overall, 
Tra1/TRRAP could be an important modifier of HD and other stress-related diseases 
through its role in regulating cellular stress responses. 
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Figure 1.6 Tra1 and cellular stress response pathways.  
Under stress conditions, cells activated stress response pathways to retain homeostasis. 
The main stress response pathways include in this thesis are the TORC1 signaling 
which regulates cell cycle, autophagy, and ribosome biogenesis; the heat shock 
response, which assists with protein folding and degradation; the cell wall integrity 
pathway that controls cell wall synthesis; and the calcineurin pathway, which 
maintains calcium homeostasis. Tra1 is critical for cellular stress response activations. 
Direct interaction between Tra1 and transcription regulator Sfp1, and HSF1 has been 
reported in yeast. Tra1 mutation leads to increased cell sensitivity to different stressors 
such as cell wall stressor caffeine and extra Ca2+. 
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1.9 Cellular stress responses and human diseases 
Dysregulation of cellular stress responses has been observed in various stress-related 
diseases including neurodegenerative disease, cancer and chemotherapy resistance in 
cancer therapy, and antifungal resistance (Chen and Xie, 2018; Cowen et al., 2014; Kim 
et al., 2015; Leak, 2014; Liu et al., 2017). Insufficient cellular stress responses can lead to 
impaired protein homeostasis and defects in multiple cell functions. In contrast, hyper-
activated stress responses result in drug resistance and limit disease treatments. Therefore, 
investigating the mechanisms of cellular stress responses is crucial for understanding 
pathological mechanisms and developing target-specific therapies. My thesis focuses on 
the regulation of cellular stress responses in HD and antifungal resistance, which I will 
describe in the following sections. 
 Cellular stress responses in neurodegeneration and cancer 
A hallmark of neurodegenerative diseases is protein misfolding (Soto and Estrada, 2008; 
Sweeney et al., 2017). Upon accumulation of misfolded proteins, neurons require 
increased activity of molecular chaperones, mainly heat shock proteins, to cope with the 
protein misfolding defect. In Alzheimer's disease (AD), Hsp70 and Hsp90 overexpression 
have been shown to inhibit Aβ formation and ameliorate disease phenotypes (Luo and Le, 
2010; Sun et al., 2017). Impaired HSR has been shown in Parkinson’s disease (PD) and 
HD, which may explain the mechanism of amyloid-like aggregations formed in neurons 
and the toxicity. For example, Hsp70 levels are decreased in Parkinson’s disease brain 
sample, suggesting the reduced HSR activation (Alvarez-Erviti et al., 2010). Moreover, 
due to the high demand for oxygen, the brain is especially vulnerable to the accumulation 
of reactive oxygen species (ROS) and oxidative stress. Increased oxidative stress has 
been found in different neurodegenerative disorders that may cause DNA damage and 
mitochondria dysregulation (Wang and Patterson, 2015). Literature has reported Aβ-
induced oxidative stress in AD (Wang et al., 2014). Oxidative imbalance was also shown 
to appear at early stage of AD, which could be a leading cause of the disease (Butterfield 
et al., 2006). Dysregulation of complex I of the respiratory chain and increased ROS 
accumulation has also been observed in PD (Blesa et al., 2015). Overall, impaired cellular 
stress responses contribute to neurodegenerative disease pathology and could be potential 
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therapeutic targets for drug development. Indeed, several drugs targeting the HSP 
proteins or oxidants have been screened for the treatment of AD and PD (Repalli and 
Meruelo, 2015; Wojsiat et al., 2018). 
Many studies have reported the role of cellular stress responses, especially the HSR, in 
cancer development. HSF1 overexpression is observed in a variety of cancer types 
(Santagata et al., 2011). It was shown that activation of HSF1 helps maintain the cellular 
malignant phenotypes by increasing resistance to apoptosis (Mendillo et al., 2012; Meng 
et al., 2010). The HSPs were also shown to promote tumorigenesis and cancer cell 
survival by stabilizing oncoprotein mutant p53 and regulating glycolysis (Dai and 
Whitesell, 2005; Zhao et al., 2009). Furthermore, activation of the HSR has been linked 
to resistance to chemotherapy. Increased expression of HSPs correlated with increased 
drug resistance in breast cancer (Vargas-Roig et al., 1998). Importantly, the HSR plays a 
critical role in tumor metastasis. Epithelial-mesenchymal transition (EMT) was reduced 
when knocking down HSF1 in the ovarian cancer spheroids (Powell et al., 2016). 
Furthermore, expression of Hsp10 was found in ascites of ovarian cancer patients which 
could be involved in T-lymphocyte inhibition (Akyol et al., 2006). High expression of 
Hsp70 correlates with the aggressiveness of ovarian cancer and leads to poor overall 
survival (Elstrand et al., 2009). Activation of the HSR provides tumor cells with a 
cytoprotective effect to survive in the anoxic, acidotic, and nutrient-deprived 
microenvironment. These results delineate the critical role of the HSR in tumor survival 
and metastasis, further emphasize the potential to target this pathway for cancer therapy. 
As such, HSF1 and HSPs have been studied as targets for drugs and immunotherapy in 
cancer treatment. One exciting result showing that inhibiting Hsp90 with a geldanamycin 
analog 17AAG43 benefits multiple cancer types in clinical trials (Wang et al., 2016; 
Workman, 2002).  
 Impaired heat shock response in Huntington’s disease 
Huntington’s disease (HD) is an autosomal recessive neurodegenerative disorder 
associated with mutations in a gene encoding the Huntingtin protein (Htt) (Whalley, 
2015). The cause of HD is an abnormal increase of polyglutamine repeats (polyQ) within 
a region of Htt encoded by the first exon of HTT (Httex1) (Gusella and MacDonald, 2009). 
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Normally, the HTT gene encodes less than 35 CAG repeats. However, an increased 
number of polyQ leads to the appearance of HD symptoms in patients, such as chorea, 
cognitive loss, involuntary movements, and diminished coordination (Roos, 2010). The 
disease is inherited, and the length of polyQ repeats can increase over consecutive 
generations. Physical symptoms usually occur at around 40 years of age. However, a 
higher number of CAG repeats leads to a juvenile HD in which symptoms start before the 
age of 20 (Ghosh and Tabrizi, 2015). 
At the cellular level, increased PolyQ expansions cause the Htt protein to incorrectly fold, 
and aggregate into cytoplasmic, non-soluble, amyloid-like fibrils termed inclusion bodies 
(IB) (Arrasate and Finkbeiner, 2012). While most studies focus on how polyQ toxicity 
leads to neuronal cell death, the effects at early time points have not been well established. 
A series of cellular processes have been found to be impaired in HD, including 
dysfunctional ER stress response, protein degradation pathways, transcription activation, 
mitochondrial activity, and calcium signaling (Duennwald and Lindquist, 2008; Jiang et 
al., 2016; Kumar et al., 2014; Papsdorf et al., 2015). Thus, expression of mutant Htt 
impairs normal cellular functions, especially the ability of cells to properly regulate stress 
response pathways. 
The principal regulator of proteostasis, the HSR, is impaired during polyQ expansion. 
Reduced HSF1 activation and HSPs expression were observed in striatal cells expressing 
full-length polyQ-expanded Htt and HD knock-in mice (Chafekar and Duennwald, 2012). 
Overexpressing Hsp26, Hsp42, and Hsp104 attenuated polyQ toxicity in the yeast HD 
model (Cashikar et al., 2005). To study the mechanisms by which polyQ expansions 
affect the HSR, a chromatin immunoprecipitation sequencing (ChIP-Seq) assay was 
performed to identify changes in HSF1 targets during expanded polyQ expression. About 
30% of genes binding to HSF1 during heat shock lost the interaction in the presence of 
polyQ. Surprisingly, genes identified were not enriched in classical HSF1 targets but 
involved in other functions such as GTPase regulation, cytoskeleton remodeling, focal 
adhesion, and cell proliferation (Riva et al., 2012). These results suggest that polyQ may 
also impair non-canonical HSR targets.  
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Compounds that induce HSR activation have shown therapeutic effects against HD. 
Treating PC12 cells expressing 81Q with celastrol, which upregulates HSPs, significantly 
reduced the neuronal death rate. Another drug, geldanamycin, which can activate the 
HSR, was shown to inhibit Htt aggregation in COS-1 cell line (Sittler et al., 2001). 
Furthermore, a study in an HD mice model demonstrated that the beneficial effects of the 
HSR activation were transient and diminished during disease progression (Labbadia et al., 
2011). The same study also found that the impairment may result from histone H4 
hypoacetylation which reduces chromatin accessibility and ability of HSF1 to bind to the 
HSP promoters. This result further links impaired the HSR in HD to histone acetylation. 
In the fifth chapter of my thesis, I will study the role of Tra1 in regulating the HSR in the 
presence of toxic polyQ. Investigating how polyQ expansions impair the HSR will 
provide us a better insight into the molecular pathogenesis of HD and help identify 
potential therapeutic targets. 
 Cellular stress responses in antifungal resistance 
The ability for fungi to survive and adapt to a variety of environmental stressors is 
formidable. Nowadays, fungal infection has become a huge problem for human health. 
Around 20 to 25% of the world’s population has skin fungal infections (Havlickova et al., 
2008). Due to the lack of understanding of fungal stress responses, the development of 
effective and target-specific antifungal reagents is still challenging. Approximately 300 
fungal species have been found to be pathogenic to humans (Casadevall, 
2018). Candida, Aspergillus, Pneumocystis, and Cryptococcus are the most common 
fungi that have been found to cause human diseases such as chronic skin infections 
including athlete’s foot and ringworm. Severe infection may cause death especially in 
people with immune diseases (Brown et al., 2012; Johnson, 2018). The widely used 
antifungal drugs are mainly azoles, polyenes, and echinocandins. Azoles and polyenes 
target ergosterol that leads to plasma membrane defects in fungi. Echinocandins 
(caspofungin and anidulafungin), on the other hand, blocks the synthesis of β(1,3)-d-
glucan, a major component of the fungal cell wall (Groll et al., 1998; Kathiravan et al., 
2012). The mechanisms of action of common antifungal agents are shown in figure 1.7. 
Resistance to common drugs has been observed in many fungal pathogens, specifically 
27 
 
among Candida species. Patients also suffer from strong side effects (Cowen, 2008; 
Cowen et al., 2014). Therefore, it is crucial to understand the mechanism of antifungal 
resistance and identify new targets for fungal infection therapy.  
The cell wall is a promising target in the study of antifungal drugs for many reasons. First, 
cell walls are unique structures in fungi so targeting cell wall synthesis can avoid side 
effects to human and animal host cells. Furthermore, as mentioned previously, cell wall 
integrity is vital for fungi survival under stress conditions (Levin, 2005). Thus, the CWI 
pathway may be a novel target for killing the fungal pathogens. Mutant Aspergillus 
strains with defects in the cell wall have shown reduced virulence in mouse infection 
models (Valiante et al., 2015). Moreover, AfMKK2 deletion leads to increased sensitivity 
to antifungals (Dirr et al., 2010). In Candida albicans, mutations in CaCAS5, a 
transcriptional regulator of CWI targets, made cells more sensitive to caspofungin (Bruno 
et al., 2006). These findings suggest that the CWI pathway is critical for fungal virulence 
and antifungal resistance. Since Tra1 may be required for the CWI pathway activation 
(Berg et al., 2018), it could be a potential target for antifungal drug development.  
Another cellular stress response pathway that has been found relevant to pathogen 
virulence and drug resistance is the calcineurin pathway. Calcineurin is vital for fungal 
virulence and survival in the host environment. A cna1 mutation Cryptococcus 
neoformans strain is viable but cannot survive at 37 °C or alkaline pH and is not toxic in 
a rabbit model (Odom et al., 1997). Reduced virulence of C. albicans carrying a 
calcineurin mutation was also seen in a mouse model of systemic infection (Blankenship 
et al., 2003). Furthermore, calcineurin inhibitors FK506 and cyclosporine A and their 
analogs have been shown to have protective effects against fungal infections (Lee et al., 
2018; Pandit, 2003). Treatment with a calcium channel blocker amlodipine, in 
combination with fluconazole, caused significant cell death in fluconazole-resistant C. 
albicans strain (Liu et al., 2016). All the evidence indicates that the calcineurin pathway 
is critical for antifungal resistance. To further study the mechanism, whole proteomic 
analyses were performed in the well-studied S. cerevisiae to identify calcineurin targets. 
Seventy candidates were found to interact with the calcineurin signaling pathway, 
involved in membrane structure, polarized growth, protein trafficking, and cell wall 
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integrity (Goldman et al., 2014), indicating the multifunctional role of calcineurin in 
regulating fungal survival. As previously demonstrated, Tra1 has been linked to 
calcineurin signaling regulation. Therefore, I will study the mechanisms on how Tra1 
regulates the calcineurin pathway activation and its role in antifungal resistance. 
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Figure 1.7 Mechanism of action of common antifungal agents.  
Azoles inhibit the cytochrome P450 dependent enzyme lanosterol 14α-demethylase, 
which interrupt the synthesis of ergosterol, the main sterol in fungal cell membrane. 
Polyenes bind to ergosterol, leading to membrane depolarization and leakage of 
intracellular cations. Echinocandins inhibit β(1,3)-d-glucan synthesis and cause cell 
wall defect. Calcineurin inhibitors which suppress calcineurin activation also prevent 
fungal infections. Figure modified from Alzohairy et al., 2014. 
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1.10 Fluorescent-tagged yeast model of Huntington’s 
Disease 
The baker's yeast S. cerevisiae has been widely studied as a model for neurodegeneration 
such as AD, PD, ALS, and HD (Bharadwaj et al., 2010; Fushimi et al., 2011; Outeiro and 
Lindquist, 2003). Although there is no HTT ortholog in the yeast genome, expressing the 
first 17 amino acids of Httex1 followed by different length of polyQ repeat sequences 
successfully mimic the toxic phenotype and protein aggregation observed in mammalian 
models of HD (Duennwald, 2011; Krobitsch and Lindquist, 2000). Several CAA codons 
are interrupted into the CAG repeats to prevent the expansion and contraction of the 
accurate number of polyQ repeats. Removal of the proline-rich region and adding a 
FLAG-tag is also required for polyQ toxicity in the yeast model (Duennwald et al., 2006). 
Furthermore, our study demonstrated that different fluorescent tag can also differentially 
affect polyQ toxicity and aggregation morphology in yeast (Jiang et al., 2017). A series of 
cellular phenotypes have been reported using the yeast model of HD, including 
transcriptional dysregulation, ER stress and ER-associated degradation defects, vesicle 
trafficking defects, and impaired mitochondrial function (Duennwald and Lindquist, 2008; 
Kumar et al., 2014; Nath et al., 2015; Quintanilla and Johnson, 2009). Overall, yeast 
provides us with an excellent model to investigate cellular mechanisms in misfolded 
protein stress responses and understand polyQ toxicity in HD.  
 Yeast model used in this thesis 
The yeast model of HD used in this thesis is optimized from previous studies (Duennwald 
and Lindquist, 2008; Krobitsch and Lindquist, 2000). Strains used in this thesis are 
derivatives of W303a or BY4741/4742. Briefly, the polyQ high expression model uses 
the human Httex1 fragment carrying non-pathological 25Q or HD-associated 46Q/72Q 
expansion regions designed under a GAL promoter, and tagged with a yeast optimized 
fluorescent protein (FP). The high expression model mimics the toxic polyQ condition. 
Cells show an obvious growth defect when 72Q is induced by switching the carbon 
source from glucose to galactose. Aggregation is observed in cells expressing 46Q and 
72Q. The polyQ low expression strain uses the human Httex1 fragment with 25Q/103Q 
regions designed under a MET25 promoter. Cells display little growth defect when 
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induced in synthetic complete media lacking methionine in standard growth condition. 
The model successfully mimics the cellular mechanisms of HD at early time points 
before neuronal cell death which provides us a good tool to investigate the underlying 
mechanisms to cope with mutant Htt accumulation and polyQ toxicity under stress 
conditions.  
 Flanking sequence affects polyQ toxicity in yeast 
Previous literature reported that the endogenous C-terminal polyproline region of Httex1 
has profound effects on polyQ toxicity in yeast (Duennwald et al., 2006). PolyQ toxicity 
requires the deletion of the proline-rich region. In the presence of the proline-rich region, 
polyQ only formed one or two tight fluorescent foci, whereas they displayed multiple 
aggregates throughout the cytosol without the proline-rich sequence. The large aggregate 
formed by mutant Htt containing proline-rich region was found to co-localize with 
aggresome markers (Wang et al., 2009). Chaperones can be recruited to aggresomes to 
help with protein refolding and degradation. Autophagy was found to facilitate 
aggresome degradation (Johnston et al., 1998). Thus, the proline-rich sequence may 
direct Htt into the aggresome to prevent misfolding. Furthermore, many proteins have 
been found to interact with proline-rich regions including molecular chaperones and 
protein remodeling proteins (Kay et al., 2000), so the mechanism may involve the 
recruitment of chaperone proteins that need further investigations. On the other hand, a 
FLAG-tag (DYKDDDDK) is critical for mutant Htt toxicity. The hypothesized 
mechanism is that FLAG-tag mimics the sumoylation of polyQ proteins because SUMO 
proteins are also enriched in negative charged amino acid at the C-terminus. And polyQ 
sumoylation has been shown to enhance its toxicity (Steffan et al., 2004). 
Previous studies including ours, suggested that the fluorescent tag can alter polyQ 
toxicity and aggregation (Duennwald et al., 2006; Jiang et al., 2017). Tagging polyQ with 
mCherry and TagBFP significantly reduce its toxicity in yeast. The full results are shown 
in chapter two and three of this thesis. Since the first fluorescent protein (FP), wild-type 
green fluorescent protein (GFP) discovered in Aequorea Victoria jellyfish, was used to 
highlight sensory neurons in C.elegans (Tsien, 1998), FPs have become a powerful tool 
in the molecular toolbox in studying protein localization, function, and interactions. A 
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series of modified FPs which are brighter, exhibit enhanced photostability and cover a 
broader spectral range have come out and provided scientists with better choices in 
monitoring different proteins and cellular structures(Chudakov et al., 2010). For instance, 
a yeast GFP clone integrated into the yeast chromosome has been made to obtain a better 
result when labelling proteins in yeast (Niedenthal et al., 1996).  
The most commonly used FPs are enhanced version of wild-type GFP (EGFP) as well as 
the original blue (BFP), cyan (CFP) or yellow (YFP) derivatives. Another group is the 
red fluorescent proteins (RFP) cloned from corals which have a longer excitation 
wavelength. However, choosing which fluorescent tag to use must consider different 
experimental conditions and the misfolding of the fusion proteins. Different FPs have 
different structures and thus chromophores. The GFP family has a barrel structure where 
an alpha-helix runs through eleven beta-sheets (Evdokimov et al., 2006; Henderson and 
Remington, 2005). The GFP-like chromophore in Aequorea victoria GFP is achieved by 
cyclization at positions 65–67 (Ser-Tyr-Gly) (Barondeau et al., 2003). Although RFPs 
have a similar structure with GFP, the post-translational modification is diverse. For 
example, the bond between the alpha-carbon and nitrogen of 66 Gln in DsRed is 
dehydrogenated, which extends the GFP chromophore by forming C==N==C==O at the 
2-position of the imidazolidinone (Gross et al., 2000; Yarbrough et al., 2001). FPs usually 
have a tendency to oligomerize, which can interfere with their fusion partners (Loening et 
al., 2007; Wall et al., 2000). Through mutation studies and protein engineering techniques, 
better FPs have been developed (Table 1.1). However, it also raises the question on which 
FPs to use and how to assess their impact on targeted proteins. Most assays available 
were performed in vitro or not suitable for large-scale analysis. Therefore, a rapid and 
high-throughput assay is imperative to assess the impact of FPs on their fusion partners. 
Overall, the ideal FP would have sufficient photostability and brightness to provide a 
detectable signal (Shaner et al., 2005). In addition, using monomeric versions of FPs 
could avoid aberrant oligomerization and toxicity (Campbell et al., 2002). Erik Snapp and 
his group have developed an array of monomeric oxidizing environment-optimized FPs 
(moxFPs). These moxFPs could avoid non-native disulphide bond formation between 
cysteine residue, providing a brighter signal and more accurate protein localization of ER 
and secretory proteins (Costantini et al., 2015). It also needs to be noted that FPs must 
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have minimal crosstalk in excitation and emission channels during multiple-labelling 
experiments (Lata et al., 2006).  
Using modern FPs, we are able to optimize the previous yeast model of HD as a 
compelling tool to study cellular functions during polyQ expansion through fluorescence 
microscopy techniques. Furthermore, the yeast polyQ model provides researchers a high 
throughput tool for assessing the impact of FPs on their target in vivo.   
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  Table 1.1 Modern fluorescent proteins 
 
 
FPs Origin Peak 
Excitation 
Advantages Oligomerization Reference 
sfGFP Aequorea 
Victoria 
GFP 
485nm High folding 
efficiency 
Monomer (Pédelacq et al., 
2006) 
NeonGreen B. 
lanceolatum 
LanYFP 
506nm Bright, 
monomeric 
Monomer (Shaner et al., 
2013) 
mCherry Discosoma 
DsRed 
587nm High 
photostability 
Monomer (Shaner et al., 
2004) 
mScarlet Synthetic 569nm Truly 
monomeric 
Monomer (Bindels et al., 
2017) 
FusionRed Entacmaea 
quadricolor 
sea anemone 
RFP 
580nm Low toxicity 
in vivo 
Monomer (Shemiakina et 
al., 2012) 
TagBFP2 Entacmaea 
quadricolor 
sea anemone 
RFP 
399nm high pH 
stability, fast 
chromophore 
formation 
Oligomer (Subach et al., 
2011) 
moxBFP Aequorea 
Victoria 
GFP 
385nm Optimized 
for oxidizing 
environments 
Monomer (Costantini et al., 
2015) 
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1.11 Objectives and hypothesis 
Cellular stress responses are crucial for cell survival and growth under stress conditions. 
Dysregulation of cellular stress responses is linked to different diseases including 
inflammation (Muralidharan and Mandrekar, 2013), cancer (Herr and Debatin, 2001), 
neurodegenerative diseases (Chafekar and Duennwald, 2012; Puspita et al., 2017), and 
fungal infections (Brown et al., 2014). The activation of stress response pathways 
requires the transcription of stress-induced genes encoding molecular chaperones, 
metabolic enzymes, and proteins involved in biomass synthesis (Estruch, 2000). However, 
the transcriptional regulations of cellular stress responses, especially the roles of 
transcription coactivators and post-translational modifications of histones, remain elusive. 
Available high throughput approaches and comparative genomics to human make S. 
cerevisiae an excellent model to study the activation of cellular stress response pathways. 
The transcriptional co-activator Tra1 within the SAGA and NuA4 HAT complexes has 
been found to be critical during cell stress (Hoke et al., 2008). How Tra1 regulates 
cellular stress responses and its implication in stress-related diseases is poorly understood. 
Therefore, my thesis investigates Tra1-dependent regulation of stress response pathways 
in a yeast model of HD, determining its role in cellular stress responses such as the 
TORC1 pathway, the HSR, and the CWI pathway, as well as their implications for 
antifungal drug resistance.  
My overall hypothesis is that Tra1 is a key regulator of cellular stress responses 
through its role in the SAGA acetyltransferase complex, activating transcription, and 
represents a potential therapeutic target for stress-related human diseases such as 
Huntington’s Disease and fungal infections.   
 Chapter 2. Polyglutamine toxicity in yeast uncovers 
phenotypic variations between different fluorescent protein 
fusions. 
Rationale: Flanking sequences could alter polyQ toxicity in yeast (Duennwald et al., 
2006). FPs differ in their physical properties and can affect protein function of their 
fusion partners. Therefore, we provide a novel series of vectors based on the latest yeast-
optimized FPs for efficient investigation of polyQ toxicity in yeast. Furthermore, there 
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are no rapid and high throughput methods available to assess the effects of FPs on their 
fusion partners. We may be able to develop an efficient assay to evaluate new FPs using 
the yeast model of HD.   
Hypothesis: Different FPs alter the polyQ aggregation morphology and toxicity. The 
yeast polyQ model is an ideal in vivo tool to assess the impact of fluorescent tags, 
especially on naturally oligomeric or misfolded proteins. 
 Chapter 3. Polyglutamine toxicity assays highlight the 
advantages of mScarlet for imaging in Saccharomyces 
cerevisiae. 
Rationale: RFPs are the most popular alternatives to GFP in fluorescent imaging. 
Different monomeric versions of RFP have been developed over the years that provide a 
stable and robust signal. Observed from our polyQ yeast model, unlike what is reported 
for green FP variants, yemRFP tagged polyQ expansions show reduced toxicity and a 
different pattern of aggregates (Jiang et al., 2017). Thus, it is crucial to test the effect of 
two latest versions of RFP, mScarlet, and FusionRed, on their binding partners using the 
method we developed.  
Hypothesis: The ymScarlet has significant advantages over the previous generation of 
red FPs for use in fluorescent fusions in yeast. 
 Chapter 4. Sfp1 links TORC1 and cell growth regulation to 
the yeast SAGA-complex component Tra1 in response to 
polyQ proteotoxicity. 
Rationale: Acetylation of histones has been shown to be impaired by polyQ expansions 
in different HD models (Gray, 2011; Steffan et al., 2001). Tra1 is an essential component 
of both the SAGA and NuA4 HAT complexes. Our preliminary data showed that Tra1 
mutant cells are more sensitive to polyQ toxicity. Moreover, previous papers have shown 
the interaction between Tra1 and Sfp1, linking the regulation of Tra1 to TORC1 pathway 
and cell growth (Lempiäinen et al., 2009). Importantly, Tra1 is considered functionally 
equivalent to TRRAP in mammals and TRRAP was identified as a cofactor for c-Myc in 
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regulating oncogenic transformation (McMahon et al., 1998). Thus, the results may 
indicate a novel pathway impaired by polyQ in HD. 
Hypothesis: PolyQ impairs Tra1 signaling through dysregulation of the TORC1/Sfp1 
pathway, leading to defect in SAGA HAT complex and transcription activation. 
 Chapter 5. Impaired Tra1-dependent transcription during 
heat shock in the presence of polyQ expansions 
Rationale: Impaired HSR by expanded polyQ expression has been found in both yeast 
and mammalian system (Chafekar and Duennwald, 2012). Importantly, upon exposure to 
stress, neuronal cells accumulate damaged proteins and lack a fully functional 
proteostasis network to cope with this damage. Therefore, the impaired protein 
homeostasis may lead to dysfunction of multiple cellular functions and reveal the 
pathological hallmarks of HD and other neurodegenerative diseases.   
Hypothesis: Heat shock sensitivity of cells expressing polyQ expansions can be traced 
back to the defect of Tra1/SAGA which regulates the activation of the heat shock 
response and the cell wall integrity pathway. 
 Chapter 6. Tra1 is a novel potential target for antifungal 
therapy.  
Rationale: The calcineurin pathway regulates cell growth and drug resistance in many 
fungal pathogens (Juvvadi et al., 2014; Liu et al., 2015). Our preliminary data suggest 
that Tra1 plays a vital role in regulating calcineurin signaling and cell sensitivity to 
antifungal drugs. Thus, Tra1 could be a new target for antifungal drug development.     
Hypothesis: Tra1 mediates cell growth and antifungal drug resistance through the 
activation of the calcium-calcineurin pathway in yeast. 
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Chapter 2  
2 Polyglutamine toxicity in yeast uncovers phenotypic 
variations between different fluorescent protein fusions 
Fluorescent proteins (FPs) have revolutionized the work of scientists by allowing the 
direct visualization of protein trafficking and localization in living cells. However, FPs 
are too often seen as interchangeable building blocks than can be easily swapped to 
accommodate a specific imaging condition. In this study, we will monitor polyQ toxicity 
and aggregation in a yeast model of HD to highlight the differential impact of the most 
common FPs on the behavior of fluorescent reporters. 
2.1 Abstract 
The palette of fluorescent proteins (FPs) available for live-cell imaging contains proteins 
that strongly differ in their biophysical properties. FPs cannot be assumed to be 
equivalent and in certain cases could significantly perturb the behavior of fluorescent 
reporters. We employed Saccharomyces cerevisiae to comprehensively study the impact 
of FPs on the toxicity of polyglutamine (polyQ) expansion proteins associated with 
Huntington's disease. The toxicity of polyQ fusion constructs is highly dependent on the 
sequences flanking the polyQ repeats. Thus, they represent a powerful tool to study the 
impact of fluorescent fusion partners. We observed significant differences on polyQ 
aggregation and toxicity between commonly used FPs.  We generated a novel series of 
vectors with latest yeast-optimized FPs for investigation of Htt toxicity, including a 
newly optimized blue FP for expression in yeast. Our study highlights the importance of 
carefully choosing the optimal FPs when designing tagging strategies. 
2.2 Introduction 
The ability to visualize protein localization in living cells or whole organisms has been 
the driving force behind a myriad of new technological innovations in fluorescence 
microscopy that revolutionized our ability to address many biological problems (Betzig, 
2015; Sengupta et al., 2014). The engineering of the green fluorescent protein (GFP) 
reporter (Chalfie et al., 1994) paved the way for the subsequent discovery and 
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optimization of other fluorescent genetically encoded reporters that can be employed to 
tag native proteins. Since the pioneer work on GFP, several other FPs have been 
characterized, covering the whole ensemble of the light spectrum, from the ultraviolet to 
the far red (Miyawaki et al., 2012; Morozova et al., 2010; Rizzo et al., 2009; Shaner et al., 
2004; Shaner et al., 2007; Shaner et al., 2013). FPs vary extensively in their physical 
features beyond just their spectral properties. These properties can include brightness, 
photostability, maturation time, oligomeric state (monomers, dimers, multimers) and 
folding capacity (Suzuki et al., 2012). While these reporter proteins have been 
instrumental in several discoveries, the addition of a fluorescent tag can disrupt the 
normal function of the protein of interest (Han et al., 2015). First, not all FPs are equally 
suitable for every cellular compartment. For example, when using fluorescent fusion 
proteins that enter the oxidizing environment of the endoplasmic reticulum, one should 
avoid FP containing internal cysteines that may cause creation of aberrant, non-native 
disulfide bond resulting in formation of misfolded and non-fluorescent FP oligomers 
(Aronson et al., 2011; Costantini and Snapp, 2013; Costantini et al., 2013; Costantini et 
al., 2015). Accumulation of a significant pool of such dark misfolded oligomers can not 
only lead to a significant underestimation of protein concentrations, but also cause 
unwanted protein interactions, especially with the cellular protein quality control 
machinery (Aronson et al., 2011). Second, all FPs originally isolated from either corals or 
jellyfish exist as oligomers in their environment of origin. For example, GFP forms a 
complex with aequorin and the original DsRed is a tetramer.  Original studies have shown 
that GFP can form dimers in crystals (Yang et al., 1996) and when present at high 
concentration in solution (Phillips, 1997). Therefore, efforts were directed into improving 
the monomeric status of FPs. Discovery of mutations that improve the monomeric nature 
of GFP (Zacharias et al., 2002) and DsRed (Shaner et al., 2004) paved the way for 
improvement of the fluorescent protein technology. The tendency of several FPs to 
oligomerize has been shown to artificially lead to cellular membrane reorganization 
(Costantini et al., 2012; Snapp et al., 2003). Moreover, several studies have shown that 
FPs originally characterized as monomers were prone to aberrant protein interactions 
(Costantini et al., 2012; Costantini et al., 2015; Lam et al., 2012; Shemiakina et al., 2012). 
It was recently shown that the choice of a specific FP can significantly alter the behavior 
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of tandem fluorescent protein timers used to measure protein turnover in living cells 
(Khmelinskii et al., 2016).  The behavior of FP’s can also be potentially affected by 
several other factors such as pH and other physical properties (Patterson et al., 1997) and 
the size of the linker domain between the fusion partners (Chen et al., 2013). Thus, when 
designing strategies to produce FP-tagged proteins, the choice of a specific FP is crucial 
in order to minimize the effect on native protein and thus obtain optimal experimental 
conditions reflecting untampered functions and properties of the native proteins (Snapp, 
2009). 
Aberrant expansion of polyglutamine (polyQ) repeats within disease-causing proteins is 
at the root of several human neurodegenerative pathologies including Huntington’s 
disease (HD) (Macdonald, 1993). In HD, expansion of the polyQ region (typically over 
36 repeats) within the N-terminal region of the first exon of the Huntingtin protein (Httex1) 
results in its misfolding and increased aggregation into detergent-insoluble, amyloid-like 
inclusion bodies (IBs) (Gövert and Schneider, 2013). Several studies showed that polyQ 
proteins assembly into toxic intermediate oligomers that preceded accumulation of IBs 
represent the most toxic species of the protein which may be associated to HD 
pathogenesis (Arrasate et al., 2004; Herrera et al., 2011; Lajoie and Snapp, 2010; Leitman 
et al., 2013; Takahashi et al., 2007). Thus, understanding the parameters regulating polyQ 
oligomer formation is critical to our understanding of HD.  In order to decipher these 
mechanisms, a yeast model of HD was developed (Duennwald, 2013; Krobitsch and 
Lindquist, 2000; Mason and Giorgini, 2011; Meriin et al., 2002), allowing rapid and 
extensive dissection of the genetic mechanisms underlying polyQ aggregation and 
toxicity. Over the years, the yeast model of HD has led researchers to identify several 
determinants of toxicity in HD, from chaperone proteins that assist protein folding 
(Muchowski et al., 2000; Sakahira et al., 2002; Schaffar et al., 2004), to activation of 
endoplasmic reticulum stress pathways (Duennwald and Lindquist, 2008), that were 
subsequently validated in other models.  
In most cases, assessment of polyQ aggregation and toxicity is performed using a 
fluorescent fusion protein consisting of Httex1 fused to fluorescent proteins at the C-
terminus following the polyQ repeats (Duennwald, 2013; Duennwald et al., 2006a; 
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Duennwald et al., 2006b; Meriin et al., 2002). Based on the aforementioned ability of 
fluorescent proteins to affect the behavior of the protein of interest, we hypothesized that 
various fluorescent proteins could differentially affect the aggregation of toxic 
polyglutamine expansion (polyQ). For example, the tendency of certain FPs to 
oligomerize could lead to changes in the ability of expanded polyQ proteins to achieve or 
maintain their toxic conformation. This assumption was supported by previous studies 
showing that the sequences flanking polyQ proteins can alter their ability to oligomerize 
into the SDS-insoluble toxic IBs characteristic of HD (Duennwald et al., 2006a).  
2.3 Materials and Methods 
 Yeast strains and culture conditions 
All strains are derived from W303 Mat a (Thomas and Rothstein, 1989). In order to 
assess polyQ protein aggregation and toxicity, cells expressing the different plasmids 
were grown overnight in synthetic complete media using appropriate selection media to 
maintain plasmids. Cells were then washed twice with media containing 2% galactose 
and resuspended to OD600nm 0.2 and incubated at 30oC in a rotator drum for the indicated 
amounts of time to induce polyQ expression. Spot assays were performed by spotting 5X 
dilutions of OD600nm 0.2 on agar plates. Plates were photographed using a GelDoc system 
(Bio-Rad Laboratories) Liquid growth assays were performed using a Bioscreen C 
(Growth Curves USA, Piscataway, NJ) plate reader set at 30oC.  
 Plasmids 
The original 25 and 72Q-CFP lacking the proline rich sequence (ΔPRO) vector were 
previously described (Duennwald et al., 2006b; Duennwald et al., 2006a). To generate the 
construct without the FP we introduced a stop codon downstream of the polyQ region. 
All new vectors were generated by cloning the GAL-polyQ-ΔPRO fragment into the 
SacI/SpeI sites of pRS415. The various new fluorescent proteins were subsequently 
cloned into the SpeI/SalI sites. All fragments were generated using standard PCR 
methods. The yemsfGFP vector was obtained from Erik Snapp (Albert Einstein College 
of Medicine) and a monomerizing mutation (V206K) was inserted using site directed 
mutagenesis. ymNeonGreen (Shaner et al., 2013) was obtained from Allelebiotech (San 
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Diego CA). yemRFP was from Neta Dean (Keppler-Ross et al., 2008). yomTagBFP2 
(#44899) was obtained from Addgene and previously characterized (Lee et al., 2013). 
ymoxBFP was synthetized by Genscript (Piscataway, NJ) based on the moxBFP 
sequence previously published (Costantini et al., 2015). All constructs were validated by 
sequencing and are listed in Table 2.1. All primer sequences can be found in Table 2.2. 
 
  
74 
 
 
  Table 2.1 Plasmids used in this study 
 
Plasmids  Number Vector 
Backbone 
Resistance Reference 
GAL-FLAG-25QΔPRO-CFP pPL001 pRS415 
(CEN/ARS) 
Leu+ This study 
GAL-FLAG-72QΔPRO-CFP pPL002 
GAL-FLAG-25QΔPRO pPL003 
GAL-FLAG-72QΔPRO pPL004 
GAL-FLAG-25QΔPRO-ymsfGFP pPL005 
GAL-FLAG-72QΔPRO-ymsfGFP pPL006 
GAL-FLAG-25QΔPRO-yemRFP pPL007 
GAL-FLAG-72QΔPRO-yemRFP pPL008 
GAL-FLAG-25QΔPRO-
ymNeonGreen 
pPL009 
GAL-FLAG-72QΔPRO-
ymNeonGreen 
pPL010 
GAL-FLAG-25QΔPRO-
yomTagBFP2 
pPL011 
GAL-FLAG-72QΔPRO-
yomTagBFP2 
pPL012 
GAL-FLAG-25QΔPRO-ymoxBFP pPL013 
GAL-FLAG-72QΔPRO-ymoxBFP 
GAL-FLAG-103Q ΔPRO-
yomTagBFP2 
GPD-yomTagBFP2 
GPD-ymoxBFP 
pPL014 
pPL015 
pPL016 
pPL017 
GPD-FLAG-103Q+PRO-GFP 
 
- pRS416 
(CEN/ARS) 
Ura+ (Duennwald et al., 
2006) 
GAL-FLAG-25QΔPRO   pPL018 pRS424 
(2µ) 
Trp+ This study 
GAL-FLAG-72QΔPRO   pPL019 
GAL-FLAG-25QΔPRO-yemsfGFP   pPL020 
GAL-FLAG-72QΔPRO-yemsfGFP   pPL021 
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Table 2.2 Primers used in this study 
 
Template  Primers 
GAL-FLAG-25/72QΔPRO F: GATCGAGCTCCGGATTAGAG CCGC 
R: GATCACTAGTGGATCCCCCGGGCTG 
ymSFGFP F: GATCACTAGTGTGAGCAAGGGCGAG 
R: GATCGTCGACCTACTTGTACAGCTCGTCCATG 
yemRFP F: GATCACTAGTGTTTCAAAAGGTGAAG 
R: GATCAAGCTTTTATTTATATAATTC 
ymNeonGreen F: GATCACTAGTGTATCCAAAGGTGAAG 
R: GATCGTCGACCTACTTATACAATTCATCCATAC 
yomTagBFP2 F: GATCACTAGTAGTGAGTTGATTAAGG 
R: GATCGTCGACTTAGTTTAGTTTGTGTCCC 
ymoxBFP F: GATCACTAGTGTCTCAAAGGGTGAAGAATTG 
R: GATCGTCGACCTTATACAATTCATCCATACCC 
ymSFGFP V206K 
 
F: TTGTCTACCCAATCAGTATTGTCCAAAGATCA 
R: TTGTCTACCCAATCAAAATTGTCCAAAGATCA 
yomTagBFP2 (with Kozak 
and ATG) 
F: GATCACTAGTCTAAAAATGAGTGAGTTGATTAAGG 	
ymoxBFP (with Kozak 
and ATG) 
F: GATCACTAGTCTAAAAATGAGTGAGTTGATTAAGG 	
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 Fluorescence microscopy 
Fluorescence microscopy was performed using a Zeiss 880 confocal microscope 
equipped with a 405 nm diode laser for yomTagBFP2 and ymoxBFP and CFP, a 488 
diode laser for ymsfGFP and ymNeonGreen and a 561 diode laser for yemRFP. Upon 
polyQ expression, cells were transferred to LabTek imaging chambers (Thermo inc.) and 
imaged at room temperature using a 63x PlanAprochromoat objective (1.4 NA). Images 
were analyzed using the ImageJ software (https://imagej.nih.gov/ij/).  
 Dot blot and SDD-AGE 
Biochemical analysis of polyQ oligomers were performed as previously described 
(Duennwald, 2013). Briefly, cells were incubated in galactose-containing media to induce 
the various polyQ constructs lysed in lysis buffer (100mM Tris pH 7.5; 200mM NaCl; 1 
mM EDTA; 5% glycerol, 1mM Dithiothreitol (DTT). Protease inhibitors were added 
directly before use: 4 mM phenylmethylsulfonyl fluoride (PSMF) and SigmaFast 
protease inhibitor cocktail (Sigma-Aldrich, St.Louis MO). Cells were lysed using glass 
beads. For dot blot, equally amount of proteins were spotted on nitrocellulose membranes 
using a vacuum manifold and processed for immunoblot detection using an anti-FLAG 
antibody (SIGMA-Aldrich, #F3040). For SDD-AGE or an anti-Pgk1 antibody, samples 
were loaded on a 1.5% agarose gel containing 0.1% SDS and transferred onto 
nitrocellulose membrane for immune detection as previously described (Halfmann and 
Lindquist, 2008).  
 Statistical analysis 
In order to quantify changes in yeast cells growth, growth curves were generated using 
the BioscreenC and area under the curve was calculated using Graphpad Prism (La Jolla, 
CA). Statistical significance was calculated using a two-tailed Student’s t-test where 
indicated.  
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2.4 Results and Discussion 
 The presence of a fluorescent protein tag unmasks expanded 
Httex1 toxicity 
In yeast, as in other model organisms, expression of Httex1 carrying disease-associated 
length of polyQ repeats results in oligomerization, aggregation into IBs and cellular 
toxicity that can be measured through reduced growth on agar plates (Duennwald, 2013). 
The original constructs systematically tested by the Lindquist group contains Httex1 
tagged at the N-terminus with a FLAG epitope tag and a fluorescent CFP at the C-
terminus (Duennwald et al., 2006b). In absence of the FLAG tag, the expanded HD-
associated fluorescent Httex1 protein displayed a significant change in IBs morphology, 
resulting in soluble and non-toxic aggregates. These results highlight the fact that the 
nature of the sequences flanking the polyQ region is indeed regulating its ability to 
acquire the toxic conformation (Duennwald et al., 2006a). In our studies, we chose to use 
an expanded Httex1 construct containing 72Q rather than the original 103Q (Duennwald et 
al., 2006b). This length induces reduced toxicity therefore allowing us to test for 
increased sensitivity to different conditions. Consistent with the finding that flanking 
sequences modulate polyQ toxicity, we found that expression of FLAG-72Q protein 
without the C-terminal CFP fragment (72Q-Stop) was not toxic (Figure 2.1A and B) even 
when expressed at high levels from a multicopy plasmid (Figure S2.1).  The CFP-tagged 
version of 72Q showed typical toxic aggregates observed by fluorescence microscopy 
(Figure 2.1C). Interestingly, both 72Q-CFP and 72Q-Stop constructs show similar ability 
to oligomerize when analyzed on Semi-Denaturing Detergent Agarose Gel 
Electrophoresis (SDD-AGE), a technique routinely employed to assess Httex1 aggregation 
and detergent solubility (Halfmann and Lindquist, 2008) (Figure 2.1D). A dot blot was 
performed using the same lysates to assess expression levels of the different constructs 
(Figure 2.1D and S2.2).  Thus, our data argue that while both fusion proteins can 
oligomerize and aggregate, only the CFP-tagged polyQ appears to be able to acquire a 
toxic conformation. It is possible that addition of the fluorescent tag changes the 
biophysical properties of Httex1 oligomers, leading to formation of the toxic species 
similarly to what is observed with the addition of the FLAG tag at the amino terminus 
end of the protein (Duennwald et al., 2006a). Indeed, recent in vitro data indicate that 
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untagged Httex1 can behave differently than the tagged versions (Vieweg et al., 2016). In 
addition, we found the CFP-tagged proteins produced a very weak fluorescent signal, 
especially for the soluble 25Q construct. This signal is so low that it is on par or even 
below that emanating from red vacuolar pigment due to the ade2-1 mutation in the W303 
strain (Weisman et al., 1987) (Figure 2.1C). Given the variety of FPs available and their 
frequent use of them as interchangeable building blocks, we sought to further determine 
the impact of some of the most popular FPs on Httex1 aggregation and toxicity.  
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Figure 2.1 C-terminal tagging of Httex1 regulates toxicity in yeast.  
(A) The different Httex1 constructs contain either non-toxic 25Q or HD-associated 
72Q followed by either a stop codon or a CFP fluorescent protein. Growth assays on 
agar plate reveals increased toxicity of 72Q CFP –tagged Httex1 compared to the 
untagged version. (B) Growth curves generated by liquid growth assays show 
increased toxicity of the 72Q CFP –tagged Httex1. Area under the curve (AUC) is 
shown. n=3 ±SEM, * p<0.001. (C) Representative fluorescent images of CFP-tagged 
Httex1 constructs following overnight induction in galactose media displays formation 
of IBs in 72Q expressing cells. (D) SDD-AGE and dot blots of cell lysates prepared 
for the indicated Httex1 constructs. For dot blots, three five-fold serial dilutions of 
protein lysates are shown. Httex1 proteins were detected using an anti-FLAG antibody.   
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 Differential impact of fluorescent proteins on Httex1 
aggregation and toxicity 
We assessed the impact of different fluorescent proteins on the ability of expanded polyQ 
proteins to aggregate into toxic oligomers and IBs. We chose some of the brightest FPs 
available for expression in yeast.  These include the yeast codon optimized and 
monomeric versions of superfolder GFP (Pédelacq et al., 2006) (ymsfGFP), mNeonGreen 
(Shaner et al., 2013) (ymNeonGreen), Cherry (Keppler-Ross et al., 2008) (yemRFP), and 
TagBFP2 (yomTagBFP2) (Lee et al., 2013). All polyQ fusion proteins were cloned into a 
low copy yeast vector under the control of the GAL1 promoter (Figure 2.2A). Expression 
of these constructs in yeast cells led to two unexpected observations: first, we observed 
that unlike its ymsfGFP, ymNeonGreen and yemRFP counterparts, 72Q-yomTagBFP2 
showed no aggregation and displayed features similar to 25Q tagged with other FPs 
(Figure 2.2A). Second, we found that that while both 72Q-ymsfGFP and ymNeonGreen 
displayed strong growth inhibition compared to their 25Q counterparts, 72Q-
yomTagBFP2 showed no toxicity and grew as well as 25Q yom-TagBFP (Figure 2.2B 
and C). Interestingly, 72Q-yemRFP showed intermediate toxicity (Figure 2.2B and C). 
Since aggregation and toxicity of Httex1 can be traced back to its ability to oligomerize, 
we tested the ability of these proteins to oligomerize using SDD-AGE (Halfmann and 
Lindquist, 2008). Surprisingly, 72Q-yemRFP displayed lower levels of SDS-resistant 
oligomers compared to ymsfGFP or ymNeonGreen (Figure 2.2D). While 72Q-yemRFP 
IBs appear similar to ymsfGFP IBs by fluorescence microscopy, these appear to have 
different levels of solubility that could explain the milder growth defect. It is important to 
note that different disease-causing aggregating proteins can form different types of IBs. 
For example TDP43, a protein associated with amyotrophic lateral sclerosis (ALS), forms 
SDS-soluble oligomers that are distinct from Httex1 oligomers (Johnson et al., 2008). 
Moreover, TDP43 IBs formation is independent of the yeast prion protein Rnq1, which is 
required for formation of Httex1 IBs (Meriin et al., 2002). We found that expanded Httex1-
yemRFP proteins still required Rnq1 since their expression in rnq1Δ cells did not result 
in appearance of IBs (Figure S2.3). Therefore, yemRFP may only slightly mask polyQ 
protein toxicity. This is consistent with a previous report that red fluorescent proteins can 
impair protein behavior (Costantini et al., 2015; Shemiakina et al., 2012; Snaith et al., 
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2010). One could envisage that robust folding of the FPs such as sfGFP and the bright 
mNeonGreen (Pédelacq et al., 2006; Shaner et al., 2013) favors formation of toxic species 
of polyQ oligomers by uncoupling the folding trajectory of the FP from the folding of 
Httex1. By contrast, slower folding FPs are more prone to aberrant interactions that could 
in turn favor the formation of non-toxic oligomers similarly to what is observed in the 
construct that contain the proline rich region adjacent to the polyQ stretch in Httex1 
(Duennwald et al., 2006a). However, we observed that robust β-barrel folders, such as 
ymsfGFP displays similar toxicity compared to the original, non-optimized, CFP tagged 
72Q construct (Figure S2.4).  These data argue against a role for an FP's folding capacity 
in Httex1 toxicity in yeast. Therefore, it appears that the phenotype observed for yemRFP 
is probably caused by the previously reported inherent ability of red FPs to 
oligomerize/aggregate (Costantini et al., 2012; Lam et al., 2012; Merzlyak et al., 2007; 
Shemiakina et al., 2012). We should also note that the original CFP construct is not 
monomerized but still induces toxicity, indicating that unlike what we observed for red 
FPs, for Aequorea-derived FPs (GFP and its derivatives), the weaker tendency to 
oligomerize does not appear to have a significant impact on Httex1-fusion toxicity. 
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Figure 2.2 Differential impact of fluorescent proteins on Httex1 aggregation and 
toxicity.  
(A) 25Q and 72Q FLAG-Httex1 were fused to indicated yeast-optimized fluorescent 
proteins. Representative fluorescent images of fluorescently tagged Httex1 constructs 
following overnight induction in galactose media. (B) Spot assay on agar plates 
reveals increased toxicity of 72Q-ymsfGFP/ymNeonGreen when compared to 72Q-
yemRFP and yomTagBFP2. (C) Growth curves generated by liquid growth assays 
show increased toxicity of the 72Q-ymsfGFP/ymNeonGreen. Area under the curve 
(AUC) is shown. n=3, ±SEM * p<0.001. (D) SDD-AGE and dot blots of cell lysates 
prepared for the indicated Httex1 constructs. For dot blots, three five-fold serial 
dilutions of protein lysates are shown. Httex1 proteins were detected using an anti-
FLAG antibody.   
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 Optimized blue Httex1 protein fusion 
Curiously, 72Q-yomTagBFP2 proteins migrated faster on the SDD-AGE gel compared to 
the other 72Q constructs tagged with either ymsfGFP or ymNeonGreen (Figure 2.2D). 
This indicates the presence of smaller oligomers that are not incorporated into IBs when 
observed by fluorescence microscopy (Figure 2.2A). We originally chose yomTagBFP2 
because it had been characterized as the optimal blue fluorescent protein for expression in 
yeast (Lee et al., 2013). Recently, a new generation of fluorescent proteins, the moxFPs 
have been described. These monomeric proteins lack internal cysteines and are therefore 
optimized for the secretory pathway (Costantini et al., 2015). We codon optimized 
moxBFP for expression in yeast and generated fusions with either 25 and 72Q Httex1 
(Figure 2.3A). Interestingly, we found that unlike yomTagBFP2 tagged fusions, 72Q-
ymoxBFP displayed robust aggregation and toxicity (Figure 2.3 A-C). When we 
compared the fluorescent signal of the diffuse 25Q constructs tagged with either of the 
blue FPs we observed that ymoxBFP was significantly brighter than yomTagBFP2 
(Figure 2.3D). Interestingly, we observed that 72Q-yomTagBFP2 displayed lower 
fluorescent signal than the 25Q-yomTagBFP2 fusion (Figure 2.3E). We have previously 
observed a similar phenomenon with the expanded mHttex1 proteins in mammalian cells 
(Lajoie and Snapp, 2010). This may reflect increased degradation of the polyQ expansion 
proteins. Thus, the yomTagBFP2 vectors could help studying the behavior of expanded 
mHttex1 in absence of IBs that complicate both biochemical and fluorescent imaging 
experiments. Finally, increased aggregation and toxicity of the moxBFP tagged 
constructs correlated with slower migration of the ymoxBFP 72Q oligomers on SDD-
AGE (Figure 2.3F).  
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Figure 2.3 New optimized ymoxBFP increases Httex1 toxicity. 
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  Figure 2.3 
(A) Httex1 constructs generated contain either non-toxic 25Q or HD-associated 72Q 
followed by either a yom-TagBFP2 or ymoxBFP fluorescent proteins. Growth assays 
on agar plates reveal increased toxicity of 72Q ymoxBFP –tagged Httex1 compared to 
the yomTagBFP2 tagged version. (B) Growth curves generated by liquid growth 
assays show increased toxicity of the 72Q ymoxBFP tagged Httex1. Area under the 
curve (AUC) is shown. n=3, ±SEM * p<0.001. (C) Representative fluorescent images 
of yomTagBFP2/ymoxBFP-tagged Httex1 constructs following overnight induction in 
galactose media displays formation of IBs in 72Q-ymoxBFP expressing cells. (D) 
ymoxBFP significantly increases fluorescent intensity of 25Q-Httex1. Representative 
fluorescent images of yomTagBFP2/ymoxBFP-tagged 25Q Httex1 constructs 
following overnight induction in galactose.  Images were collected using the same 
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted 
black and white images are shown for clarity. Plot of quantified individual cell mean 
fluorescent intensities is shown for comparison. * p<0.001 (E) 72Q- yom-TagBFP2 is 
significantly dimmer than its 25Q counterpart. Images were collected using the same 
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted 
black and white images are shown for clarity. Plot of quantified individual cell mean 
fluorescent intensities is shown for comparison. * p<0.001 (F) SDD-AGE and dot 
blots of cell lysates prepared for the indicated Httex1 constructs. For dot blots, 3 
different serial dilutions of protein lysates are shown. Httex1 proteins were detected 
using an anti-FLAG antibody.   
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Our imaging result contrasts with the original report showing that TagBFP is significantly 
brighter that than EBFP2, at least in solution (Subach et al., 2008). However, optimal 
brightness will be possible only when FPs are expressed alone or when fused with well 
folded proteins (Pédelacq et al., 2002; Waldo et al., 1999). Indeed, the superfolder variant 
of GFP was created by screening for its ability to fluoresce when fused to poorly folded 
proteins (Pédelacq et al., 2006). Thus, fusion of yomTagBPF2 with misfolded Httex1 
could be problematic. It is important to note that the new moxBFP generated by 
Costantini et al (Costantini et al., 2015) contains both superfolded mutations and 
additional cycle-3 GFP mutations (F99S and V163A) (Crameri et al., 1996) that would 
make it a robustly folded fusion partner. Indeed, we found that when expressed alone in 
the yeast cytosol under a constitutive promoter, yomTagBFP2 was slightly brighter than 
moxBFP (Figure 2.4). While the mean fluorescent intensity across the cell population 
was similar, the standard deviation of the fluorescence signal was significantly higher for 
yomTagBFP2. This result indicates that while yomTagBFP2 may be the brightest blue FP, 
ymoxBFP performs better in the context of fusion protein reporters. These results should 
be taken in consideration when designing new blue fluorescent protein fusions.   
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Figure 2.4 Cytoplasmic, untagged yomTagBFP2 is brighter than ymoxBFP.  
Cells constitutively expressing either yomTagBFP2 or ymoxBFP from the GPD 
promoter were cultured to early log phase. Images were collected using the same 
acquisition parameters to allow direct comparison of fluorescent intensities. Inverted 
black and white images are shown for clarity. Plot of quantified individual cell mean 
fluorescent intensities is shown for comparison. 
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TagBFP2 (Subach et al., 2011) is an optimized version of TagBFP (Subach et al., 2008), 
which was originally derived from TagRFP (Merzlyak et al., 2007), which, like most red 
FPs was derived from multimeric proteins isolated from Anthozoa corals and anemones. 
While these proteins are reported to be monomeric, several studies have found that they 
are actually strongly dimerizing (Costantini et al., 2012; Lam et al., 2012; Merzlyak et al., 
2007; Shemiakina et al., 2012). Unlike mCherry, which is only weekly dimerizing 
(Costantini et al., 2015) and allows for the formation of IBs (Figure 2.2A), the TagRFP 
family of FPs are very prone to dimerization/oligomerization (Costantini et al., 2012; 
Costantini et al., 2015).  Therefore, it is plausible that yomTagBFP2 strong tendency to 
oligomerize  prevents expanded Httex1 interaction either with other Httex1 molecules or 
with other cellular components required for incorporation of polyQ proteins into IBs such 
as the prion protein Rnq1 or chaperone proteins (Duennwald et al., 2006b; Meriin et al., 
2002).  
It was previously shown that polyQ-expanded Httex1 proteins are recruited into 
preexisting IBs formed by non-toxic Httex1 expansion reporters containing the proline-
rich domain adjacent to the polyQ repeats, irrespective of the flanking sequences 
(Duennwald et al., 2006b). Thus, we used the previously published construct encoding a 
non-toxic 103Q containing the Httex1 proline-rich domain tagged with eGFP (103QP-GFP) 
under the constitutively active GPD promoter (Duennwald et al., 2006b) to test whether 
yomTagBFP2 tagged constructs could be recruited into preexisting IBs induced by other 
Httex1 fusion constructs. We observed strong recruitment of both 25Q and 72Q-
yomTagBFP2 into 103QP-GFP IBs upon induction in galactose (Figure 2.5A). Moreover, 
recruitment of 72Q-yomTagBFP2 in IBs results in increased toxicity compared to 25Q 
(Figure 2.5B).  These observations were not solely the result of the increased total 
amount of Httex1 proteins since expression of 72Q-yomTagBFP2 from a multicopy 
plasmid failed to induce IBs or cause significant toxicity (Figure 2.6A and B).  Another 
possibility would be that 103Q Httex1 has a greater affinity for 72Q and can override the 
yomTagBFP2 tendency to oligomerize. However, expression of a 103Q-yomTagBFP2 
construct did not result in either IBs formation or toxicity (Figure 2.6C). Interestingly, 
IBs induced in the presence of 103QP-GFP were equally bright for both and ymoxBFP 
(Figure S2.5). This might be an indication that the combination of both a longer 103Q 
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Httex1 and the presence of GFP are required to alleviate the phenotype caused by 
yomTagBFP2.  
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Figure 2.5 Httex1-yomTagBFP2 oligomers are recruited to preexisting 103Q-
PRO-GFP IBs. 
Cells constitutively expressing 103Q-PRO-GFP were grown in galactose containing 
media overnight for induction of the various Httex1-yomTagBFP2/moxBFP 
constructs. (A) Representative fluorescent images show incorporation of either Httex1-
yomTagBFP2 or ymoxBFP constructs into 103Q-PRO-GFP IBs. (B) Spot assays on 
agar plates reveal increased toxicity of 72Q- yomTagBFP2 when incorporated in 
103Q-PRO-GFP IBs.  
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Figure 2.6 Effects of yomTagBFP2 on Httex1 toxicity and aggregation.  
(A) High expression of 72Q Httex1-yomTagBFP2 is not toxic. Representative 
fluorescent images of yomTagBFP2 and ymsfGFP tagged 25Q and 72Q Httex1 
constructs expressed from high copy 2µ vectors following overnight induction in 
galactose media. (B) Growth assays on agar plates show that unlike for ymsfGFP, no 
significant toxicity of different 72Q-yomTagBFP2 Httex1 compared to the 25Q 
version. (C) Growth assay on agar plate and fluorescent imaging shows that Httex1-
yomTagBFP2 is not toxic and remain diffused in the cytoplasm even in presence of 
103Q.  
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These results indicate that while Httex1-yomTagBFP2 constructs are unable to form IBs 
when expressed alone, they can be recruited by Httex1 proteins tagged with other FPs 
(Figure 2.4C). Based on these data, it appears that the affinity of yomTagBFP2 is stronger 
than Httex1. yomTagBFP2 oligomerization may prevent assembly of Httex1 into toxic 
oligomers and IBs by either preventing interaction between different Httex1 proteins or by 
potential sterically challenge recruitment of factors required for IBs formation such as 
Rnq1 (Figure 2.7). This strongly suggests that the inability of 72Q-yomTagBFP2 to form 
higher oligomers and incorporate into IBs is at the root of the decreased toxicity observed 
with this particular construct (Figure 2.2) Therefore, these results should be taken in 
considerations when using yomTagBFP2 and other red FPs and their derivatives for 
fusion proteins design. 
Finally, it is important for scientists to appreciate the differences between the various 
properties of FPs when designing fusion proteins in experiments. In Figure 2.8, we 
compared side-by-side the complete panel of polyQ constructs used in our study. For 
each fluorescent fusion, imaging conditions were kept the same to acquire images of 25 
and the 72Q variants (Figure 2.8). A negative control was also included to compare the 
fluorescent intensity of the different constructs over the autofluorescent background of 
W303 yeast cells.  These experiments revealed interesting phenotypes regarding the 25Q 
Httex1 fusions. While ymsfGFP, ymNeonGreen and yemRFP displayed robust signal, the 
CFP tagged version showed a much dimmer signal, closer to the background noise. Also, 
CFP tagged 25Q was much dimmer than the 72Q-CFP. An opposite phenotype was 
observed with the optimized FPs. These data highlight the advantages of using bright 
codon optimized FPs which greatly improved detection of the soluble 25Q Httex1 fusions.  
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Figure 2.7 Hypothetical model of regulation of polyQ toxicity by fluorescent 
proteins.  
While Httex1-yomTagBFP2 cannot form IBs on their own, the can be recruited to 
preexisting IBs suggesting that the fluorescent proteins impairs Httex1 interaction with 
cellular component that regulate IBs formation. 
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Figure 2.8 Comparison of fluorescent intensities of the different Httex1 fusions. 
 Httex1 constructs generated contain either non-toxic 25Q or HD-associated 72Q 
followed by either a CFP, ymsfGFP, yemRFP, ymNeonGreen, yom-TagBFP2 or 
ymoxBFP fluorescent proteins. For each fusion reporter, the imaging parameters were 
kept the same to acquire the images of W303 cells expressing either an empty vector, 
the 25Q- Httex1 or 72Q Httex1 fluorescent constructs.  
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 Conclusion 
Our study shows that Httex1 polyQ toxicity assays in yeast can be used to detect variations 
among fluorescent protein fusions and could therefore be useful for development and 
optimization of current and future FPs. Our results using blue fluorescent proteins clearly 
show that there is no single FP that fits all the requirement for every experiments. Thus, 
we encourage scientists to use technical resources available to guide them though 
fluorescent proteins design (Costantini and Snapp, 2013; Costantini et al., 2012; 
Costantini et al., 2015; Cranfill et al., 2016; Lee et al., 2013; Snapp, 2009). In addition, 
our new palettes of optimized fluorescent Httex1 constructs could be used for optimal 
imaging conditions to study Httex1 aggregation in living cells. Finally, our study supports 
a role for sequences flanking the polyQ region in the toxicity observed in HD. Together 
with previous reports (Atwal et al., 2011; Caron et al., 2013; Duennwald et al., 2006a; 
Tam et al., 2009),  our results suggest that targeting these regions may represent a 
suitable approach in modulating Htt toxicity in HD. 
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Figure S 2.1 High expression of 72Q Httex1 is not toxic in absence of a fluorescent 
protein tag.  
Cells expressing either 25Q or 72Q Httex1-stop from a 2µ plasmid were cultured on 
galactose overnight and spotted on agar plates.   
 
 
 
 
 
Figure S 2.2 Specificity of the dot blot approach.  
Whole lysates of yeast cells expressing either an empty vector W303 cells expressing 
an empty vector or the 25/72Q- Httex1 either untagged or tagged with CFP constructs 
were processed for dot blotting using an anti-FLAG and anti PGK1 antibodies.   
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Figure S 2.3 RNQ1 is required for aggregation and toxicity of the various 
fluorescent 72Q Httex1 constructs. 
 (A) Representative fluorescent images of fluorescently tagged 25Q and 72Q Httex1 
constructs expressed in rnq1Δ cells following overnight induction in galactose media. 
(B) Growth assay on agar plates shows no toxicity of different 72Q tagged Httex1 
constructs compared to the 25Q version. 
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Figure S 2.5 Fluorescent intensities of IBs induced by blue fluorescent proteins 
in cells expressing 103QP-GFP.  
Plot of quantified individual cell mean fluorescent intensities is shown for 
comparison for cells expressing either 25Q or 72Q-yomTagBFP2 or ymoxBFP in 
presence of 103QP-GFP.  
 
 
 
 
 
 
Figure S 2.4 CFP and ymsfGFP tagged Httex1 are equally toxic.  
Growth assays on agar plates show no significant difference in toxicity between the 
CFP and ymsfGFP tagged 72Q Httex1. Both are significantly more toxic than their 
25Q counterpart.  
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Chapter 3 
3 Polyglutamine toxicity assays highlight the advantages 
of mScarlet for imaging in Saccharomyces cerevisiae 
The yeast polyQ model has been shown to be a good tool for assessing new fluorescent 
proteins. Although polyQ-yemRFP forms aggregates in yeast, it shows reduced toxicity. 
In this chapter, we will tag polyQ with newest red fluorescent proteins FusionRed and 
mScarlet to test their impact on fusion partners and on the other hand, generating an 
optimized yeast model of HD featured RFP.  
3.1 Abstract 
Development of fluorescent proteins (FPs) enabled researchers to visualize protein 
localization and trafficking in living cells and organisms. The extended palette of 
available FPs allows simultaneous detection of multiple fluorescent fusion proteins. 
Importantly, FPs are originally derived from different organisms from jelly fish to corals 
and each FP displays its own biophysical properties. Among these properties, the 
tendency of FPs to oligomerize inherently affects the behavior of its fusion partner. Here 
we employed the budding yeast Saccharomyces cerevisiae to determine the impact of the 
latest generation of red FPs on their binding partner. We used a yeast assay based on the 
aggregation and toxicity of misfolded polyQ expansion proteins linked to Huntington’s 
disease. Since polyQ aggregation and toxicity are highly dependent on the sequences 
flanking the polyQ region, polyQ expansions provide an ideal tool to assess the impact of 
FPs on their fusion partners. We found that unlike what is observed for green FP variants, 
yemRFP and yFusionRed-tagged polyQ expansions show reduced toxicity. However, 
polyQ expansions tagged with the bright synthetically engineered ymScarlet displayed 
severe polyQ toxicity. Our data indicate that ymScarlet might have significant advantages 
over the previous generation of red FPs for use in fluorescent fusions in yeast. 
3.2 Introduction 
Following the development of the green fluorescent protein (GFP) from the jellyfish 
Aequorea Victoria (Chalfie et al., 1994), several other FPs with various spectral 
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properties have been characterized (Thorn, 2017), allowing simultaneous detection of 
multiple fluorescent reporters. Among the most popular alternatives to GFP are the red 
fluorescent proteins (RFPs) isolated from Anthozoa coral and anemone species. One of 
the drawbacks of RFPs is that Anthozoa derived FPs are obligate tetramers (Baird et al., 
2000; Verkhusha and Lukyanov, 2004). While development of RFPs into monomeric 
versions has been successful, it is often associated with reduced brightness of the 
fluorescent signal (Campbell et al., 2002) and therefore reduced overall performance of 
the resulting monomeric FPs. Moreover, RFPs such as TagRFP and mRuby2 reported as 
monomeric by passing purified proteins through sizing columns still display high 
tendency to oligomerize in living mammalian cells (Costantini et al., 2012; Costantini et 
al., 2015). Thus, under specific circumstances, FPs reported as monomeric can still be 
prone to oligomerization. Unwanted formation of oligomers could potentially 
significantly alter the function/localization of the protein of interest fused to the FP and 
render reporters unreliable (Costantini et al., 2015; Snapp et al., 2003; Zacharias et al., 
2002). Indeed, various RFPs (mCherry, mKate2, mRuby, mKO2, mApple, TagRFP-T) 
have been shown to have differential effects on localization of cdc12 in yeast (Lee et al., 
2013). Thus, being able to assess the behavior of fluorescent reporter in a given organism 
and/or cellular compartment is critical to help optimize fluorescent reporter design 
(Snapp, 2009). 
We recently established a method to rapidly compare the behavior of FPs against a 
monomeric variant of superfolder GFP (msfGFP) in yeast (Jiang et al., 2017). The assays 
exploit the ability of polyglutamine expansions associated with Huntington’s disease (HD) 
to form toxic aggregates in yeast cells. The cause of HD can be traced back to abnormal 
expansion of a polyQ stretch within the first exon of the gene encoding the Huntingtin 
protein (Httex1) resulting in chorea and cognitive defects in patients (Gusella and 
MacDonald, 1995; Huntington, 2003; Penney et al., 1997). Expansion over 36 repeats is 
known to cause the Htt protein to misfold and aberrantly accumulate into detergent-
insoluble amyloid-like aggregates in the cytoplasm of striatal neurons (Penney et al., 
1997). Expression of expanded Httex1 in yeast results in severe polyQ aggregation and 
growth defect (Duennwald, 2013; Krobitsch and Lindquist, 2000; Mason and Giorgini, 
2011; Meriin et al., 2002). Interestingly, the nature of the sequences flanking the polyQ 
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regions (in this case fluorescent or epitope tags) greatly affects the propensity of the 
polyQ expansions to aggregate and to display significant growth defects in yeast 
(Duennwald et al., 2006). Using polyQ toxicity assays in yeast, we previously showed 
that a yeast-optimized version of mCherry termed yemRFP (Keppler-Ross et al., 2008) 
displays only a mild growth defects compared to yeast-optimized msfGFP (ymsfGFP) 
(Jiang et al., 2017). These results lead us to exploit the polyQ toxicity and aggregation 
assays to explore the effects of two of the most recently available RFPs. Here, we focused 
on FusionRed, a red monomeric fluorescent variant of mKate2 known for its low 
cytotoxicity in cells (Shemiakina et al., 2012) that displays low propensity to oligomerize 
in mammalian cells (Costantini et al., 2015). We also included mScarlet, a monomeric 
synthetic RFP that was recently shown to outperform other RFPs in terms of brightness 
of the fluorescent signal (Bindels et al., 2017). Both have yet to be characterized for 
expression in yeast. 
3.3 Materials and Methods 
 Yeast strains and culture conditions 
All strains are derived from W303-1A (Thomas and Rothstein, 1989). All experiments 
were conducted in synthetic complete media (SC) at 30 °C. 
 DNA constructs 
yemRFP (Keppler-Ross et al., 2008) was previously described. yFusionRed and 
ymScarlet were codon optimized for expression in yeast and synthesized by Genscript Inc. 
based on previously published sequences (Bindels et al., 2017; Shemiakina et al., 2012). 
RFPs were cloned into the SpeI/SalI site of p415 GPD. Alternatively, RFPs were cloned 
into the SpeI/SalI sites of p415 GAL1 25Q/68Q Httex1 lacking the proline rich domain, as 
previously described (Jiang et al., 2017). To generate 2µ vectors, the GAL1 25Q/68Q 
Httex1-ymsfGFP or GAL1 25Q/68Q Httex1-yFusionRed fragments were cloned into the 
SacI/SalI sites of pRS42N (Taxis and Knop, 2006).  All Httex1 constructs lack the proline-
rich domain since absence of this domain is required for Httex1 toxicity in yeast 
(Duennwald et al., 2006). We also noted that since the publication of our previous study 
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(Jiang et al., 2017), the original 72Q Httex1 plasmid has mutated into 68Q. We, therefore, 
used the latter in this study. See Table 3.1 for a list of plasmids used in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Growth assays 
Yeast growth was measured by spotting assay on agar plates. Briefly, cells were cultured 
overnight to saturation in appropriate selection media. The next day, cells densities were 
equalized to OD 600 0.2 and 5x serial dilutions were spotted on agar plates. Alternatively, 
cell densities were equalized to OD 600 0.1 and 300 µl of cell suspensions were 
transferred into a 96 well plate and incubated at 30oC for 24h with constant shaking in a 
Biotek Epoch 2 microplate spectrophotometer and OD 600 was recorded every 15 minutes.  
Table 3.1 Plasmids used in this study 
 
Plasmids Resistance  
marker 
Source 
P415 GPD Leu 
 
 
 
 
 
 
 
 
 
 
 
 
(Mumberg et al., 1995) 
P415 GPD-yemRFP This study 
P415 GPD-yFusionRed 
P415 GPD-ymScarlet 
P415 Gal1-FLAG-25Q-ymsfGFP (Jiang et al., 2017) 
P415 Gal1-FLAG-68Q-ymsfGFP This study 
P415 Gal1-FLAG-25Q-yemRFP (Jiang et al., 2017) 
P415 Gal1-FLAG-68Q-yemRFP This study 
P415 Gal1-FLAG-25Q-yFusionRed 
P415 Gal1-FLAG-68Q-yFusionRed 
P415 Gal1-FLAG-25Q-ymScarlet 
P415 Gal1-FLAG-68Q-ymScarlet 
PRS42N Gal1-FLAG-25Q-ymsfGFP natNT2 
 
This study 
PRS42N Gal1-FLAG-68Q-ymsfGFP 
PRS42N Gal1-FLAG-25Q-yFusionRed 
PRS42N Gal1-FLAG-68Q-yFusionRed 
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 Dot blot 
After induction in galactose media overnight, cells were lysed using glass beads in lysis 
buffer (100 mM Tris pH 7.5; 200 mM NaCl; 1 mM EDTA; 5% glycerol, 1 mM 
Dithiothreitol (DTT) 4 mM phenylmethylsulfonyl fluoride (PMSF) and protease inhibitor 
cocktail). Equal amount of proteins were spotted on a nitrocellulose membrane. 
Membranes were blocked for 30 min in PBS-0.05%Tween at room temperature and then 
processed for immunoblot. Membranes were probed with anti-FLAG primary antibody 
(Sigma F3040, 1:5000 dilution) overnight at 4 °C and subsequently with a secondary 
anti-mouse fluorescent antibody (Thermo Alexa 555 #A21424, 1:5000 dilution) for 1h at 
room temperature and imaged using a Bio-Rad ChemiDoc MP imaging system. 
Membranes were then stripped using the Gene Bio-Application stripping buffer and 
reprobed with an anti-Pgk1 primary antibody (Thermo 22C5D8) using the same 
secondary antibody. In Figure 3, for each individual antibody, both membranes were 
imaged simultaneously to allow direct comparison of fluorescent signal. Densitometric 
analysis was performed using Image J.  
 Fluorescence microscopy 
Under the different experimental conditions, cells were diluted 10x in growth media and 
plated in Lab-tek (Thermo Inc.) imaging chambers and processed for fluorescence 
microscopy. Images in Figure 3.1 were acquired using a Zeiss AxioVert A1 wide field 
fluorescence microscope equipped with a 63X NA 1.4 Plan Apopchromat objective, a 
560 to 600 nm excitation/630 to 705 nm emission bandpass filter and Zeiss Axiocam 506 
mono camera. Images presented in Figure 3.2 and Figure 3.4 were collected using a Zeiss 
800 confocal microscope equipped with 488 nm and 561 nm diode lasers and a 63x 
PlanApochromat NA 1.4 objective. 
 Flow cytometry 
Cell were cultured with appropriate media and processed for flow cytometry using a BD 
Bioscience FACS Celesta flow cytometer equipped with a 561 Yellow laser for imaging 
of RFPs. Data were analyzed using the BD FACS Diva software. All conditions were 
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performed in triplicates, 20,000 cells were analyzed and median fluorescence intensities 
were calculated. No gates were applied. 
 Statistical analysis 
A one-way ANOVA followed by a multiple comparison test (Tukey’s or Dunnett’s 
according to figure legends) was used to determine statistical significance between the 
different experimental conditions in Figure 3.1D, 3.2B, 3.3 and 3.4A using GraphPad 
Prism v6.0h. 
3.4 Results and Discussion 
 mScarlet has higher fluorescent intensity in yeast  
To analyze the performance of the three different RFPs in yeast, we first generated codon 
optimized versions of both FusionRed and mScarlet (termed yFusionRed and ymScarlet, 
respectively) (Table 3.2). Centromeric plasmids encoding yFusionRed, yemRFP and 
ymScarlet under the control of the constitutive GPD promoter were transformed in yeast 
(Figure 3.1A). Fluorescence intensities were compared using wide-field fluorescence 
microscopy (Figure 3.1B). Median fluorescence intensity (MFI) was then quantified 
using flow cytometry. Quantification revealed that yFusionRed was significantly dimmer 
(~5x) than yemRFP (Figure 3.1C and D). This result was surprising given that previously 
published data reported a slightly increased brightness for FusionRed when compared to 
mCherry (Shemiakina et al., 2012). However, it is known that fluorescent brightness of 
FPs expressed in yeast can be different from the ones registered for pure purified proteins 
(Lee et al., 2013). As opposed to yFusionRed, ymScarlet displayed the strongest 
fluorescent signal (~2x brighter than yemRFP) (Figure 3.1C and D). These results are in 
agreement with previous studies reporting increased brightness of mScarlet compared to 
other RFPs variants (Bindels et al., 2017). Based on the intensity of the fluorescent signal, 
ymScarlet appears to be the optimal RFP for imaging in yeast. 
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Table 3.2 Sequences of yeast optimized fluorescent proteins in this study 
Name Sequences 
yFusionRed ATGGTTTCTGAATTGATTAAAGAAAACATGCCAATGAAGTTGTACA
TGGAAGGTACTGTTAACAACCATCATTTTAAATGTACATCAGAAGG
TGAAGGTAAACCATACGAAGGTACTCAAACAATGAGAATTAAAGT
TGTTGAAGGTGGTCCATTGCCATTTGCTTTCGATATTTTGGCAACTT
CTTTTATGTACGGTTCAAGAACTTTTATTAAGCATCCACCAGGTATT
CCAGATTTCTTTAAGCAATCTTTCCCAGAAGGTTTTACTTGGGAAA
GAGTTACTACATATGAAGATGGTGGTGTTTTGACTGCAACACAAGA
TACATCATTGCAAGATGGTTGTTTGATCTATAACGTTAAAGTTAGA
GGTGTTAATTTTCCAGCTAATGGTCCAGTTATGCAAAAGAAAACTT
TGGGTTGGGAAGCTTCTACTGAAACAATGTACCCAGCAGATGGTG
GTTTAGAAGGTGCTTGTGATATGGCATTGAAATTGGTTGGTGGTGG
TCATTTGATCTGTAATTTGGAAACTACATACAGATCTAAGAAACCA
GCTACAAATTTGAAGATGCCAGGTGTTTACAACGTTGATCATAGAT
TGGAAAGAATTAAAGAAGCAGATGATGAAACTTACGTTGAACAAC
ATGAAGTTGCTGTTGCAAGATACTCTACAGGTGGTGCTGGTGACGG
TGGTAAATAA 
ymScarlet ATGGTTTCTAAAGGTGAAGCAGTTATTAAGGAATTCATGAGATTCA
AGGTACACATGGAAGGTTCTATGAATGGTCACGAATTTGAAATTG
AAGGTGAAGGTGAAGGTAGACCATATGAAGGTACTCAAACTGCTA
AGTTGAAGGTTACTAAAGGTGGTCCATTGCCATTTTCTTGGGATAT
TTTGTCTCCACAATTCATGTACGGTTCTAGAGCTTTTACAAAACATC
CAGCAGATATTCCAGATTACTACAAGCAATCATTCCCAGAAGGTTT
TAAATGGGAAAGAGTTATGAACTTCGAAGATGGTGGTGCAGTTAC
TGTTACACAAGATACTTCTTTGGAAGATGGTACATTGATCTATAAG
GTTAAGTTGAGAGGTACTAATTTTCCACCAGATGGTCCAGTTATGC
AAAAGAAAACTATGGGTTGGGAAGCTTCAACAGAAAGATTGTACC
CAGAAGATGGTGTTTTGAAGGGTGACATTAAGATGGCATTGAGAT
TGAAGGATGGTGGTAGATATTTGGCTGATTTCAAGACTACATACAA
GGCTAAGAAACCAGTTCAAATGCCAGGTGCTTACAACGTTGATAG
AAAGTTGGATATTACTTCTCATAATGAAGATTACACAGTTGTTGAA
CAATATGAAAGAAGTGAAGGTAGACACAGTACAGGTGGTATGGAT
GAATTATACAAATGA 
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Figure 3.1 Comparison of red fluorescent proteins (RFPs) fluorescent intensities 
in yeast.  
(A) yemRFP, yFusionRed and ymScarlet were introduced into centromeric vectors 
under the control of a constitutive GPD promoter. (B) Representative images from 3 
fields of yeast cells expressing different RFPs. Imaging conditions were kept constant 
between samples to allow direct comparison of fluorescent intensities. Inverted black 
and white images are shown for clarity. Bar: 5µm (C) Yeast cells expressing the 
different RFPs were analyzed by flow cytometry and compared to cells carrying an 
empty vector. (D) Median fluorescent intensities of the various RFPs were calculated 
from fluorescent data acquired using flow cytometry. *p<0.05. 
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 PolyQ-mScarlet displays a toxic phenotype 
Next, we sought to determine how the three different FPs affect their fusion partners in 
living yeast. To this end, we employed the polyQ toxicity assays. Each RFP was cloned 
in frame with a galactose inducible version of Httex1 carrying either 25Q (non-
pathological length) or 68Q (HD-associated) (Figure 3.2A). 25Q constructs show no 
growth differences across the different FPs in both uninduced (glucose media) and 
polyQ-induced (galactose media) conditions indicating that expression of the different 
constructs results in similar growth phenotypes. When fused to 68Q Httex1, yFusionRed 
displayed no significant toxicity when compared to the non-toxic 25Q fusion (Figure 
3.2B). Interestingly, ymScarlet displayed severe toxicity, showing a slow growth 
phenotype comparable to what was observed for ymsfGFP (Figure 3.2B). Based on these 
observations, we then investigated the effects of the different RFPs on polyQ aggregation 
using fluorescence microscopy. We found that yemRFP displayed robust 68Q 
aggregation similar to ymsfGFP as we previously described (Jiang et al., 2017). It is 
important to note that while prone to aggregation, yemRFP polyQ proteins were shown to 
form aggregates with different biophysical properties (increased detergent solubility) that 
can account for their moderately toxic nature (Jiang et al., 2017). In accordance with the 
absence of toxicity noted in the growth assay, 68Q-FusionRed did not form visible 
aggregates, while ymScarlet displayed strong aggregation propensity (Figure 3.2C).  
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Figure 3.2 ymScarlet displays a toxic polyQ phenotype similar to ymsfGFP.  
(A) FPs were cloned in frame with FLAG-Httex1 into a centromeric vector carrying a 
GAL1 inducible promoter. (B) Yeast cells carrying a vector or 25/68Q Httex1 fused to 
either ymsfGFP, yemRFP, yFusionRed or ymScarlet were grown to saturation 
overnight in glucose (control) or galactose (polyQ induced) containing media. The 
next days, cell concentrations were equalized to OD600 0.2 and 5 fold serial dilutions 
of the cell suspension spotted on synthetic complete agar media plates containing 
either glucose or galactose. (C) Yeast cells carrying an empty vector or 25/68Q Htt 
ex1 fused to ymsfGFP, yemRFP, yFusionRed or ymScarlet or carrying an empty 
vector were induced overnight in galactose containing media and protein levels 
analyzed by dot blot using either an anti-FLAG (detection of fluorescent fusions) or 
anti-Pgk1 antibody (loading control). (D) Representative fluorescent images from 3 
fields of yeast cells expressing 25/68Q Htt ex1 fused to ymsfGFP, yemRFP, 
yFusionRed or ymScarlet after overnight induction in galactose-containing media. 
 
. 
 
116 
 
In addition, assessment of protein abundance for each construct using dot blot revealed 
that both 25 and 68Q yFusionRed fusions were present at lower levels compared to other 
fluorescent counterparts (Figure 3.3A). The cause of this phenotype is unclear and could 
result from increased turnover rate of the fusions. Interestingly, expression of 68Q-
yFusionRed from a multicopy 2µ vector resulted in a growth defect, albeit toxicity was 
reduced compared to ymsfGFP-tagged polyQ (Figure 3.4A). Moreover, under these 
conditions, 68Q-yFusionRed displayed robust aggregation. This indicates that the lower 
expression levels observed for yFusionRed constructs can potentially explain, at least 
partially, the absence of polyQ toxicity when expressed at lower levels. Reduced toxicity 
of the 68Q-yFusionRed is also consistent with our previous observation showing that 
yomTagBFP2, a blue fluorescent proteins similarly does not form toxic aggregates (Jiang 
et al., 2017). In fact, both FusionRed and mTagBFP2 (Subach et al., 2011) are evolved 
versions of the wild-type RFP from sea anemone Entacmaea quadricolor (Merzlyak et al., 
2007). In the case of mScarlet, the protein was evolved from a synthetic template design 
for generating a monomeric protein. Therefore, based on our data, mScarlet appears to be 
an attractive alternative to mCherry, which minimizes the effect of the FP on its fusion 
partner. 
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Figure 3.3 yFusionRed-tagged Httex1 fusions are expressed at lower levels 
compared to other fluorescent fusions.  
Yeast cells carrying an empty vector or 25/68Q Htt ex1 fused to ymsfGFP, yemRFP, 
yFusionRed or ymScarlet or carrying an empty vector were induced overnight in 
galactose containing media and protein levels analyzed by dot blot using either an 
anti-FLAG (detection of fluorescent fusions) or anti-Pgk1 antibody (loading control). 
Quantification of the FLAG/Pgk1 ration is shown from 3 independent experiments. 
***p<0.001 according to a one way ANOVA followed by a Tukey’s multiple 
comparison test comparing samples to ymsfGFP-tagged fusion of the same polyQ 
length.   
 
 
. 
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Figure 3.4 Expanded Httex1-yFusionRed is toxic when expressed at high levels.  
(A) Images of yeast growth assays on agar plates. Yeast cells carrying 25/68Q Htt 
ex1 fused to either ymsfGFP or yFusionRed in a 2µ multicopy vector were grown to 
saturation overnight in glucose (control). The next days, cell concentrations were 
equalized to OD 600 0.2, and 5-fold serial dilutions of the cell suspension spotted on 
synthetic complete agar media plates containing either glucose (control) or galactose 
(+polyQ). Alternatively, cells were cultured in liquid media and optical densities 
were recorded over time to generate growth curves. The area under the curve (AUC) 
was calculated from 3 experimental replicates. **p<0.01 and ****p<0.0001 
according to a one way ANOVA followed by a Tuckey’s multiple comparison test 
comparing the 68Q sample to its 25Q counterpart unless indicated otherwise.  (B) 
Representative fluorescent images from 3 fields of yeast cells expressing 25/68Q Htt 
Httex1 fused to ymsfGFP or yFusionRed from a multicopy 2µ vector after overnight 
induction in galactose-containing media. Under these conditions, 68Q-yFusionRed 
displays robust aggregation. 
 
 
 
. 
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4 Sfp1 links TORC1 and cell growth regulation to the 
yeast SAGA-complex component Tra1 in response to 
polyQ proteotoxicity 
In the past two chapters, we introduced the optimized yeast model of HD by tagging 
mutant Httex1 with different modern FPs. With the help of the yeast polyQ model, we are 
able to investigate the fundamental cellular mechanisms during HD. Proteotoxic stress 
disrupts trafficking and triggers transcriptional responses to cope with the accumulation 
of misfolded proteins. Transcriptional defects have been observed in different models of 
HD. The mechanisms involve dysregulation of transcription factors, coactivators, RNA 
polymerase II, and importantly, histones. In this chapter, we show that cells expressing 
toxic polyQ expansions display impaired assembly of the SAGA acetyltransferase 
complex that regulates chromatin remodeling and gene expression during stress. This 
culminates in the Sfp1/TORC1-dependent increased expression of the SAGA component 
Tra1. Our data identify a new nexus that links TORC1 to the regulation of SAGA activity 
during loss of proteostasis. 
4.1 Abstract 
Chromatin remodeling regulates gene expression in response to the accumulation of 
misfolded polyQ proteins associated with Huntington’s disease (HD). Tra1 is an essential 
component of both the SAGA/SLIK and NuA4 transcription co-activator complexes and 
is linked to multiple cellular processes, including protein trafficking and signaling 
pathways associated with misfolded protein stress. Cells with compromised Tra1 activity 
display phenotypes distinct from deletions encoding components of the SAGA and NuA4 
complexes, indicating a potentially unique regulatory role of Tra1 in the cellular response 
to protein misfolding.  Here, we employed a yeast model to define how the expression of 
toxic polyQ expansion proteins affects Tra1 expression and function.  Expression of 
expanded polyQ proteins mimics deletion of SAGA/NuA4 components and results in 
growth defects under stress conditions. Moreover, deleting genes encoding SAGA and, to 
a lesser extent, NuA4 components exacerbates polyQ toxicity. Also, cells carrying a 
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mutant Tra1 allele displayed increased sensitivity to polyQ toxicity. Interestingly, 
expression of polyQ proteins upregulated the expression of TRA1 and other genes 
encoding SAGA components, revealing a feedback mechanism aimed at maintaining 
Tra1 and SAGA functional integrity. Moreover, deleting the TORC1 effector SFP1 
abolished upregulation of TRA1 upon expression of polyQ proteins. While Sfp1 is known 
to adjust ribosome biogenesis and cell size in response to stress, we identified a new role 
for Sfp1 in the control of TRA1 expression, linking TORC1 and cell growth regulation to 
the SAGA acetyltransferase complex during misfolded protein stress.  
4.2 Introduction 
Eukaryotic cells need to correctly fold proteins to ensure their accurate function and 
avoid the aggregation of toxic misfolded intermediates, which form the basis of several 
human diseases (Balch et al., 2008; Henning and Brundel, 2017; Klaips et al., 2018; 
Ruegsegger and Saxena, 2016). In Huntington’s disease (HD), expansion of a 
polyglutamine region encoded by the first exon of the gene encoding the Huntingtin 
protein (Httex1) leads to Htt misfolding and aggregation in detergent-insoluble, amyloid-
like inclusion bodies (IBs) in the cytoplasm and nuclei of neuronal cells (Gusella et al., 
2014; Huang et al., 1998; Telenius et al., 1994). Accumulation of toxic polyQ oligomers 
is linked to several cellular dysfunctions such as defects in protein trafficking, autophagy 
and endoplasmic reticulum stress (Ashkenazi et al., 2017; Duennwald and Lindquist, 
2008; Jiang et al., 2016; Koga et al., 2011; Lajoie and Snapp, 2011; Ravikumar et al., 
2004; Vidal et al., 2012). In response to the accumulation of misfolded proteins, 
including polyQ huntingtin, cells modify their gene expression profile to favor adaptive 
responses directed at restoring protein homeostasis (Becanovic et al., 2010; Neueder and 
Bates, 2014; Tauber et al., 2011). Well-characterized responses to proteotoxic stress, such 
as the unfolded protein response of the endoplasmic reticulum (Duennwald and Lindquist, 
2008; Haynes et al., 2004; Lajoie and Snapp, 2011; Leitman et al., 2014; Vidal and Hetz, 
2012; Vidal et al., 2012; Walter and Ron, 2011) and the heat shock response (Bersuker et 
al., 2013; Chafekar and Duennwald, 2012; Fujikake et al., 2008; Verghese et al., 2012) in 
the cytoplasm, increase the folding capacity of their respective compartments upon 
accumulation of misfolded polyQ expansions. These responses prevent the protein quality 
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control machinery from being overwhelmed by sudden changes in the misfolded protein 
burden.  
It is now clear that multiple signaling pathways act in parallel to regulate gene expression 
during misfolded protein stress. Acetyltransferase complexes regulate chromatin 
remodeling, a process affected in HD (Dong et al., 2015; Guiretti et al., 2016; McFarland 
et al., 2012; Sharma and Taliyan, 2015; Steffan et al., 2001; Valor et al., 2013). The 
SAGA (Spt-Ada-Gcn5-Acetyltransferase) and NuA4 (Nucleosome acetyltransferase of 
H4) complexes were first identified in yeast as containing the lysine acetyltransferases 
Gcn5 and Esa1, respectively (Allard et al., 1999; Auger et al., 2008; Grant et al., 1997). 
Both complexes have homologues in mammalian cells, hSAGA and Tip60, respectively.  
The PIKK family member Tra1/TRRAP is an essential component of both SAGA and 
NuA4 complexes in yeast and mammalian cells (Ikura et al., 2000; McMahon et al., 
1998). The group of PIKK proteins also includes mTOR, ATM and ATR, which are 
characterized by a C-terminal PI3K domain (Baretić and Williams, 2014). In SAGA and 
NuA4, Tra1 interacts with transcriptional activators thereby recruiting the complexes to 
target promoters (Bhaumik et al., 2004; Brown et al., 2001; Fishburn et al., 2005; Reeves 
and Hahn, 2005). Because of its presence in both SAGA and NuA4, reducing Tra1 
function affects cells distinctly from deletions of components specific to either individual 
complex. For example, impaired Tra1 function causes generation-dependent telomere 
shortening, a phenotype that is not detected in cells carrying deletions of either SAGA or 
NuA4 components (Mutiu et al., 2007b). 
Misfolded polyQ expansions specifically alter the composition of the SAGA complex and 
SAGA-regulated gene transcription in both yeast and mammalian models (Burke et al., 
2013; Chen et al., 2012; Helmlinger et al., 2004; Lan et al., 2015; McMahon et al., 2005; 
Yang et al., 2015). These studies employed polyQ-expanded ataxin-7/Sca7, which causes 
the neurodegenerative disease spinocerebellar ataxia 7 (Holmberg et al., 1998). 
Sca7/ataxin-7 is a component of SAGA and SLIK (SAGA-like) acetyltransferase 
complexes, explaining the effect of polyQ expanded-Sca7 on SAGA function (McMahon 
et al., 2005; Yang et al., 2015). Targeting Httex1 to the yeast nucleus also alters 
transcription similarly to cells carrying deletions in genes encoding SAGA components 
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(Hughes et al., 2001); however, the specific molecular mechanism by which Httex1 polyQ 
expansions affect SAGA function remains unclear. Our previous genetic screen for 
synthetic interactions linked Tra1 to the regulation of several stress responses, including 
protein misfolding stress (Hoke et al., 2008). Tra1 is therefore a strong candidate target to 
regulate the transcriptional response to protein misfolding stress caused by polyQ 
proteins.  
To study the effect of Httex1 polyQ expansion on yeast, we employed a well-characterized 
model that involves expressing fluorescently-tagged Httex1 (Albakri et al., 2018; 
Duennwald, 2013; Duennwald et al., 2006a; Duennwald et al., 2006b; Jiang et al., 2017; 
Meriin et al., 2002). We define the interplay between Tra1 and polyQ-induced stress and 
identify the TORC1 effector Sfp1 as a regulator of polyQ toxicity that regulates Tra1 
expression during proteotoxic stress. Our study thus expands the understanding of its role 
beyond the regulation of cell growth and ribosome biogenesis (Fingerman et al., 2003; 
Jorgensen et al., 2004; Marion et al., 2004) and defines how TORC1, Sfp1 and Tra1 
respond to toxic polyQ proteins.  
4.3 Materials and Methods 
 Yeast genetic manipulation and growth assays 
All strains are derivatives of either BY4741/4742 or W303a (see Table 4.1). Gene 
deletions were performed using standard yeast genetics procedures (Janke et al., 2004) 
and validated by sequencing. Plasmids were transformed using the lithium acetate 
method (Gietz and Woods, 2002). Cell growth was assessed by both spot assay on agar 
plates and growth in liquid culture as previously described (Jiang et al., 2018). Yeast cells 
were cultured overnight in selective synthetic complete media with 2% glucose as a sole 
carbon source. For spot assays, cultures were diluted to equal concentrations and then 
spotted in 4 five-fold dilutions using a pinning tool with the most concentrated spot 
equalized at OD600 0.2. Cells were grown on selective plates at 30 °C for 2 days and 
imaged using a GelDoc system (Bio-Rad). For liquid culture, cells were diluted to OD600 
0.1 and incubated at 30oC. OD600 was measured every 15 min using a BioscreenC plate 
reader (Growth curves USA) for 24 hours. Growth curves were generated and the area 
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under the curve calculated for each biological replicates and a two-tailed Student’s t-test 
was used to determine statistical significance between the different experimental 
conditions using Graphpad (Prism). To generate the sfp1Δ tra1Q3 double mutant, 
the sfp1Δ and tra1Q3 (CY6586) were mated and diploids were selected on media 
containing G418 and lacking leucine. The diploid strain (CY8479) was sporulated in 3 
mL 1% potassium acetate and tetrads were dissected. The haploid double sfp1 
tra1Q3 strain (CY8482) was selected based on its ability to grow on media containing 
G418 and media lacking leucine and histidine. 
 Drugs 
Stock solutions of tunicamycin (5 µg/ml in DMSO; Amresco), Trichostatin A (10 mM in 
H2O; Biovision), calcofluor white (30 mg/ml in H2O; Sigma-Aldrich), rapamycin (1 
mg/ml in DMSO, Fisher Scientific), H2O2 (9.79 M) cycloheximide (10 mg/ml in 
H2O;Fisher Scientific), and MMS (99%; Acros Organics) were prepared and used at the 
indicated concentrations.  
 DNA constructs 
Plasmids encoding fluorescently tagged Httex1 and LacZ reporter constructs carrying 
TRA1, PHO5, and NCW2 (Berg et al., 2018; Mutiu et al., 2007a) promoters in YCp87 
(Brandl et al., 1993) were previously described (see Table 4.2). SPT7 promoter sequences 
relative to the translational start, -633 to +68, NGG1 promoter sequences -430 to +5 and 
EAF1 promoter sequences -890 to +31 were engineered by PCR as BamHI/HindIII 
fragments using oligonucleotides listed in Table 3 and cloned into YCp87 (Brandl et al., 
1993) to generate transcriptional reporters. Vectors encoding fluorescently tagged Tra1 
with yemRFP (Keppler-Ross et al., 2008) were generated by replacing the eGFP coding 
sequence by the new codon-optimized fluorescent proteins using the BamHI/NotI sites in 
the previously described eGFP-Tra1 vector (Genereaux et al., 2012) using primers listed 
in Table 4.3. 
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  Table 4.1 Strains used in this study 
 
Strains Genotype Reference 
W303 
MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-
1 his3-11,15 
 (Thomas and 
Rothstein, 1989) 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0  (Brachmann et al., 
1998) BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
W303 GAL-
FLAG-25Q 
ΔPRO-CFP 
Isogenic to W303 + GAL-FLAG-25Q ΔPRO-
CFP 
(Duennwald et al., 
2006) 
W303 GAL-
FLAG-46Q 
ΔPRO-CFP 
Isogenic to W303 + GAL-FLAG-46Q ΔPRO-
CFP 
W303 GAL-
FLAG-72Q 
ΔPRO-CFP 
Isogenic to W303 + GAL-FLAG-72Q ΔPRO-
CFP 
TS161 MATα ura3-52 (Takahara and 
Maeda, 2012) TS184 MATα ura3-52 TOR L2134M 
BY4742 sch9Δ Isogenic to BY4742 sch9Δ:: KAN Thermo/deletion 
collection BY4742 sfp1Δ  Isogenic to BY4742 sfp1Δ:: KAN 
W303 sfp1Δ  Isogenic to W303 sfp1Δ:: NAT  This study 
BY4741 eaf1Δ  Isogenic to BY4741, eaf1Δ:: KAN Thermo/deletion 
collection 
  BY4741 ada2Δ  Isogenic to BY4741, ada2Δ:: KAN 
yMS928  Isogenic to BY4742, SFP1-GFP:: KAN (Lopez et al., 2011) 
CY4350 
MATa ura3Δ0 his3Δ0 leu2Δ0 tra1-F3744A-
HIS3 
(Hoke et al., 2010) CY4353 MATa ura3Δ0 his3Δ0 leu2Δ0 TRA1-HIS3 
CY8479 MATa/α SFP1/sfp1::KanMX TRA1/tra1Q3-HIS3 
YCplac111-DED1pr-YHR100C This study 
CY8482 Matα spf1::KanMX tra1Q3-HIS3 YCplac111-
Ded1pr-YHR100C This study 
CY6808 Isogenic to BY4742 except URA3-Flag5-TRA1 
(Berg et al., 2018) 
YSC1178-
202230655 
Isogenic to BY4741 except TAP-ADA2 
(Ghaemmaghami et 
al., 2003) 
YSC1178-
202230938 
Isogenic to BY4741 except TAP-EPL1 	
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Table 4.2 Plasmids used in this study 
 
Plasmids Number Vector backbone Resistance Reference 
MET-25Q ΔPRO-CFP   
  pRS426 URA (Duennwald et al., 2006) MET-103Q ΔPRO-CFP 
GAL-FLAG-25Q ΔPRO-
ymsfGFP  pPL005 
pRS415 LEU 
  
 (Jiang et al., 2017) 
GAL-FLAG-72Q ΔPRO-
ymsfGFP  pPL006 
GAL-FLAG-25Q ΔPRO-
CFP 
 pRS416  URA (Duennwald et al., 2006) 
GAL-FLAG-103Q 
ΔPRO-CFP 
TRA1-ymsfGFP pPL022 
 pTZ19 URA 
This study 
TRA1-yemRFP pPL023 This study 
TRA1-LacZ 
  
  
  
  
  
YCp87 
  
  
  
  LEU 
 (Berg et al., 2018) 
SPT7-LacZ  This study 
NGG1-LacZ  This study 
EAF1-LacZ  This study 
PHO5-LacZ  (Mutiu et al., 2007) 
NCW2-LacZ  (Berg et al., 2018) 	
Table 4.3 Primers used in this study 
 
Gene Forward Primer Reverse Primer 
U3 CCCAGAGTGAGAAACCGAAA AGGATGGGTCAAGATCATCG 
RPL6 GCGTGCCTCTCTAGTTCCAG CGTTGACACCTTCGACAGAA 
RPL30 ATCATTGCCGCTAACACTCC CCGACAGCAGTACCCAATTC 
RPL38 GACGTTAAGACCGCCACTGT AAGTTGGTGGCAAAGATGG 
TRA1 CTACTGCCACCACAAGCTGA CCTTTGCTTCAGGTCTTTGC 
SPT7 
promoter 
GGATCCGCGAGCTACTATTTG
TTGAAGG 
 
AAGCTTCAGTCAATTTAAGTA
AAGCTTTG 
 
NGG1 
promoter 
GGGGATCCTTCTCTCACAGTT
TTAGC 
GGGAAGCTTCAGACATTATTC
CTGTCCAATACTTCTCGT 
EAF1 
promoter 
CCCAAGCTTTGAGTGACATCG
GCAAAATGC 
 
AAAGGATCCACCGGAAGTCG
TTCCACCTT 
ymsfGFP CGGGATCCATGGTATCCAAAG
GTGAAGAAT 
ATAAGAATGCGGCCGCCTTAT
ACAATTCATCCATACCG 
 
YemRFP CGGGATCCATGGTTTCAAAAG
GTGAAGAAG 
ATAAGAATGCGGCCGCTTTAT
ATAATTCATCCATACCACC 
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 Fluorescence microscopy 
Cells were diluted 10X and transferred to LabTek imaging chambers (Thermo Inc.) and 
imaged at room temperature. Fluorescence microscopy was performed using a Zeiss 800 
confocal microscope equipped with a 63× Plan Aprochromoat objective (1.4 NA). 
Images were analyzed using the ImageJ software (Schindelin et al., 2015). 
 qRT-PCR 
RNA extraction was performed using MasterPure Yeast RNA Purification Kit (Lucigen). 
cDNA synthesis was done by qScript Flex cDNA Synthesis Kit (Quanta Bioscience). The 
cDNA preparations were used as the template for amplification using PerfeCTa SYBR-
Green Supermix (Quanta Bioscience). The primers used are listed in supplemental Table 
3. The relative expression level was calculated using the comparative Ct method and U3 
was used as a reference gene. 
 Western blot 
Yeast cells were lysed using 0.1 M NaOH for 5 min at room temperature, resuspended in 
SDS sample buffer and boiled for 5 min (Kushnirov, 2000). Proteins were separated 
using SDS-PAGE and transferred to PVDF membrane. The membrane was blocked with 
5% milk. Then the membrane was incubated with anti-Flag (M2, Sigma-Aldrich), anti-
PGK1 (Invitrogen), anti-histone H3 and anti-acetyl-histone H3K14 (Abcam) overnight, 
followed by 1 h incubation with the appropriate fluorescent secondary antibody and 
imaged with an Odyssey infrared imager (Licor) to detect the signal. 
 β-galactosidase assay 
Cells were harvested and resuspended in LacZ buffer. β -galactosidase activity from 50 µl 
of cell lysate was calculated using o-nitrophenol-β-D-galactosidase as substrate and 
values were normalized to cell densities as previously described (Berg et al., 2018; Mutiu 
et al., 2007b).   
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 Pull-down assay 
Pull down was performed as previously described (Berg et al., 2018). 4L of cells were 
harvested and washed in IPP150 buffer, expelled into liquid nitrogen and grinded to 
powder. Lysates were resuspended in 1ml IPP150 buffer and spun at 40k rpm for 1h at 
4 °C. The middle layer was extracted and then transferred to a column and mixed with 
400 µl IgG agarose resin. The column was then rotated at 4 °C for 2 h before transfer to a 
new column with 250 µl TEV cleavage buffer and 3 µl TEV. The column was inverted 
manually every 15 min for 3 h. Proteins were then collected in a new column with 
calmodulin resin and rotated 1 h at 4 °C. Samples were eluted with calmodulin elution 
buffer. Finally, protein was mixed with SDS sample buffer and processed for gel 
electrophoresis followed by staining with coomassie blue and imaging with a GelDoc 
system (Bio-RAD). 
 Statistical analysis  
Unless indicated otherwise, a Student’s t-test was used to determine statistical 
significance between the different experimental conditions using GraphPad Prism v6.0h. 
4.4 Results  
 PolyQ expansions compromise the SAGA histone 
acetyltransferase complex 
In our experiments, Httex1 is placed under the control of the GAL1 promoter and induced 
by growth in galactose as sole carbon source. Under these conditions, expressing HD-
associated polyQ lengths 46Q and 72Q result in a polyQ length-dependent growth defect 
compared to the non-HD associated 25Q (Duennwald and Lindquist, 2008; Duennwald et 
al., 2006b; Duennwald et al., 2006a) (Figure 4.1A). 25Q does not cause a growth defect 
when compared to the corresponding empty vector (Supplemental Figure 4.1). As 
opposed to other disease-causing misfolded proteins, such as α-synuclein, polyQ 
expression inhibits cell growth but does not cause significant cell death as measured by 
either regrowth assays or labeling of dead cells with propidium iodide (Supplemental 
Figure 4.2). The effect of a 103Q Httex1 polyQ expansion is also apparent when expressed 
at lower levels under the transcriptional control of the relatively weak MET25 promoter 
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(Duennwald and Lindquist, 2008) (Figure 4.1B). This model allows testing low polyQ 
toxicity without altering the carbon source. High expression of polyQ expanded Httex1 
results in polyQ length-dependent formation of cytoplasmic aggregates that can be 
observed using fluorescence microscopy (Figure 4.1C).  
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Figure 4.1 PolyQ expansions are toxic and aggregate in yeast. 
 (A) The yeast model of HD as previously developed (Duennwald, 2013; Duennwald 
and Lindquist, 2008; Duennwald et al., 2006a). Cell expressing high levels of CFP-
tagged Httex1 driven by the GAL1 promoter display polyQ length-dependent toxicity. 
25Q serves as a control for non-pathological Httex1. Cell growth was assessed by 
serial dilutions on SC plates containing either glucose (control) or galactose (polyQ 
induced). (B) Cells expressing low levels of CFP-tagged Httex1 driven by the MET25 
promoter display only modest growth defect even in presence of 103Q. Cell growth 
was assessed by serial dilutions on SC plates containing presence (control) or 
absence (polyQ induced) of methionine. (C) Fluorescent images show accumulation 
of inclusion bodies in 46Q and 72Q-expressing cells as opposed to diffused cytosolic 
distribution of 25Q after induction in galactose. 
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Misfolded polyQ proteins associated with the polyglutamine disease spinocerebellar 
ataxia disrupt assembly of the SAGA complex and SAGA-dependent transcription 
(McMahon et al., 2005). The ensuing phenotype resembles those associated with 
deletions of SAGA complex components. Sca7, the protein responsible, is a subunit of 
the hSAGA complex. Thus, its impact on SAGA function is expected. To investigate the 
relationship between Httex1, a protein that is not part of the acetyltransferase complexes, 
we examined genetic interactions of Httex1 with deletions of NuA4 (eaf1Δ, eaf6Δ, yaf9Δ) 
and SAGA (ada2Δ, spt8Δ, ubp8Δ) components (Figure 4.2A). Expanded polyQ 
expression displayed increased growth defects with deletion of the SAGA components 
Ada2 and Ubp8, but not Spt8. This could indicate that specific Spt8 activities such as 
interaction of SAGA with the TATA-box binding protein (TBP) are not targeted by 
polyQ expansions (Mohibullah and Hahn, 2008; Warfield et al., 2004).  72Q expression 
affected growth in one of the NuA4 related deletions, eaf6Δ. To look at the effect of 
polyQ on a Tra1 mutant, we employed a previously characterized loss-of–function 
mutant of TRA1 (tra1-F3744A) that carries a mutation in the C-terminal FATC domain 
(Hoke et al., 2010). tra1-F3744A displayed growth defects in presence of expanded 46 Q 
in both plate and liquid growth assays (Figure 4.2B).  Supporting these data, polyQ 
expression sensitized cells to stresses that result in slow growth of strains carrying TRA1 
mutations, i.e. calcofluor white, growth at 39 °C, 5% ethanol, MMS and caffeine (Berg et 
al., 2018) (Figure 4.2C).  Expression of expanded polyQ proteins was also associated 
with decreased activity from SAGA regulated promoters (HIS4 and PHO5) but not from 
the SAGA-independent NCW2 promoter (Figure 4.3A).  Similar to the results of 
expanded PolyQ on SAGA function described by Hughes et al., 72Q reduced global 
acetylation of the SAGA modified histone H3 approximately to 60% of wild-type (Figure 
4.3B). Global acetylation of the NuA4-modified histone H4 was reduced to a lesser 
extent, approximately 80% of wild-type (Figure 4.3B).  
  
136 
 
 
  
 
Figure 4.2 PolyQ enhanced toxicity in strains deleted for the SAGA components 
UBP8 and ADA2 as well as a tra1-F3744A mutant strain.  
(A) Wild-type, ada2Δ, spt8Δ, ubp8Δ (SAGA) and eaf1Δ, eadf6Δ, yaf9Δ (NuA4) cells 
expressing either GAL1-inducible 25Q or 46Q Httex1 assessed by growth assays on 
SC media plates in presence of glucose (control) or galactose (polyQ induced). (B) 
Wild-type and tra1-F3744A cells expressing either GAL1-inducible 25Q or 46Q 
Httex1 were assessed by growth assay on SC media plates and in liquid growth assay 
in presence of glucose (control) or galactose (polyQ induced). The area under the 
curve was quantified for each replicates (n=3) **p<0.005. (C) Cells expressing either 
MET25-inducible 25Q or 103Q Httex1 were spotted on plates containing various 
stressors (0.1% caffeine, 6µg/ml calcofluor white (CFW), 5% ethanol (ETOH), 0.1% 
caffeine, 0.03% methyl methanesulfonate (MMS) or incubated at 39oC) in presence 
or absence of methionine.  
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Figure 4.3 PolyQ expansions reduce Tra1-regulated gene expression.  
(A) Expression of GAL1-inducible 72Q induced a significant decrease in the 
expression from the SAGA-regulated genes HIS4 and PHO5. NCW2 is shown as a 
control.  Gene expression was analyzed using LacZ transcriptional reporters and was 
assessed after overnight induction of polyQ in galactose under conditions that 
induced each promoter (absence of histidine or low phosphate respectively). 
**p<0.005, n=3±SEM. (B) Reduced histone acetylation in cells expressing expanded 
polyQ.  Immunoblot of total (H3 and H4) and acetylated histone H3 (H3-AcK14) and 
H4 (H4-AcK16) with or without expression of GAL1-inducible 25 and 72Q. *p<0.05, 
**p<0.005, n=3±SEM. 
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 Accumulation of misfolded polyQ proteins increase TRA1 
expression  
We previously observed that Tra1 bearing mutations in its PI3K domain (tra1Q3) decrease 
nuclear localization of the protein (Berg et al., 2018). We therefore assessed whether 
expressing polyQ expansion affects Tra1 localization using confocal microscopy. We 
found that expanded polyQ expression (72Q-ymsfGFP) did not change the nuclear 
localization of fluorescently tagged Tra1 (yemRFP-Tra1) (Figure 4.4A). Consequently, 
polyQ possibly alters SAGA function independently of Tra1 sequestration into 
cytoplasmic polyQ inclusions, possibly by altering composition of the SAGA complex. 
We tested this possibility by pulling down SAGA using a TAP-tagged Ada2 in cells 
expressing either 25 or 72Q and analyzing the associated proteins by SDS-PAGE. As 
shown in Figure 4.4B Tra1 was still assembled into SAGA in strains expressing 72Q. 
However other components such as Ngg1 and Spt7 displayed reduced incorporation. 
Cells also respond to the defective tra1Q3 allele by increasing the transcription of the 
TRA1 gene (Berg et al., 2018). We assayed expression from the TRA1 promoter to 
evaluate whether expanded polyQ results in increased TRA1 expression. As shown in 
Figure 4.4A, we found a ~2.5 fold increase in TRA1 expression of a TRA1-promoter LacZ 
fusion upon expression of 72Q compared to the non-toxic 25Q. Increased transcription 
was also observed from promoters of other components of SAGA and NuA4, i.e. NGG1, 
SPT7 and EAF1, as was the case for tra1Q3 (Berg et al., 2018) (Figure 4.5A). We also 
observed that the polyQ-induced increase in TRA1 expression was abolished when cells 
expressing 72Q were treated with the HDAC inhibitor trichostatin A (TSA) (Figure 4.5B), 
suggesting that changes in chromatin remodeling regulate TRA1 expression in the 
presence of polyQ expansion. As a consequence of increased mRNA levels (as measured 
by qRT-PCR (Figure 4.5C), Tra1 protein abundance increased upon expression of 72Q 
(Figure 4.5D). These results suggest that expanded polyQ impairs Tra1 function inducing 
a feedback mechanism to cope with disrupted SAGA/NuA4 function. As shown in Figure 
4.5E, the increased TRA1 expression was specific to polyQ and was not observed with 
other stressors that result in protein misfolding, such as induction of endoplasmic 
reticulum stress by tunicamycin, heat shock, oxidative stress caused by H2O2, or 
perturbation of cell wall integrity by calcofluor white (Figure 4.5E).  Moreover, 
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expression of α-synuclein, another disease causing misfolded protein, reduced TRA1 
promoter activity, indicating that various misfolded proteins differentially affect TRA1 
transcriptional regulation (Figure 4.5F). This is in agreement with previous data showing 
that α-synuclein and Httex1 expression in yeast display a different subset of genetic 
interactions and differential induction of stress responses (Cooper et al., 2006; 
Willingham et al., 2003).  
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Figure 4.4 Tra1 is not sequestered into polyQ inclusion bodies.  
(A) Tra1 remains localized to the nucleus in the presence of polyQ aggregates. 
Fluorescent images showing localization of GAL1-inducible polyQ-ymsfGFP (25 and 
72Q) and yemRFP-Tra1 after overnight culture in glucose (control) or galactose 
(polyQ induced). (B) Pull-down assay using Ada2TAP shows that Tra1 still 
incorporates into SAGA in presence of GAL1-inducible 72Q-ymsfGFP. However, 
levels of Ngg1 and Spt7 are reduced upon expression of 72Q-ymsfGFP.  
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Figure 4.5 TRA1 expression is increased in presence of toxic polyQ expansions. 
 (A) Increased expression of TRA1 and other SAGA (NGG1, SPT7) and NuA4 
(EAF1) components as well as the control NCW2 after overnight induction of GAL1-
inducible 72Q-CFP compared to 25Q-CFP.  Expression was analyzed using 
promoter-LacZ reporters. **p<0.005, ***p<0.001 n=3±SEM (B) Treatment with the 
HDAC inhibitor trichostatin A (TSA) abolished TRA1 upregulation caused by polyQ 
expansions. GAL1-inducible 25 and 72Q-CFP were induced overnight in galactose 
media in presence or absence of 80 µM TSA.  (C) Overnight expression of GAL1-
inducible 72Q-CFP leads to increased expression of TRA1 as measured by qRT-PCR. 
(D) Expanded polyQ increases Tra1 protein abundance. Cells expressing 
eitherGAL1-inducible 25 or 72Q-CFP and a chromosomally integrated Tra15x-Flag 
were cultured in glucose or induced overnight in galactose and processed for 
immunoblot. (E) Effects of other stressors on TRA1 expression. Cells expressing the 
TRA1-LacZ reporter were treated with tunicamycin (Tm; 5 µg/ml), heat shocked at 
42 °C, treated with calcofluor white (CFW; 300 µg/ml) or H2O2 (300 µM) for 2 hr. 
n=3 ±SEM.  (F) Expression of α-synuclein decreased TRA1 expression. Cells 
expressing a galactose inducible version of α-synuclein-GFP were cultured in either 
glucose or galactose overnight and TRA1 expression was measured using a LacZ 
reporter. n=3.  
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 Both inhibition and hyperactivation of TORC1 exacerbate 
polyQ toxicity 
Our previous genetic screen highlighted a potential role for Tra1 in stress responses 
(Hoke et al., 2008), including the control of cellular homeostasis by the TORC1 (Target 
of Rapamycin Complex 1) regulated signaling cascades that link nutrient availability to 
cell growth and division. In this screen, a tra1 mutant displayed a synthetic slow growth 
phenotype with a deletion of tor1 (Hoke et al., 2008). Studies in mammalian cells report 
both a protective and adverse role for TORC1 in HD (Ferrarelli, 2015; Lee et al., 2015; 
Pryor et al., 2014; Ravikumar et al., 2002; Ravikumar et al., 2004; Renna et al., 2010). 
We therefore tested the effect of modulating TORC1 activity on polyQ toxicity in yeast. 
First, we determined the effects of TORC1 inhibition using rapamycin (Figure 4.6A and 
B). We found that rapamycin treatment significantly reduced growth of cells expressing 
expanded 103Q protein in both solid and liquid media assays when compared to the 
untreated condition. Interestingly, rapamycin treatment did not significantly alter polyQ 
aggregation (Figure 4.6C). This result argues against a protective role for TORC1 
inhibition by rapamycin through stimulating polyQ aggregates removal through 
autophagy (Ravikumar et al., 2002). Similar to rapamycin, a hyperactive allele of TOR1 
(TOR1L2134M) (Takahara and Maeda, 2012) also exacerbated polyQ toxicity (Figure 4.6D 
and E). The TOR1 mutant had only a modest effect on the toxicity of TDP-43 
(Supplemental Figure 4.4), a protein linked to amyotrophic lateral sclerosis (ALS) 
(Johnson et al., 2008), indicating that the role of TORC1 may diverge in different 
diseases. TORC1 hyperactivation did not prevent the formation of polyQ aggregates 
(Figure 4.6F).  These data indicate that precise regulation of TORC1 signaling is crucial 
for cells to cope with polyQ expansion. Interestingly, the same hyperactive TOR1 mutant 
decreases levels of glutathione (Oku et al., 2013), which is important to counteract ROS 
accumulation in HD models (Mason et al., 2013). TORC1 regulates translation and 
ribosome biogenesis in both yeast and mammals and decreased translation has been 
proposed as a contributor to polyQ toxicity in mammals (Leitman et al., 2014). 
Incidentally, cells expressing 72Q displayed increased sensitivity to the translational 
inhibitor cycloheximide (Figure 4.7A and B) and decreased expression of ribosomal 
protein genes (Figure 4.7C) when compared to 25Q, further supporting a role for TORC1 
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signaling in polyQ toxicity. Therefore, we next investigated the role of downstream 
TORC1 effectors in polyQ toxicity.  
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Figure 4.6 Both inhibition and hyperactivation of TORC1 exacerbate polyQ 
toxicity.  
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   Figure 4.6 
(A) TORC1 inhibition by rapamycin exacerbates polyQ toxicity. Wild-type cells 
expressing either MET25-inducible 25Q or 103Q Httex1 assessed by growth assay on 
SC containing media plates untreated or supplemented with 2 ng/ml rapamycin in 
presence (control) or absence (polyQ induced) of methionine. (B) Wild-type cells 
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid 
growth assay in presence (control) or absence (polyQ induced) of methionine ± 2 
ng/ml rapamycin. The area under the curve was quantified for each replicates (n=3) 
***p<0.001. (C) Representative fluorescent images of wild-type cells expressing 
GAL1-inducible 25Q or 72Q Httex1-ymsfGFP after overnight induction in galactose 
containing media untreated or supplemented with 100 ng/ml rapamycin. (D) Wild-
type and TOR1L2134M cells expressing either MET25-inducible 25Q or 103Q Httex1 
assessed by growth assay on SC containing media plates in presence (control) or 
absence (polyQ induced) of methionine. (E) Wild-type and TOR1L2134M cells 
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid 
growth assay in presence (control) or absence (polyQ induced) of methionine ± 100 
ng/ml rapamycin. The area under the curve was quantified for each replicates (n=3) 
***p<0.001. (F) Representative fluorescent images of wild-type and TOR1L2134M 
cells expressing GAL1-inducible 25Q or 72Q Httex1-ymsfGFP after overnight 
induction in galactose containing media.  
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Figure 4.7 PolyQ expansions sensitize cells to translational inhibition.  
(A) PolyQ increased cell sensitivity to cycloheximide. Wild-type cells expressing 
either MET25-inducible 25Q or 103Q Httex1 assessed by growth assay on SC 
containing media plates untreated or supplemented with 0.1 µg/ml cycloheximide in 
presence (control) or absence (polyQ induced) of methionine. (B) Wild-type cells 
expressing either MET25-inducible 25Q or 103Q Httex1 were assessed by liquid 
growth assay in presence (control) or absence (polyQ induced) of methionine ± 0.1 
µg/ml cycloheximide. The area under the curve was quantified for each replicate (n=3) 
***p<0.001. (C) PolyQ expression decreased expression of ribosomal protein genes. 
RNA was isolated from wild-type cells expressing GAL1-inducible 25Q or 72Q Httex1-
CFP after overnight induction in galactose containing media and processed for RT-
qPCR to assess transcript levels of RPL6, RPL30 and RPL38. *p<0.05, **p<0.01. 
(n=3) 
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 Sfp1/TORC1 regulates TRA1 expression  
In yeast, TORC1 controls gene expression via two main downstream effectors, the 
mammalian S6 kinase homologue Sch9 and the transcription factor Sfp1 (Loewith and 
Hall, 2011). Sch9 localizes to the vacuolar membrane and mediates TORC1 signaling 
that regulates ribosomal protein gene expression and cell cycle progression (Urban et al., 
2007). Tor1 also interacts with the transcription factor Sfp1, which regulates expression 
of ribosomal proteins (Jorgensen et al., 2004; Lempiäinen et al., 2009; Marion et al., 2004; 
Singh and Tyers, 2009). During exponential growth, Sfp1 localizes to the nucleus, where 
it drives transcription of ribosomal protein genes. During various types of stress, 
including protein misfolding, oxidative stress, and nutrient deprivation, Sfp1 translocates 
to the cytoplasm (Jorgensen et al., 2004; Lempiäinen et al., 2009; Marion et al., 2004; 
Singh and Tyers, 2009) where it is degraded by the proteasome (Lopez et al., 2011). Here, 
we found that deleting SFP1, but not SCH9 exacerbated polyQ toxicity (Figure 4.8A). 
This agrees with Sfp1 and Sch9 having non-overlapping functions(Jorgensen et al., 2004). 
Indeed, the two deletion strains display specific phenotypes. Relevant to our study, sfp1Δ 
increases rapamycin sensitivity as compared to sch9Δ (Lempiäinen et al., 2009). 
Increased polyQ toxicity in sfp1Δ cells was not associated with significant changes in 
formation of inclusion bodies (Figure 4.8B). Expression of ribosomal protein genes 
decreased in the presence of misfolded polyQ (Figure 4.7C) consistent with a loss of 
Sfp1-mediated TORC1 signaling. This may include the global effects on translation due 
to targeting the ribosomal protein genes, since loss of protein translation due to 
cycloheximide treatment exacerbates polyQ toxicity. In the same way, reduced 
translation is linked to polyQ toxicity in mammalian cells (Leitman et al., 2014). 
Surprisingly, sfp1Δ cells crossed with the tra1Q3 mutant allele are viable with the 
mutations displaying epistasis, suggesting that both genes function in the same pathway 
(Figure 4.8C). Indeed, tra1Q3 displayed reduced ribosomal protein gene expression 
(Figure 4.8D). In the same way, nuclear depletion of Tra1 using the anchor-away 
approach decreases recruitment of Esa1 and Gcn5 to ribosomal protein gene promoters 
(Bruzzone et al., 2018).  
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Figure 4.8 Deletion of SFP1 exacerbates polyQ toxicity.  
(A) Deletion of SFP1 but not SCH9 exacerbates polyQ toxicity. Wild-type, sfp1Δ and 
sch9Δ cells expressing either MET25-inducible 25Q or 103Q Httex1 assessed by 
growth assay on SC media plates in presence (control) or absence (polyQ induced) of 
methionine. (B) Deletion of SFP1 does not affect formation of polyQ IBs. 
Representative fluorescent images of wild-type and sfp1Δ cells expressing GAL1-
inducible 25Q or 72Q Httex1-ymsfGFP after overnight induction in galactose 
containing media. (C) The tra1Q3 allele displays an epistatic phenotype with sfp1Δ. 
Cells carrying the SFP1 deletion were crossed with cells carrying the tra1Q3 allele. 
Growth of the double mutant and the parental strains were assessed by spotting 
assays on agar plates. (D) The tra1Q3 allele displays reduced levels of ribosomal 
protein gene expression. Wild-type cells and cells carrying the tra1Q3 allele were 
processed for RT-qPCR to assess transcript levels of RPL6, RPL30 and RPL38. 
***p<0.005. (n=3) 
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In agreement with reduction of ribosome protein gene levels, Sfp1-GFP relocalized to the 
cytoplasm upon 103Q expression, in contrast to its nuclear localization in cells expressing 
non-toxic 25Q (Figure 4.9A). Interestingly, cytoplasmic Sfp1 is recruited to polyQ 
aggregates (Figure 4.9A). To quantify recruitment or exclusion of Sfp1 in polyQ 
aggregates we adapted a size-normalized, averaging based analysis method developed by 
Li et al. for studying Httex1 aggregates in mammalian cells (Li et al., 2016). Briefly, we 
analyzed several 1.75 x 1.75 µm polyQ-aggregates containing regions of interest (Figure 
4.9B). Then, we generated an intensity map by averaging multiple regions for 20 
different cells (Figure 4.9C). We next calculated the fluorescent intensity of 103Q-RFP 
and Sfp1-GFP along a line across the region to generate an intensity curve for both 
channels. Similar shaped curves revealed incorporation of Sfp1-GFP into polyQ 
aggregates (Figure 4.9D).  
Interestingly, Lempiäinen et al. demonstrated that Sfp1 physically interacts with Tra1, 
suggesting that Tra1 may be regulated by Sfp1 in the presence of polyQ proteins 
(Lempiäinen et al., 2009). Tra1 protein levels (Figure 4.10A) but not mRNA (Figure 
4.10B) were modestly decreased in sfp1Δ cells, potentially reflecting reduced global 
translation due to decreased ribosome production (Fingerman et al., 2003; Jorgensen et al., 
2004; Lempiäinen et al., 2009; Marion et al., 2004). Thus, it appears that Tra1 function 
rather than protein level is affected by Sfp1. Indeed, sfp1Δ cells are sensitive to high 
temperature, ethanol, MMS and calcofluor white treatment, hallmarks of impaired Tra1 
function (Figure 4.10C). Reduced Tra1 activity in sfp1Δ cells was further supported by 
the reduced expression of PHO5, a Tra1/SAGA regulated gene (Barbaric et al., 2003; 
Gregory et al., 1998). This phenotype was reversed by the HDAC inhibitor TSA (Figure 
4.11A), indicating that deleting SFP1 may affect SAGA and possibly NuA4-mediated 
chromatin modifications that regulate PHO5 transcription (Barbaric et al., 2003; Gregory 
et al., 1998). We next tested the effect of deleting SFP1 on the polyQ-induced 
upregulation of SAGA and NUA4 components observed in Figure 4.5A. Whereas the 
transcription from the SPT7, NGG1 and EAF1 promoters were still increased upon 
expression of misfolded 72Q, SFP1 deletion abolished TRA1 upregulation (Figure 4.11B). 
These results suggest that Sfp1 is required for proper control of TRA1 expression upon 
polyQ expression. Sfp1 is a known TORC1 effector and TORC1 inhibition with 
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rapamycin downregulates TRA1 expression (Marion et al., 2004) (Figure 4.11C) 
highlighting a role for TORC1 in the control of TRA1 transcriptional regulation. Since 
deleting SFP1 causes hyperactivation of TORC1 as a compensatory mechanism 
(Lempiäinen et al., 2009; Rousseau and Bertolotti, 2016), we hypothesized that 
hyperactivation of TORC1 may prevent upregulation of TRA1 upon accumulation of 
misfolded polyQ expansion. Indeed, TRA1 was not significantly upregulated after 
expression of expanded 103Q in the hyperactive TOR1L2134M strain (Figure 4.11D). 
Coupled to the observed decrease in TRA1 expression upon TORC1 inhibition by 
rapamycin (Figure 4.11C), our results establish that TORC1 signaling regulates TRA1 
expression. 
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Figure 4.9 SFP1 accumulates in cytoplasmic aggregates in response to expanded 
polyQ expression.  
(A) Representative fluorescent images of wild-type cells expressing GAL1-inducible 
25Q or 103Q Httex1-RFP and Sfp1-GFP after 2hr induction in galactose containing 
media. Red arrows highlight localization of Sfp1 into polyQ aggregates. Bar = 5µm. 
(B) Intensity maps for 20 polyQ aggregates containing regions. Panels displaying 
fluorescent signal for both 103Q-RP and Sfp1-GFP are shown. (C) Average of each 
panel presented in (B). An intensity trend line is calculated across the region. (D) 
Intensity plots as a function of the distance across the region are presented for both 
channels. N= 20 regions.  
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Figure 4.10 Loss of SFP1 does not significantly affect Tra1 expression but 
sensitizes cells to stress.  
(A) Deletion of SFP1 has minimal effect on Tra1 protein abundance. Immunoblot 
performed with cell lysates of from wild-type and sfp1Δ cells expressing a 
chromosomally integrated Tra15x-Flag. Blot was probed with anti-Flag. Anti-Pgk1 was 
used as loading control. Densitometric analysis from 3 independent samples is 
shown. (B) Deletion of SFP1 has minimal effect on TRA1 mRNA levels. RNA was 
isolated from wild-type and sfp1Δ cells and processed for RT-qPCR to assess 
transcript levels of TRA1. (C) Wild-type and sfp1Δ cells were spotted on YPD agar 
plates untreated, supplemented with 6µg/ml calcofluor white (CFW), 5% ethanol 
(ETOH), 0.03% methyl methanesulfonate (MMS) or incubated at 39oC. 
 
 
 
 
 
 
 
 
153 
 
 
 
 
  
 
Figure 4.11 Sfp1 and TORC1 regulate TRA1 expression in response to misfolded 
polyQ.  
(A) Sfp1 regulates PHO5 expression. Cells expressing the PHO5-LacZ reporter were 
incubated in absence of phosphate overnight and treated with trichostatin A (TSA) at 
the indicated concentration. Expression from the NCW2 promoter is shown as 
control.  β-galactosidase activity is shown as the average of 3 replicates with the 
SEM indicated by the error bars. ***p<0.001 using a one-way anova followed by a 
Tukey’s multi comparison test. (B) Deletion of SFP1 specifically abolishes TRA1 
upregulation by polyQ. Gene expression from TRA1 and other SAGA (NGG1, SPT7) 
and NuA4 (EAF1) promoters after overnight induction of GAL1-inducible 72Q-CFP 
compared to 25Q-CFP in wild-type and sfp1Δ cells. Gene expression was analyzed 
using LacZ transcriptional reporters. **p<0.005, ***p<0.001 n=3±SEM. (C) 
Rapamycin treatment decreases transcription from the TRA1 promoter in both wild-
type and sfp1Δ cells. Gene expression was analyzed using the TRA1-LacZ 
transcriptional reporter. **p<0.005, ***p<0.001 n=3±SEM. (D) Hyperactive TORC1 
signaling prevents upregulation of TRA1 by polyQ. RNA was isolated from wild-type 
and TOR1L2134M cells after overnight induction of GAL1-inducible 25 and 103Q 
Httex1-CFP in galactose media and processed for RT-qPCR to assess transcript levels 
of TRA1.  
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4.5 Discussion 
 Tra1/SAGA and polyQ toxicity 
The ability of cytoplasmic polyQ expanded Httex1 to disrupt Tra1 functions echoes 
previous reports showing that expressing nuclear-targeted Httex1 results in transcriptional 
changes similar to deleting components of the SAGA complex (Hughes et al., 2001). 
Other reports show a similar phenotype using a different disease-associated polyQ protein, 
the SAGA-associated spinocerebellar ataxia 7 (SCA7) (Hughes et al., 2001; McMahon et 
al., 2005). We do not detect significant nuclear localization of Httex1 in our model (Figure 
4.1). Since Tra1 remains localized to the nucleus upon expression of expanded polyQ, it 
is unlikely that the two directly interact, thus favoring indirect regulation of Tra1 function 
by polyQ. Our previous genetic screen using a tra1 mutant allele revealed that Tra1 is 
linked to cellular responses of proteotoxic stress, such as the heat shock response, 
mitochondria homeostasis and TORC1 signaling (Hoke et al., 2008). Interestingly, all 
these processes are linked to polyQ toxicity (Chafekar et al., 2012; Costa et al., 2010; 
Ferrarelli, 2015; King et al., 2008; Lee et al., 2015; Oliveira et al., 2007; Pryor et al., 
2014; Ravikumar et al., 2004; Sakahira et al., 2002; Shirendeb et al., 2011; Squitieri et al., 
2006; Wyttenbach et al., 2002). It is reasonable to deduce that impaired Tra1-regulated 
transcription has an important role in the toxic phenotype observed in HD models. Indeed, 
reduced histone acetylation is closely associated with HD and histone deacetylase 
inhibitors improve the HD phenotype in animal models (Guiretti et al., 2016; Jia et al., 
2016; McFarland et al., 2012; Sharma and Taliyan, 2015; Steffan et al., 2001; Yeh et al., 
2013). Thus, further analysis of the role of the major regulators of chromatin remodeling, 
gene expression and their specific targets may provide avenues for modulating the 
toxicity of polyQ expansion in HD.  
 Sfp1/TORC1 regulates TRA1 expression in presence of toxic 
polyQ proteins 
Sfp1 is well characterized for its role in adjusting cell size and ribosome production 
during stress (Fingerman et al., 2003; Jorgensen et al., 2004; Lempiäinen et al., 2009; 
Marion et al., 2004; Singh and Tyers, 2009), yet its functions outside the control of 
ribosome biogenesis are understudied. Recently, Matthew et al. found that sequestration 
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of the splicing factor Hsh155 during genotoxic stress was regulated via TORC1 signaling 
through Sfp1 (Mathew et al., 2017). Together with our data showing that Sfp1 regulates 
TRA1 expression, this study supports an expanded role for Sfp1 in stress response, 
beyond regulating ribosome biogenesis. The mechanism by which Sfp1 contributes to 
TRA1 expression during proteotoxic stress is unclear, but the results mimic our previous 
findings showing that compromising Tra1 function by mutating its PI3-kinase domain 
increases transcription of TRA1 (Berg et al., 2018).  It appears that the cells use a 
transcriptional feedback mechanism to increase the expression of TRA1 and other 
components of the SAGA and NuA4 complexes to compensate for the loss of Tra1 
function. Whether a common transcription factor is involved remains unknown.  
PolyQ expansions and expression of the tra1Q3 mutant allele (Berg et al., 2018) are the 
only experimental conditions identified to date that increase TRA1 expression. Deletion 
of other SAGA/NuA4 components does not upregulate TRA1, indicating that disruption 
of HAT complexes cannot solely explain the phenotype (Berg et al., 2018). Moreover, 
polyQ expansions also upregulated TRA1 in the absence of ADA2 (Supplemental Figure 
4.5). Thus, an intact SAGA complex does not appear to be required for TRA1 
upregulation by polyQ. Interestingly, polyQ-induced TRA1 expression requires Sfp1 
(Figure 4.8). Microarray analyses revealed that overexpressing SFP1 does not upregulate 
TRA1, indicating that Sfp1 might regulate Tra1 indirectly (Jorgensen et al., 2004). Similar 
to what we observe with TRA1, deleting SFP1 abolishes upregulation of the proteasome 
regulator ADC17 during tunicamycin-induced endoplasmic reticulum stress (Rousseau 
and Bertolotti, 2016). Since in both cases, stress leads to Sfp1 relocalization to the 
cytoplasm, it appears that Sfp1 regulates these targets indirectly, potentially via its 
regulation of TORC1. In our case, relocalization of Sfp1 to the cytoplasm may disrupt the 
previously reported Sfp1 interaction (Lempiäinen et al., 2009) with Tra1 (which remains 
in the nucleus). Moreover, recruitment of Sfp1 to polyQ aggregates could contribute to 
reduced Sfp1 function and signaling in these cells, resulting in impaired Tra1/SAGA 
function. Sfp1 is known for its ability to acquire a prion form termed  [ISP+] (Matveenko 
et al., 2016; Rogoza et al., 2010; Volkov et al., 2002). At the same time, polyQ toxicity 
relies on certain prions such as [RNQ+] (Manogaran et al., 2011; Meriin et al., 2002) and 
polyQ expansions both stimulate formation (Derkatch et al., 2004) and interact with 
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prions (Douglas et al., 2009). Thus, one could postulate that recruitment of Sfp1 and/or 
its prion form [ISP+] could play a role in restricting Tra1 function. That could explain 
why TRA1 upregulation observed with polyQ is not seen with α-synuclein, which toxicity 
is largely independent of the prion status (Derkatch et al., 2004).  It is also possible that 
Sfp1/[ISP+] interacts with polyQ oligomers outside of the visible aggregates. Several 
studies in mammalian cells have implicated intermediate oligomers as the cause of 
toxicity in HD (Arrasate et al., 2004; Lajoie and Snapp, 2010; Moily et al., 2017; 
Takahashi et al., 2007).  
The physiological relevance of the Tra1-Sfp1 interaction will require further investigation.  
A possible explanation for TRA1 transcriptional regulation by Sfp1/TORC1 is that TRA1 
is regulated at multiple levels, one that involves TORC1 but also other pathways 
modulated by toxic polyQ expansions. Interestingly, recent data show that Sfp1 can 
negatively regulate a subset of genes, in particular the Swi4 regulon, which are 
upregulated when Sfp1 is depleted from the nucleus (Albert et al., 2018). This offers an 
attractive model where Sfp1 could act as a negative regulator of TRA1 expression. Finally, 
though there is no homologue of SFP1 in mammals, Sfp1 shares key functions with the 
mammalian proto-oncogene MYC. These functions include regulating ribosomal protein 
gene expression and cell growth (Dang et al., 2006). Importantly, mammalian TRRAP 
interacts with and is required for the activity of Myc (Bhattacharya and Ghosh, 2015; 
Kenneth et al., 2007; Liu et al., 2003; Zhang et al., 2014). These results delineate a link 
between Myc and TRRAP that is reminiscent of the Sfp1/Tra1 connection observed in 
yeast. 
 TORC1, SAGA and polyQ toxicity 
Our data show that TORC1 has to be finely tuned for yeast cells to compensate for polyQ 
toxicity. This is not surprising considering the multitude of cellular processes regulated 
by TORC1 (Betz and Hall, 2013; González and Hall, 2017; Liko and Hall, 2015). 
Interestingly, both activation and inhibition of TORC1 are protective in rodent models of 
HD (Ferrarelli, 2015; Lee et al., 2015; Pryor et al., 2014; Ravikumar et al., 2004). Our 
results suggest that downstream targets of TORC1 function in mammalian cells, similar 
to Sfp1 in yeast, to regulate polyQ toxicity.  The inter-relationship of these targets is 
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important for understanding the therapeutic potential of TORC1 for HD. A TRA1 mutant 
allele is hypersensitive to rapamycin and results in a synthetic slow growth phenotype 
with tor1 deletion (Hoke et al., 2008). In fission yeast, SAGA control of cell proliferation 
and differentiation in response to starvation requires the differential TORC1/TORC2-
dependent phosphorylation of the SAGA component Taf12 (Laboucarié et al., 2017). 
TORC1 also regulates yeast histone acetylation by regulating the sirtuin deacetylases 
Hst3 and Hst4 (Workman et al., 2016) and integrates signals through the INO80 
chromatin remodeling complex (Beckwith et al., 2018). Because of the breadth of cellular 
functions affected by TORC1 and transcriptional regulators like SAGA, a comprehensive 
understanding of how these pathways converge to regulate homeostasis is crucial. 
Inhibiting histone deacetylase is protective in various disease models, including HD (Jia 
et al., 2016; Valor, 2015; Valor and Guiretti, 2014; Yeh et al., 2013). Defining how 
disease-associated proteins affect the global acetylome and identifying specific targets for 
acetylation, including non-histone targets, could lay the basis for the development of new 
small molecule/compounds for combinational therapy.  
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Figure S 4.1 The non-HD associated 25Q Httex1 does not induce a growth defect. 
 Cell expressing high levels of GAL1-inducible CFP-tagged 25Q-Httex1 display no 
growth defect when compared to the corresponding empty vector. Cell growth was 
assessed by serial dilutions on SC plates containing either glucose (control) or 
galactose (polyQ induced). 
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Figure S 4.2 PolyQ expansions do not cause cell death.  
(A) Representative fluorescent images of wild-type cells expressing GAL1-inducible 
25Q or 72Q Httex1-CFP after overnight induction in galactose containing media and 
stained with propidium iodide (PI). Boiled cells are shown as a positive control.  (B) 
α-synuclein expression results in yeast cell death. Growth of cells expressing an 
empty vector or α-synuclein-GFP was assessed by serial dilutions on SC plates 
containing either glucose (control) or galactose (induced). Staining with PI assessed 
cell viability.  
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Figure S 4.3 Hyperactive TOR1L2134M strain is resistant to rapamycin.  
(A) Growth of wild-type and TOR1L2134M cells on agar plate containing 10 ng/ml 
rapamycin. 
 
 
 
 
 
 
 
 
 
 
 
 
161 
 
 
  
 
Figure S 4.4 Hyperactive TORC1 signaling has minimal effect on TDP-43 
toxicity. 
 (A) Growth of wild-type and TOR1L2134M cells expressing a control empty vector 
(+Vector) or TDP-43 (+TDP-43) was assessed by serial dilutions on SC plates 
containing either glucose (control) or galactose (TDP-43 induced). Cells were 
incubated either in glucose (top) or galactose (bottom) prior to spotting on agar plate. 
(B) Growth of wild-type and TOR1L2134M cells expressing an empty vector or TDP-43 
was assessed by growth in either glucose (control) or galactose (TDP-43 induced) 
liquid media. Cells were incubated either in glucose (top) or galactose (bottom) prior 
to spotting on agar plate. (C) Quantification of the liquid growth assays. The area 
under the curve was quantified for each replicates (n=3) ***p<0.001 when compared 
to the control empty vector under the same conditions unless noted otherwise. 
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Figure S 4.5 ADA2 deletion does not abolish Tra1 upregulation by polyQ 
expansions.  
Increased expression of TRA1 after overnight induction of GAL1-inducible 103Q-
CFP compared to 25Q-CFP in wild-type and ada2Δ cells.  Expression was analyzed 
using promoter-LacZ reporters. ***p<0.001 n=3±SEM. 
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Chapter 5 
5 Impaired Tra1-dependent transcription during heat 
shock in the presence of polyQ expansions 
In the last chapter, we demonstrated that HD-associated polyQ expansions lead to 
abnormal upregulation of TRA1 and dysregulate the SAGA HAT complex assembly. As 
reviewed in chapter one, impaired activation of the HSR is one of the hallmarks of HD. 
How expanded polyQ expression dysregulates the HSR remains unclear. Given that 
Tra1/SAGA is involved in the activation of the HSR, we next focused on how polyQ–
dependent impairment of Tra1/SAGA affects the HSR. Studying Tra1-dependent 
transcription during heat shock in polyQ cells will provide new insights into the 
mechanisms underlying the loss of proteostasis in HD.   
5.1 Abstract 
Dysregulation of proteostasis is a significant contributor of polyglutamine (polyQ) 
toxicity in Huntington’s Disease (HD). The heat shock response (HSR) is a vital pathway 
activated under multiple stress conditions to maintain protein homeostasis. The activation 
of HSR allows transcription of genes encoding the heat shock proteins (HSPs) to improve 
the cellular folding environment. Impaired HSR activation has been observed in HD and 
correlates with the reduced cellular capacity to fix damaged protein under stresses such as 
exposure to high temperature and oxidative stress. To understand how polyQ expansions 
impair the HSR, we used a yeast model of HD to study the transcriptional regulation 
under heat shock in the presence of polyQ expansions. The yeast cell wall protects cell 
survival during stresses associated with protein misfolding, including heat shock. We 
found that polyQ impairs the cell wall integrity and exacerbates cell sensitivity to heat 
shock. The transcription co-activator Tra1 has been found to be involved in cellular stress 
response that regulate polyQ toxicity. Our data showed that cells with a mutant Tra1 
allele fail to activate the HSR. These cells were also more sensitive to cell wall stress. 
Our findings suggest that polyQ impairs cell growth under heat shock stress through a 
non-canonical HSR that allows the yeast cells to remodel their cell wall. Thus, our data 
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reveals a new mechanism by which polyQ impairs cellular stress responses and 
proteostasis in the yeast model of HD.  
5.2 Introduction 
Protein homeostasis is crucial for cell viability. Accumulation of misfolded proteins is at 
the root of many neurodegenerative disorders (Parakh and Atkin, 2016; Tan et al., 2009; 
Tayubi et al., 2015). One example is Huntington’s disease (HD), which is linked to 
expanded polyglutamine (polyQ) repeats within the exon 1 of Huntingtin (Htt) protein 
(Gusella and MacDonald, 2009). Misfolded Htt oligomerizes into insoluble aggregates in 
the cytosol and nucleus of the neuronal cells, causing a series of cellular dysfunctions 
such as transcriptional dysregulation, increased endoplasmic reticulum stress, 
mitochondria defects, and impaired HSR (Chafekar and Duennwald, 2012; Duennwald 
and Lindquist, 2008; Kumar et al., 2014; Quintanilla and Johnson, 2009). PolyQ 
expansion leads to neurodegeneration resulting in chorea, cognitive decline, and muscle 
contracture (Roos, 2010). 
Cellular stress responses are signaling pathways induced under stress conditions, which 
are crucial to increase cellular capacity to handle misfolded protein accumulation and 
maintain proteostasis. The HSR is an evolutionarily conserved signaling pathway to 
regulate protein folding and degradation during cell stress (Morimoto and Westerheide, 
2010). Reduced activation of heat shock factor 1 (HSF1), the major transcription 
regulator of the HSR, as well as decreased expression of heat shock proteins (HSPs) 
during heat shock has been observed in cells expressing mutant Htt and in HD knock-in 
mice (Chafekar and Duennwald, 2012). However, the mechanism of how polyQ impairs 
HSR is not clear. A chromatin immunoprecipitation sequencing study reported that most 
genes lost HSF1 binding during polyQ expansion were not directly related to proteostasis, 
but involved in cytoskeletal binding, focal adhesion, and GTPase activity (Riva et al., 
2012). Furthermore, overexpressing Hsp26, Hsp42, and Hsp104 have been shown to 
attenuate polyQ toxicity in a yeast HD model (Cashikar et al., 2005). Interestingly, 
knocking out HSP26 or HSP42 causes cell dehydration, cytoskeleton and cell wall 
damage (Haslbeck et al., 2004). These results suggest that the impaired HSR in cells 
181 
 
expressing expanded polyQ is linked to multiple cellular processes not necessarily linked 
to protein folding. 
Yeast cells have a cell wall structure which is vital in protecting cell integrity and 
survival under stress conditions (Lesage and Bussey, 2006). The cell wall integrity (CWI) 
pathway is activated in response to cellular stresses which regulates cell wall biosynthesis 
and actin cytoskeleton polarization (Levin, 2005).  Previous studies demonstrated a clear 
link between the CWI pathway and the HSR in yeast (Dunayevich et al., 2018; Lamoth et 
al., 2012; Levin, 2011). For example, Truman et al. suggested the crosstalk between the 
two stress response pathways by showing that the osmotic stabilizer sorbitol rescued the 
temperature sensitivity of cells carrying a mutant HSF1 lacking the C terminal domain, 
and  that cells with an impaired CWI displayed a growth defect during heat shock 
(Truman et al., 2007).   
Transcriptional regulation of stress-induced genes is critical for the activation of cellular 
stress responses (Boy-Marcotte et al., 1999; Godon et al., 1998; Rep et al., 2000). Many 
stress-related gene transcriptions require the recruitment of the SAGA histone 
acetyltransferase (HAT) complex (Bonnet et al., 2014; Huisinga and Pugh, 2004; 
Koutelou et al., 2010; Sanz et al., 2016). Tra1, an essential component of the SAGA 
complex, has been shown to be involved in cellular stress responses (Berg et al., 2018; 
Hoke et al., 2008; Hoke et al., 2010). Our previous study found that polyQ dysregulated 
Tra1 expression and SAGA assembly (Jiang et al., 2019). Thus, the impaired cellular 
stress responses during polyQ expansion may be traced back to Tra1-dependent 
transcriptional defects.  
We found that cells expressing expanded polyQ displayed impaired cell wall homeostasis, 
which contributes to the previously reported high-temperature sensitivity. Furthermore, 
cells carrying a Tra1 PI3K mutant (tra1Q3) allele failed to activate the HSR during heat 
shock. These cells also showed a cell wall defect. Our results raise the possibility that 
polyQ impairs cellular stress responses through the dysregulation of Tra1-dependent 
transcription.         
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5.3 Materials and Methods 
 Yeast strains 
All yeast strains used in this study were derived from BY4741/4742. The Tra1 mutant 
strain was described in Berg’s study (Berg et al., 2018). The polyQ strains were described 
in our previous paper (Jiang et al., 2019). 
 Monitoring yeast growth 
Yeast growth assays were performed in both agar plate spot and liquid growth curve 
following previous protocols (Jiang et al., 2017). Briefly, cells were cultured in selective 
synthetic complete media to stationary phase. For cells expressing 25/103Q, cells were 
washed twice and re-incubated in media without methionine overnight. For spot assay, 
each yeast culture was diluted to OD600 0.2, 0.04, 0.008, 0.0016 and spotted on selective 
plates. After incubating for two days, images were taken with a GelDoc system (Bio-Rad). 
Yeast cultures were also diluted to OD600 0.1 into a 96 well plate and incubated in a plate 
reader (Biotek). Concentration was measured every 15 min for 24 h. Growth curves were 
generated and quantified by Student's t-test using GraphPad (Prism). 
 Chemicals 
Caffeine (1% in H2O; ScholAR Chemistry), Trichostatin A (10 mM in H2O; Biovision) 
and calcofluor white (30 mg/mL in H2O; Sigma-Aldrich) were diluted to indicated 
concentration for each experiment. 
 Western blot 
Cells were lysed using standard protocol. The concentrations of each sample were 
measured using BCA assays and diluted equally. Samples were separated using SDS-
PAGE and transferred to PVDF membranes by semi-dry blotting. Membrane was 
blocked with 5% milk, washed with PBST and then incubated with indicated antibodies 
overnight. The anti-Hsp104 antibody was from the Linquist lab (Whitehead Institute, 
MIT, USA). The anti-Hsp26 antibody was from the Buchner’s lab (TU Munich, 
Germany). Next, the membrane was washed and incubated with secondary antibody for 
1h. Membrane was washed before images taken using a Odyssey infrared imager (Licor). 
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 Real-time qPCR 
Cells expressing 2X MET25-polyQ were heat shock at 42 °C for 1 hour. RNA was 
extracted using the MasterPure Yeast RNA Purification Kit. The reverse transcription 
was performed using Quanta Bioscience qScript Flex cDNA Synthesis Kit. Then, 1 μl 
cDNA was used as the template for qPCR reaction and detected by PerfeCTa SYBR-
Green Supermix (Quanta Bioscience). U3 was used as a reference control. Primers used 
are listed below. 
 
 
 
 
 
 
 Fluorescence microscopy 
20 μl of overnight culture was loaded to LabTek imaging chambers (Thermo Inc.) and 
mixed with 180 μl of growth media. Images were acquired using a Zeiss 800 confocal 
(63X) and then analyzed using the free ImageJ software. 
 Statistical analysis 
Student’s t-test was performed using the GraphPad Prism 7 to analyze the statistical 
significance between the different experimental groups in Figure 5.1B, 5.3A, and 5.3B. 
 
 
 
 
 
Table 5.1 Primers used in this study 
Gene Forward Primer Reverse Primer 
U3 CCCAGAGTGAGAAACCGAAA AGGATGGGTCAAGATCATCG 
HSP26 AAGGCGGCTTAAGAGGCTAC GACACCAGGAACCACGACTT 
HSP42 TGAACGCATTACCAACCAA TGTCTTGTAGTGCCGCTGTC 
HSP104 AGCAGGCTCGTCAAGGTAAA TTACCGATACCTGGCTCACC 
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5.4 Results and Discussion 
 PolyQ impairs the heat shock response in yeast 
Impaired HSR has been observed in a striatal cell line expressing full-length Htt with 
polyQ expansion and HD knock-in mouse model (Chafekar and Duennwald, 2012). 
However, the underlying mechanisms remain elusive. Studying the highly conserved and 
well-characterized HSR in yeast will help us better determine how polyQ affects stress 
response thus further understand the basic pathology of HD. In our model, Httex1 
expressing expanded polyQ was designed under a MET25 promoter. The expression was 
induced by culturing cells in growth media without methionine. To investigate the effects 
of polyQ on the HSR, we incubated cells expressing Htt carrying non-pathological (25Q) 
and HD-associated polyQ (103Q) at 39 °C. Cells expressing toxic 103Q showed a growth 
defect at high temperature compared to cells growth at 30 °C (Figure 5.1A). Consistent 
with the previous findings in mammals, there was a substantial decrease in the expression 
of Hsp26, Hsp42, and Hsp104 in 103Q cells upon heat shock at both mRNA and protein 
level (Figure 5.1B), indicating reduced activation of the HSR.  
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Figure 5.1 PolyQ impairs the heat shock response in yeast.  
(A) Cells expressing polyQ showed a growth defect at high temperature. Cells were 
induced in growth media without methionine overnight and spotted on selective 
plates incubated at 30 or 39 °C. (B) Expression of Hsp104, Hsp26 were reduced in 
polyQ cells during heat shock. Cells were heat shock at 42 °C or incubated at room 
tempreture for 1 hour before lysed. Protein expression was measured by western 
blotting. Pgk1 was used as a control. The mRNA level of HSP104, HSP42, and 
HSP26 was also quantified in cells expressing 2X polyQ after heat shock for 1 hour. 
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 Dysregulation of the cell wall integrity pathway during polyQ 
expansion 
Previous studies found that the osmotic stabilizer sorbitol can rescue the growth of cells 
expressing truncated HSF1 at high temperature (Truman et al., 2007). Thus, we tested 
whether sorbitol attenuates growth defect caused by polyQ at 39 °C. Indeed, the growth 
defect of polyQ cells incubated at high temperature was improved by the addition of 1M 
sorbitol (Figure 5.2A). Thus, the growth defect of cells expressing 103Q at high 
temperature can be traced back to cell wall defects. To test whether polyQ expansion 
leads to cell wall stress, cells carrying wild-type or expanded polyQ were treated with cell 
wall stressor caffeine. 103Q cells showed increased sensitivity to caffeine, suggesting 
these cells had cell wall defects (Figure 5.2B). The CWI pathway activation has been 
shown to have a protective effect under conditions that affect cell wall integrity (Levin, 
2005). Thus, we examined the impact of polyQ expansion in cells carrying a deletion of 
SLT2, a gene encoding the MAP kinase essential for the proper execution of the CWI 
transcription program. The slt2Δ cells displayed exacerbated polyQ toxicity (Figure 5.2C). 
This result further supports that polyQ impairs the CWI pathway, rendering to multiple 
stresses such as heat shock.  
Interestingly, Truman et al. showed that overexpressing Hsp90 rescues Slt2 activity 
during heat shock in cells expressing a defective HSF1 (Truman et al., 2007). However, 
we did not observe the same effect in polyQ cells (Figure S5.1). It therefore appears that 
the phenotype associated with polyQ expansion is somewhat different from the HSF1 
mutant. The CWI pathway is functionally conserved with the MAP kinase pathways in 
mammalian cells, which plays an important role in regulating cell proliferation and 
differentiation (Wang et al., 2006). Especially, ERK5, the human homolog of Slt2, is vital 
in cardiovascular development and neural differentiation (Truman et al., 2006; Wang et 
al., 2006). Interaction between ERK5 and HSPs such as Hsp70 and Hsp90 have also been 
studied (Sohn et al., 2002; Zheng and Studzinski, 2017). Furthermore, polyQ expansions 
have been found to dysregulates ERK signaling and activating the ERK pathways showed 
protective effects against HD (Apostol et al., 2006; Maher et al., 2011; Varma et al., 
2007). Even though human cells do not have a cell wall, investigating the crosstalk 
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between the CWI pathway and the HSR in the yeast model will help to understand the 
role of ERK in polyQ toxicity and identify potential therapeutic targets for HD.  
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Figure 5.2 PolyQ impairs the cell wall integrity pathway. 
 (A) Sorbitol rescues sensitivity to high temperature of polyQ cells. Cells were 
induced in growth media without methionine overnight and spotted on selective plates 
incubated at 39 °C ± 1M sorbitol. (B) Cells expressing toxic polyQ were sensitive to 
cell wall stressor. Cells were induced in growth media without methionine overnight 
and spotted on selective plates in the presence or absence of 0.05% caffeine and 
incubated at 30 °C for 2 days ± 1M sorbitol. (C) Deletion of SLT2 exacerbates polyQ 
toxicity. Wild type and Slt2 deletion cells expressing polyQ were induced in growth 
media without methionine overnight and spotted on selective plates and incubated at 
30 °C for 2 days. 
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 Tra1 is involved in cellular stress response 
Previous studies have shown that Tra1, and its mammalian homolog TRRAP, play a 
crucial role in the activation of HSR (Breitkreutz et al., 2010; Herceg et al., 2003). 
However, the mechanism needs further investigation. The PI3K domain is vital for Tra1 
function (Berg et al., 2018). Thus, I tested the HSR activation in cells carrying a tra1Q3 
allele in which the three arginine residues within the PI3K domain are mutated to 
glutamine. When incubating the tra1Q3 cells at 39 °C, they displayed a strong growth 
defect at high temperature (Figure 5.3A). 
Moreover, treating the cells with a histone deacetylase inhibitor trichostatin A (TSA) 
attenuated the phenotype (Figure 5.3A). The data indicated that Tra1 regulates the HSR 
through its role in histone acetylation. To further study how Tra1 regulates the HSR, a 
GFP reporter fused to the heat shock element (HSE) was expressed in wild-type and 
tra1Q3 cells. As shown by fluorescence microscopy, GFP intensity was significantly 
lower in tra1Q3 cells compared to wild-type after heat shock for 2 hours, suggesting a 
failure to activate HSPs transcription in the tra1Q3 strain (Figure 5.3B). The tra1Q3 cells 
were also shown to be more sensitive to cell wall stress (Berg et al., 2018). I was able to 
reproduce the experiment by treating these cells with a cell wall stressor calcofluor white. 
Cells carrying the tra1Q3 mutation displayed a growth defect under cell wall stress. 
Furthermore, the defect can be rescued by adding sorbitol, indicating that Tra1 is vital for 
cell wall stress responses. Moreover, the growth defect of tra1Q3 strain at 37 oC was also 
alleviated by sorbitol treatment (Figure 5.4). Overall, these data suggested that Tra1 
regulation is crucial in cellular stress responses. 
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Figure 5.3 Tra1 plays an important role in the heat shock response. 
 (A) Tra1 mutant cells displayed growth defect at high temperature. Cells were 
induced in growth media without methionine overnight and spotted on selective plates 
incubated at 30 or 39 °C for 2 days. WT and tra1Q3 cells treated with TSA were 
assessed by liquid growth assay at 37 °C. The area under the curve was quantified for 
each replicate (n = 3), ***P < 0.001. (B) Reduced HSE transcription during heat 
shock in Tra1 mutant cells. Representative fluorescent image of WT and tra1Q3 cells 
incubated at 42 °C for 2 hours. Fluorescent intensity was quantified by imageJ. ***P 
< 0.001. 
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Figure 5.4 Tra1 is crucial in regulating cell wall stress. 
 Cells expressing tra1Q3 mutation are more sensitive to heat shock and cell wall 
stress. The defect was rescued by sorbitol. Cells were spotted on selective plates with 
calcofluor white and incubated at 30 or 37 °C for 2 days ±1M sorbitol. 
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The connection between impaired cellular stress response during polyQ expansion and 
the regulation of Tra1 needs further investigation. The Triple T complex which contains 
Tel2, Tti1, and Tti2 is required for the stabilization of PIKK family proteins (Hurov et al., 
2010). Tti2 has been shown to be involved in stress responses via its role in maintaining 
Tra1 folding and nuclear localization (Genereaux et al., 2012; Hoffman et al., 2016). 
Therefore, polyQ may affect Tra1 dependent cellular stress responses through the 
dysregulation of Tti2. Our data showed that Tti2 was sequestered into polyQ aggregates, 
indicating that polyQ impairs Tti2 function (Figure 5.5). However, overexpressing Tti2 
was not able to rescue the sensitivity to heat shock and cell wall stress in cells expressing 
toxic polyQ (Figure S5.2). Thus, increased sensitivity to high temperature could be, at 
least in part, linked to loss of function of Tti2.  
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Figure 5.5 Tti2 is sequestered into polyQ aggregates.  
Cells expressing GAL1-25/68Q-mScarlet were induced in galactose overnight and 
then monitored by confocal microscope. Representative fluorescent images showed 
co-localization between Tti2-GFP and 68Q aggregates. 
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 Perspective 
I have shown that cell wall stress and defect in the CWI signaling pathway is involved in 
cell sensitivity to heat shock during polyQ expansions. Tra1-dependent transcriptional 
regulation plays a critical role in the HSR activation and cell wall stress response. Thus, 
Tra1 dysregulation caused by expanded polyQ expression may explain the impaired 
cellular stress responses in HD (Figure 5.6). Future studies need to determine the 
recruitment of Tra1 to the promoters of HSPs and CWI targets using Chromatin 
immunoprecipitation during polyQ toxicity to better understand the mechanism. Defining 
how polyQ impairs cellular stress responses and the transcriptional regulation will guide 
future studies in developing target specific compounds for HD therapy. 
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Figure 5.6 Hypothetical model of heat shock sensitivity in a yeast model of HD. 
The sensitivity to high temperature in cells expressing expanded polyQ is due to 
dysregulation of HSR and a cell wall defect. The impaired HSR and CWI during 
polyQ expansions may be caused by dysregulation of Tra1-dependent stress-induced 
gene transcriptions.  
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Figure S 5.1 Overexpressing Hsp90 did not rescue growth defect at high 
temperature in polyQ cells.  
MET25 induced 25/103Q cells were induced in -methionine media overnight before 
spotted on selective plates and incubated at 30 or 37 °C for 2 days. 103Q cells 
overexpressing Hsc82 still displayed a growth defect at 37 °C. 
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Figure S 5.2 Overexpressing Tti2 did not rescue sensitivity to cell stress in polyQ 
cells.  
Cells carrying MET25 induced 25/103Q and GAL1 induced Tti2 were induced in -
methionine media overnight before spotted on selective plates containing 10 μg/ml 
Calcofluor white. 103Q cells overexpressing Tti2 were still more sensitive to high 
temperature and cell wall stress compared to 25Q.  
 
 
 
 
 
 
 
25Q+VEC
103Q+VEC
25Q+Tti2
103Q+Tti2
 
CFW
37°C
25Q+VEC
103Q+VEC
25Q+Tti2
103Q+Tti2
25Q+VEC
103Q+VEC
25Q+Tti2
103Q+Tti2
No Induction polyQ induced Tti2 induced Both induced
198 
 
5.5 References 
Apostol, B. L., Illes, K., Pallos, J., Bodai, L., Wu, J., Strand, A., Schweitzer, E. S., 
Olson, J. M., Kazantsev, A., Marsh, J. L., et al. (2006). Mutant huntingtin alters 
MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against 
mutant huntingtin-associated toxicity. Hum. Mol. Genet. 15, 273–285. 
Berg, M. D., Genereaux, J., Karagiannis, J. and Brandl, C. J. (2018). The 
Pseudokinase Domain of Saccharomyces cerevisiae Tra1 Is Required for Nuclear 
Localization and Incorporation into the SAGA and NuA4 Complexes. G3 
(Bethesda) 8, 1943–1957. 
Bonnet, J., Wang, C.-Y., Baptista, T., Vincent, S. D., Hsiao, W.-C., Stierle, M., Kao, 
C.-F., Tora, L. and Devys, D. (2014). The SAGA coactivator complex acts on 
the whole transcribed genome and is required for RNA polymerase II 
transcription. Genes Dev. 28, 1999–2012. 
Boy-Marcotte, E., Lagniel, G., Perrot, M., Bussereau, F., Boudsocq, A., Jacquet, M. 
and Labarre, J. (1999). The heat shock response in yeast: differential regulations 
and contributions of the Msn2p/Msn4p and Hsf1p regulons. Mol. Microbiol. 33, 
274–283. 
Breitkreutz, A., Choi, H., Sharom, J. R., Boucher, L., Neduva, V., Larsen, B., Lin, 
Z.-Y., Breitkreutz, B.-J., Stark, C., Liu, G., et al. (2010). A global protein 
kinase and phosphatase interaction network in yeast. Science 328, 1043–1046. 
Cashikar, A. G., Duennwald, M. and Lindquist, S. L. (2005). A chaperone pathway in 
protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate 
reactivation by Hsp104. J. Biol. Chem. 280, 23869–23875. 
Chafekar, S. M. and Duennwald, M. L. (2012). Impaired heat shock response in cells 
expressing full-length polyglutamine-expanded huntingtin. PLoS One 7, e37929. 
Duennwald, M. L. and Lindquist, S. (2008). Impaired ERAD and ER stress are early 
and specific events in polyglutamine toxicity. Genes Dev. 22, 3308–3319. 
199 
 
Dunayevich, P., Baltanás, R., Clemente, J. A., Couto, A., Sapochnik, D., Vasen, G. 
and Colman-Lerner, A. (2018). Heat-stress triggers MAPK crosstalk to turn on 
the hyperosmotic response pathway. Sci. Rep. 8, 15168. 
Genereaux, J., Kvas, S., Dobransky, D., Karagiannis, J., Gloor, G. B. and Brandl, C. 
J. (2012). Genetic evidence links the ASTRA protein chaperone component Tti2 
to the SAGA transcription factor Tra1. Genetics 191, 765–780. 
Godon, C., Lagniel, G., Lee, J., Buhler, J. M., Kieffer, S., Perrot, M., Boucherie, H., 
Toledano, M. B. and Labarre, J. (1998). The H2O2 stimulon in Saccharomyces 
cerevisiae. J. Biol. Chem. 273, 22480–22489. 
Gusella, J. F. and MacDonald, M. E. (2009). Huntington’s disease: the case for genetic 
modifiers. Genome Med. 1, 80. 
Haslbeck, M., Braun, N., Stromer, T., Richter, B., Model, N., Weinkauf, S. and 
Buchner, J. (2004). Hsp42 is the general small heat shock protein in the cytosol 
of Saccharomyces cerevisiae. EMBO J. 23, 638–649. 
Herceg, Z., Li, H., Cuenin, C., Shukla, V., Radolf, M., Steinlein, P. and Wang, Z.-Q. 
(2003). Genome-wide analysis of gene expression regulated by the HAT cofactor 
Trrap in conditional knockout cells. Nucleic Acids Res. 31, 7011–7023. 
Hoffman, K. S., Duennwald, M. L., Karagiannis, J., Genereaux, J., McCarton, A. S. 
and Brandl, C. J. (2016). Saccharomyces cerevisiae Tti2 Regulates PIKK 
Proteins and Stress Response. G3 (Bethesda) 6, 1649–1659. 
Hoke, S. M. T., Guzzo, J., Andrews, B. and Brandl, C. J. (2008). Systematic genetic 
array analysis links the Saccharomyces cerevisiae SAGA/SLIK and NuA4 
component Tra1 to multiple cellular processes. BMC Genet. 9, 46. 
Hoke, S. M. T., Irina Mutiu, A., Genereaux, J., Kvas, S., Buck, M., Yu, M., Gloor, G. 
B. and Brandl, C. J. (2010). Mutational analysis of the C-terminal FATC domain 
of Saccharomyces cerevisiae Tra1. Curr. Genet. 56, 447–465. 
200 
 
Huisinga, K. L. and Pugh, B. F. (2004). A genome-wide housekeeping role for TFIID 
and a highly regulated stress-related role for SAGA in Saccharomyces cerevisiae. 
Mol. Cell 13, 573–585. 
Hurov, K. E., Cotta-Ramusino, C. and Elledge, S. J. (2010). A genetic screen 
identifies the Triple T complex required for DNA damage signaling and ATM and 
ATR stability. Genes Dev. 24, 1939–1950. 
Jiang, Y., Di Gregorio, S. E., Duennwald, M. L. and Lajoie, P. (2017). Polyglutamine 
toxicity in yeast uncovers phenotypic variations between different fluorescent 
protein fusions. Traffic 18, 58–70. 
Jiang, Y., Berg, M. D., Genereaux, J., Ahmed, K., Duennwald, M. L., Brandl, C. J. 
and Lajoie, P. (2019). Sfp1 links TORC1 and cell growth regulation to the yeast 
SAGA-complex component Tra1 in response to polyQ proteotoxicity. Traffic 20, 
267–283. 
Koutelou, E., Hirsch, C. L. and Dent, S. Y. R. (2010). Multiple faces of the SAGA 
complex. Curr. Opin. Cell Biol. 22, 374–382. 
Kumar, A., Vaish, M. and Ratan, R. R. (2014). Transcriptional dysregulation in 
Huntington’s disease: a failure of adaptive transcriptional homeostasis. Drug 
Discov. Today 19, 956–962. 
Lamoth, F., Juvvadi, P. R., Fortwendel, J. R. and Steinbach, W. J. (2012). Heat 
shock protein 90 is required for conidiation and cell wall integrity in Aspergillus 
fumigatus. Eukaryotic Cell 11, 1324–1332. 
Lesage, G. and Bussey, H. (2006). Cell wall assembly in Saccharomyces cerevisiae. 
Microbiol. Mol. Biol. Rev. 70, 317–343. 
Levin, D. E. (2005). Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol. 
Mol. Biol. Rev. 69, 262–291. 
Levin, D. E. (2011). Regulation of cell wall biogenesis in Saccharomyces cerevisiae: the 
201 
 
cell wall integrity signaling pathway. Genetics 189, 1145–1175. 
Maher, P., Dargusch, R., Bodai, L., Gerard, P. E., Purcell, J. M. and Marsh, J. L. 
(2011). ERK activation by the polyphenols fisetin and resveratrol provides 
neuroprotection in multiple models of Huntington’s disease. Hum. Mol. Genet. 20, 
261–270. 
Morimoto, R. I. and Westerheide, S. D. (2010). The heat shock response and the stress 
of misfolded proteins. In Handbook of cell signaling, pp. 2231–2239. Elsevier. 
Parakh, S. and Atkin, J. D. (2016). Protein folding alterations in amyotrophic lateral 
sclerosis. Brain Res. 1648, 633–649. 
Quintanilla, R. A. and Johnson, G. V. W. (2009). Role of mitochondrial dysfunction in 
the pathogenesis of Huntington’s disease. Brain Res. Bull. 80, 242–247. 
Rep, M., Krantz, M., Thevelein, J. M. and Hohmann, S. (2000). The transcriptional 
response of Saccharomyces cerevisiae to osmotic shock. Hot1p and 
Msn2p/Msn4p are required for the induction of subsets of high osmolarity 
glycerol pathway-dependent genes. J. Biol. Chem. 275, 8290–8300. 
Riva, L., Koeva, M., Yildirim, F., Pirhaji, L., Dinesh, D., Mazor, T., Duennwald, M. 
L. and Fraenkel, E. (2012). Poly-glutamine expanded huntingtin dramatically 
alters the genome wide binding of HSF1. J. Huntingtons. Dis. 1, 33–45. 
Roos, R. A. C. (2010). Huntington’s disease: a clinical review. Orphanet J Rare Dis 5, 
40. 
Sanz, A. B., García, R., Rodríguez-Peña, J. M., Nombela, C. and Arroyo, J. (2016). 
Cooperation between SAGA and SWI/SNF complexes is required for efficient 
transcriptional responses regulated by the yeast MAPK Slt2. Nucleic Acids Res. 
44, 7159–7172. 
Sohn, S. J., Sarvis, B. K., Cado, D. and Winoto, A. (2002). ERK5 MAPK regulates 
embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular 
202 
 
endothelial growth factor expression. J. Biol. Chem. 277, 43344–43351. 
Tan, J. M. M., Wong, E. S. P. and Lim, K.-L. (2009). Protein misfolding and 
aggregation in Parkinson’s disease. Antioxid. Redox Signal. 11, 2119–2134. 
Tayubi, I. A., Firoz, A. and Malik, A. (2015). Protein misfolding and amyloid 
formation in alzheimer’s disease. In Proteostasis and chaperone surveillance (ed. 
Singh, L. R.), Dar, T. A.), and Ahmad, P.), pp. 119–135. New Delhi: Springer 
India. 
Truman, A. W., Millson, S. H., Nuttall, J. M., King, V., Mollapour, M., Prodromou, 
C., Pearl, L. H. and Piper, P. W. (2006). Expressed in the yeast Saccharomyces 
cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss 
of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase. Eukaryotic Cell 
5, 1914–1924. 
Truman, A. W., Millson, S. H., Nuttall, J. M., Mollapour, M., Prodromou, C. and 
Piper, P. W. (2007). In the yeast heat shock response, Hsf1-directed induction of 
Hsp90 facilitates the activation of the Slt2 (Mpk1) mitogen-activated protein 
kinase required for cell integrity. Eukaryotic Cell 6, 744–752. 
Varma, H., Cheng, R., Voisine, C., Hart, A. C. and Stockwell, B. R. (2007). Inhibitors 
of metabolism rescue cell death in Huntington’s disease models. Proc. Natl. Acad. 
Sci. USA 104, 14525–14530. 
Wang, Y., Su, B. and Xia, Z. (2006). Brain-derived neurotrophic factor activates ERK5 
in cortical neurons via a Rap1-MEKK2 signaling cascade. J. Biol. Chem. 281, 
35965–35974. 
Zheng, R. and Studzinski, G. P. (2017). Nuclear ERK5 inhibits progression of leukemic 
monocytes to macrophages by regulating the transcription factor PU.1 and heat 
shock protein HSP70. Leuk. Lymphoma 58, 1468–1480. 
203 
 
Chapter 6 
6 Tra1 is a novel potential target for antifungal therapy  
The emergence of drug-resistant strains among fungal pathogens represents a major 
public health challenge. Thus, it is essential to identify new therapeutic targets to fight 
pathological yeast infections.  The previous chapters demonstrated that Tra1 plays a vital 
role in promoting yeast survival during stress conditions (including cell wall perturbation; 
a major mode of action of antifungal compounds), suggesting that it could represent a 
rational target for antifungal treatment. In this chapter, I will investigate the role of Tra1 
in antifungal drug resistance, especially through the regulation of the calcineurin pathway. 
6.1 Abstract 
Fungal infections have become a growing threat to human health. Current treatment is 
very limited and often insufficient. Furthermore, several pathological yeast strains have 
acquired significant multidrug resistance. Thus, it is urgent to understand the mechanisms 
of fungal stress resistance to identify new therapeutic targets for antifungal drug 
development. The conserved Tra1 protein is involved in the yeast cellular stress 
responses critical for cell viability and survival under stress conditions. Our new data 
showed that Tra1 is involved in the calcineurin signaling pathway that regulates calcium 
homeostasis, which has been shown to be crucial for fungi virulence and drug resistance. 
Cells expressing a mutant Tra1 allele displayed impaired activation of the calcineurin 
pathway and were more sensitive to antifungal drugs. Furthermore, Tra1 plays a critical 
role in the cell wall stress response. Synthesis of the cell wall is the target of a major class 
of antifungal drugs such as echinocandins. Our study provides new insights into the 
mechanisms of cellular stress responses in yeast and identifies Tra1 as a novel target for 
antifungal drug development. 
6.2 Introduction 
Fungal infections are affecting 25% of the population worldwide (Havlickova et al., 
2008). Most common fungal pathogens include Cryptococcus, Candida, and Aspergillus, 
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which can cause serious chronic diseases and are potentially fatal if not diagnosed and 
treated in time (Brown et al., 2012). There are only a limited number of antifungal agents 
available. Azoles, such as fluconazole and miconazole, target ergosterol synthesis by 
inhibiting lanosterol 14α-demethylase that converts lanosterol to ergosterol, a major 
component of fungal plasma membranes. Membrane sterol is also targeted by polyenes 
through direct binding which causes changes in membrane permeability and leakage of 
cytoplasmic material. Another class of antifungal drugs is the echinocandins (caspofungin 
and anidulafungin), which inhibit fungal β(1,3)-d-glucan biosynthesis and lead to severe 
cell wall defect (Ghannoum and Rice, 1999; Groll et al., 1998; Kathiravan et al., 2012). 
These drugs usually have strong side effects and they speed the fungal evolution to gain 
antifungal resistance. Multidrug resistance of fungal pathogens has been observed in 
many cases, specifically among Candida species (Cowen, 2008; Cowen et al., 
2014). Therefore, developing new antifungal drugs which are more specific and efficient 
is challenging but urgent. 
Cellular stress responses including the heat shock response (HSR), the cell wall integrity 
(CWI) pathway and the calcium-calcineurin pathway are activated under stress conditions 
to regulate cell viability and survival by assisting with protein folding, cell wall synthesis, 
and maintaining calcium homeostasis (Cyert, 2003; Levin, 2005; Morimoto and 
Westerheide, 2010). Therefore, key proteins in the cellular stress response pathways can 
be targets for antifungal drug development. For example, a major heat shock protein 
Hsp90 has been found to be involved in antifungal resistance (Lamoth et al., 2016). 
Hsp90 inhibitors significantly enhance the efficacy of antifungal drugs (Cowen et al., 
2009). The combination of Candida albicans Hsp90 antibody and an antifungal agent 
amphotericin B has shown beneficial effects in a clinical trial (Pachl et al., 2006). The 
regulation of cell stress responses requires the transcription of stress-induced genes. The 
transcriptional regulation involves the recruitment of specific activators and co-activators 
such as histone acetyltransferase (HAT) complexes (Bonnet et al., 2014). An essential 
component of SAGA and NuA4 complexes, Tra1, has been shown to be involved in 
cellular stress responses (Hoke et al., 2008; Hoke et al., 2010). Literature showed that 
yeast cells expressing mutant Tra1 were more sensitive to cell stressors MMS, ethanol, 
and caffeine (Berg et al., 2018; Mutiu et al., 2007). Therefore, Tra1 is critical for cell 
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survival and growth during stress and could be a target for antifungal therapy. To test the 
role of Tra1 in antifungal resistance, we assessed the effects of common antifungal agents 
on yeast growth in cells carrying a mutant Tra1 (tra1Q3) allele in the well-characterized 
Saccharomyces cerevisiae. 
Calcineurin signaling is conserved among fungal species, critical for cell growth and 
stress responses (Cyert, 2003).  The calcineurin pathway has been shown to be involved 
in pathogen virulence and drug resistance in different fungal pathogens through its role in 
the cell membrane and cell wall synthesis (Juvvadi et al., 2014; Liu et al., 2015; Yu et al., 
2014). Furthermore, calcineurin inhibitors FK506 and cyclosporine A and their analogs 
have been studied for antifungal treatment (Lee et al., 2018; Pandit, 2003). However, due 
to the immunosuppressive effects, they cannot be directly used in the clinic. Tra1 mutant 
strain showed significant growth defect in presence of high calcium, suggesting that Tra1 
is vital for calcium homeostasis (Berg et al., 2018). However, the mechanism of how 
Tra1 regulates the calcineurin pathway remains unclear. Understanding the vital role of 
Tra1 in the calcineurin pathway activation is crucial for developing target-specific drugs 
for antifungal treatment. 
Using the well-studied yeast model, we found that Tra1 is essential for the calcineurin 
pathway activation. Cells expressing tra1Q3 failed to activate the calcineurin signaling, 
leading to increased sensitivity to antifungal drugs. Our results expand the understanding 
on the role of Tra1 in cellular stress responses and identify its potential for the 
development of novel antifungal therapy.   
6.3 Materials and Methods 
 Yeast strains and culturing 
The TRA1/tra1Q3 strains used in this study was described in Berg et al., 2018. Preparation 
of growth media was instructed by standard protocol from Amberg and Strathern, 2005. 
Cell growth was assessed by spot and liquid culture. After OD600 of the overnight culture 
was measured, cells were diluted to OD600 0.2 and then spotted in three fivefold dilutions 
for spot assay. For liquid culture assay, yeast cells were diluted to OD600 0.1 from the 
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beginning. Three replicates for each group were cultured in a 96 well plate and 
concentration was measured per 15 minutes by a plate reader (Biotek) for 24 hours. 
 Chemicals and drugs 
Trichostatin A (10 mM in H2O; Biovision), calcofluor white (30 mg/mL in H2O; Sigma-
Aldrich), tunicamycin (5 μg/mL in DMSO; Amresco), fluconazole (50 mg/ml in DMSO; 
Alfa Aesar), miconazole (30 mg/ml in DMSO; Alfa Aesar), and caspofungin (1mg/ml in 
H2O; Sigma-Aldrich) were diluted to concentrations listed for each experiment. 
 qRT-PCR 
Cells were treated with 200mM CaCl2 for four hours before RNA extracted using 
MasterPure Yeast RNA Purification Kit. Reverse transcription was done by qScript Flex 
cDNA Synthesis Kit (Quanta). The cDNA samples were diluted five times as the qPCR 
reaction templates. PerfeCTa SYBR-Green Supermix (Quanta) was employed for 
amplified DNA measurement. The primers used were listed in Table 6.1. The relative 
expression level was calculated by the ΔΔCT method using U3 as a housekeeping control. 
 
 
 
 
 
 Beta-galactosidase assay 
Overnight culture was washed and resuspended by lacZ buffer. To measure beta-
galactosidase activity, 50 μl of cells were diluted in 950 μl lacZ buffer with 2.7μl β-
mercaptoethanol, one drop 0.1% SDS, two drops chloroform and incubated 15 minutes at 
30 °C. 100 μl ONPG (4mg/ml) was added to each sample to start the reaction. Then the 
cells were put back to 30 °C until the color changed to yellow. Time was recorded. To 
Table 6.1 Primers used in this study 
Gene Forward Primer Reverse Primer 
U3 CCCAGAGTGAGAAACCGAAA AGGATGGGTCAAGATCATCG 
PMR1 TGCCGTTTTTGAAATGATGA ATAGCAGCAACCGCTAAGGA 
PMC1 GATGGCAGGTTCCATGATCT CCCATCGTTTCACAGCTTCT 
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stop the reaction, 300 μl 1M Na2CO3 was added. The beta-galactosidase activity was 
determined by measuring 420 nm absorbance using a plate reader (Biotek), standardizing 
to cell density. 
 Statistical analysis 
Growth curves were generated to quantify the differences in yeast growth under different 
conditions. The area under the curve was measured using the Graphpad Prism 7 software. 
Statistical significance was calculated using the Student’s t-test.  
6.4 Results and Discussion 
 Tra1 is a regulator of the calcium-calcineurin pathway 
The calcineurin pathway is crucial for fungal survival and resistance to antifungal drugs 
(Juvvadi et al., 2014). Literature showed that the activation of the signaling pathway 
requires an intact SAGA complex. Deletion of the gene encoding the histone 
acetyltransferase Gcn5 leads to a significant downregulation of the calcineurin A subunit 
in fungal pathogen Cryptococcus neoformans (O’Meara et al., 2010). To 
comprehensively determine the effects of SAGA and NuA4 components on the regulation 
of calcium homeostasis in S. cerevisiae, we assessed the sensitivity to high calcium stress 
in strains carrying deletions of the major components of the SAGA or NuA4 HAT 
complexes (Han et al., 2014; Searle et al., 2017). We found that knocking out the SAGA 
components GCN5, ADA2, and SPT20 or NuA4 component EAF1 resulted in a severe 
growth defect in presence of 200 mM CaCl2 (Figure 6.1). The data suggest that both 
SAGA and NuA4 are required for calcium homeostasis.  
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Figure 6.1 SAGA and NuA4 complexes are essential for calcium homeostasis.  
Deletion of SAGA/NuA4 components increases cell sensitivity to high Ca2+. Cells 
were incubated in YPD media containing 0.05M succinic acid overnight before 
spotted on YPD plus 0.05M succinic acid plates in the presence or absence (Control) 
of 200mM CaCl2 and incubated for 2 days. 
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Tra1 is the only essential subunit within both SAGA and NuA4 complexes and has been 
found to be involved in stress responses (Hoke et al., 2008). Therefore, we further 
investigated whether Tra1 played a role in regulating cell growth towards high calcium. 
The Tra1 PI3K domain is essential for maintaining protein stability and nuclear 
localization (Berg et al., 2018). My study involved a tra1Q3 allele, where three arginine 
residues within the PI3K domain were mutated to glutamine (Berg et al., 2018). As 
shown in Figure 6.2, the mutant tra1Q3 stain had a significant growth defect when 
cultured in media containing 200mM CaCl2.  
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Figure 6.2 A functional Tra1 is required for growth in presence of high calcium 
levels. 
Tra1 mutation strain displayed a growth defect at high calcium concentration. WT and 
tra1Q3 cells were incubated in YPD media containing 0.05M succinic acid overnight 
before spotted on YPD plus 0.05M succinic acid plates in the presence or absence 
(Control) of 200mM CaCl2 and incubated for 2 days. Growth of WT and tra1Q3 cells 
were also assessed by liquid growth assay. The area under the curve was quantified for 
each replicate (n = 3), ***P < 0.001. 
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Previous synthetic genetic array analysis showed a negative genetic interaction between 
Tra1 and the calcineurin regulatory subunit, Cnb1 (Hoke et al., 2008). Indeed, the tra1Q3 
mutant displays a synthetic slow growth phenotype when crossed with the CNB1Δ strain 
(Figure 6.3A). The activation of the calcineurin pathway targets requires Crz1 binding to 
the calcineurin-dependent response element (CDRE) (Stathopoulos and Cyert, 1997). To 
further explore the mechanisms underlying the sensitivity to high calcium of the tra1Q3 
strain, we measured the activation of the calcineurin pathway using a lacZ reporter under 
the control of a promoter carrying the CDRE motif (Stathopoulos and Cyert, 1997). 
Results in Figure 6.3B indicated that cells expressing tra1Q3 fails to activate the calcium-
calcineurin pathway when treated with a high concentration of Ca2+. Moreover, unlike in 
wild-type cells, the expression of downstream calcineurin target genes PMR1 and PMC1 
in tra1Q3 cells remained unchanged upon treatment with high calcium (Figure 6.3C). The 
data suggested that Tra1 is vital for activation of the calcineurin pathway to regulate 
calcium homeostasis. Furthermore, addition of TSA, a histone deacetylase inhibitor 
significantly alleviated the growth defect in Tra1 mutant cells at high CaCl2 concentration, 
indicating the critical role of histone acetylation in regulating the calcineurin pathway 
(Figure 6.3D). How Tra1 is involved in the calcineurin pathway activation remains 
unclear. Expression of a truncated CNA1 without the autoinhibitory domain that leads to 
constitutive activation of calcineurin (Chaudhuri et al., 1995), or overexpressing the 
transcriptional regulator CRZ1 did not rescue the sensitivity to high Ca2+ treatment of 
cells expressing the tra1Q3 allele (Figure S6.1). The data suggested that Tra1 is required 
for the activation of Crz1 downstream target gene transcriptions, potentially by targeting 
the transcription factor to its targeted promoters. 
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Figure 6.3 Tra1 regulation is required for the calcineurin pathway.  
(A) Genetic interaction between Tra1 and Cnb1. CNB1 deletion strain carrying Tra1 
mutation cause slow cell growth. (B) Cells carrying tra1Q3 allele cannot activate the 
calcineurin pathway. Cells expressing the CDRE-LacZ reporter were incubated in SC 
media containing 0.05M succinic acid in the presence or absence of 200mM CaCl2. 
Gene expression was analyzed using LacZ transcriptional reporters. ***P < 0.001, n = 
3 ± SEM. (C) Reduced PMR1 and PMC1 expression during high calcium stress in 
cells expressing mutant Tra1. WT and cells carrying the Tra1Q3 allele were processed 
for RT-qPCR to assess transcript levels of PMR1 AND PMC1. **P < 0.005, ***P < 
0.001 (n = 3). (D) Inhibiting histone deacetylation partially attenuates sensitivity to 
high Ca2+ in Tra1 mutant cells. The growth of WT and tra1Q3 cells were assessed by 
liquid growth assay. Experimental groups were treated with 40 μM trichostatin A 
(TSA). The area under the curve was quantified for each replicate (n = 3), ***P < 
0.001. 
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 Tra1 is involved in yeast tolerance of antifungal agents 
Since Tra1 is vital for the activation of the calcineurin pathway, we next investigated the 
role of Tra1 in cell sensitivity to antifungal reagents. As shown in Figure 6.4A, the tra1Q3 
strain was significantly more sensitive to the antifungal agents fluconazole, miconazole, 
and caspofungin. To test the activation of calcineurin signaling, the expression of CDRE 
was determined by a lacZ reporter. We found that cells carrying mutant Tra1 were unable 
to activate the calcineurin pathway when treated with azoles (Figure 6.4B). 
Previous studies and our results show that Tra1 plays an essential role in cellular stress 
responses such as the HSR and cell wall stress response. As shown in Figure 6.5A, tra1Q3 
cells displayed a growth defect when treated with a cell wall stressor calcofluor white as 
well as incubated at a higher temperature. In addition, the tra1Q3 mutant shows no growth 
defect when treated with tunicamycin, suggesting that the requirement for Tra1 function 
(or at least its PI3K domain) is specific to several stresses. Furthermore, our data show 
that osmotic stabilizer sorbitol attenuated the growth defect of the tra1Q3  mutant cells 
when treated with antifungal drugs (Figure 6.5B), reinforcing the crucial role of Tra1 in 
cell wall homeostasis. The stress responses are vital in regulating cell survival when 
exposed to antifungals. Thus, Tra1 emerges as a new potential therapeutic target for 
fungal infections. The Tra1 PI3K domain is highly conserved from S. cerevisiae to fungal 
pathogen C. albicans (Figure 6.6). Therefore, the results found in S. cerevisiae can direct 
future investigations on the role of Tra1 in C. albicans and antifungal drug development.  
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Figure 6.4 Tra1-dependent activation of calcineurin pathway is critical for 
antifungal resistance.  
(A) Cells expressing tra1Q3 mutation are more sensitive to antifungals. WT and tra1Q3 
cells were spotted on selective plates containing fluconazole, miconazole, and 
caspofungin at indicated concentrations and incubated for 2 days. Cell growth was 
assessed by liquid growth assay. (B) Tra1 mutant cells fail to upregulate the calcium-
calcineurin pathway treated with antifungals. Cells expressing the CDRE-LacZ 
reporter were incubated in SC media in the presence or absence of fluconazole for 6 
hours or miconazole for 4 hours. Gene expression was analyzed using LacZ 
transcriptional reporters. **P < 0.005, n = 3 ± SEM. 
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Figure 6.5 Tra1 plays an important role in cellular stress responses.  
(A) Cells expressing mutant Tra1 are more sensitive to heat shock and cell wall stress. 
Cells were spotted on selective plates with calcofluor white (CFW) or tunicamycin 
(TM) and incubated at 30 or 39 °C for 2 days. (B) The sensitivity to antifungals of 
tra1Q3 cells is linked to cell wall stress. WT and Tra1 mutant cells were spotted on 
selective plates containing fluconazole, miconazole, or caspofungin and incubated at 
30 °C for 2 days ±1M sorbitol. 
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Figure 6.6 Sequence alignment of homologous Tra1 PI3K domain. 
The PI3K domain of Tra1 in S. cerevisiae, C. albicans, and TRRAP in human was 
aligned using the online MUSCLE tool (http://www.ebi.ac.uk/Tools/msa/muscle/). 
The three arginine (R3389, R3390, R3456) to make the tra1Q3 strain was marked with 
the red box.  
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 Perspective 
My study investigated the role of Tra1 in the activation of the calcineurin pathway and 
antifungal resistance. Future studies including growth assays, protein expression 
quantification, ChIP, and genome-wide sequencing assays comparing tra1Q3 to wild-type 
strain will be performed in the fungal pathogen C. albicans in collaboration with Dr. 
Rebecca Shapiro at the University of Guelph to investigate whether the phenotypes 
observed in S. cerevisiae are recapitulated in pathogenic fungi. These experiments will 
help gain a better understanding on the mechanisms of Tra1 regulated stress responses 
during antifungal drug treatment. 
The PI3K domain is vital for Tra1 stability and function. Although lacking kinase motifs, 
structural studies suggested that the PI3K domain of  Tra1/TRRAP is still able to catalyze 
the transfer of a modifying unit other than phosphate moieties (Mutiu et al., 2007). Many 
PI3K inhibitors and small molecules have been designed targeting the PI3K domain of 
the PIKK family proteins for treatment of cancer and several other diseases (Fruman et al., 
2017), this domain could be an excellent binding target for target-specific antifungal drug 
development. Sequence alignment has identified the differences between fungal Tra1 and 
human TRRAP within the PI3K domain (Berg et al., 2018), further studies should 
investigate the structure and function of these specific targets in regulating Tra1 and cell 
survival.  
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Figure S 6.1 Hyperactivation of the calcineurin pathway did not rescue sensitivity 
to high Ca2+ concentration in cells expressing mutant tra1Q3.  
(A) Constitutively activated calcineurin did not rescue the growth defect of tra1Q3 
cells at high Ca2+ treatment. Truncated Cna1 was transformed into wild-type and Tra1 
mutant cells. Cells were incubated in YPD media containing 0.05M succinic acid 
overnight before spotted on YPD plus 0.05M succinic acid plates in the presence or 
absence (Untreated) of 200mM CaCl2 and incubated for 2 days. (B) Overexpressing 
Crz1 showed little effects on cells carrying the tra1Q3 allele. GAL1 induced Crz1 was 
expressed in WT and tra1Q3 mutant cells. Cells were incubated with 0.05M succinic 
acid overnight before spotting on selective plates containing 200mM CaCl2.    
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Chapter 7 
7 Discussion 
In this last chapter, I will summarize the main findings and discuss the overall 
implications and significance of my thesis project. First, I will introduce the methods 
available to assess new fluorescent proteins including the advantage of using the yeast 
assay I have developed. Then, I will address the link between protein aggregation and 
toxicity in neurodegenerative disorders. Furthermore, I will discuss the controversial role 
of the TORC1 signaling in HD and the importance of combining different experimental 
models in HD research. Finally, I will evaluate the therapeutic potential of Tra1/TRRAP 
for human disease therapy. 
7.1 Summary of major results 
The main goal of my thesis is to investigate the function of Tra1 in regulating cellular 
stress responses and the implications for stress-related diseases. To accomplish that, I 
employed the well-characterized yeast model of HD to investigate Tra1-dependent 
regulation on polyQ toxicity. First, I developed an optimized yeast model to study polyQ 
toxicity and aggregation in yeast by tagging mutant Htt exon1 with newest yeast codon 
optimized FPs. I found that different FPs can alter polyQ toxicity and aggregation 
formation. Following this, I assessed the effects of two latest generation of RFP, 
FusionRed and mScarlet, using the yeast polyQ model. I found that tagging polyQ with 
FusionRed attenuated its toxicity in yeast. With the help of the optimized HD model in 
yeast, I revealed how Tra1 and SAGA complex regulates polyQ toxicity. My data 
suggested that polyQ expansion impairs SAGA assembly and leads to upregulation of 
Tra1 expression dependent on Sfp1, a downstream target of the TORC1 signaling 
pathway regulating ribosome biogenesis. Impaired HSR has been found in HD before; 
however, the precise mechanism remains unclear. Functional Tra1 has been linked to 
cellular stress responses. Therefore, I studied how Tra1 regulates heat shock tolerance in 
the presence of expanded polyQ. I showed that the heat shock sensitivity of cells 
expressing polyQ is linked to a defect in cell wall integrity, which requires Tra1 
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regulation. Since Tra1 is crucial for cellular stress responses and yeast survival, I then 
investigated its role in antifungal resistance. My results indicated that a functional Tra1 is 
vital for yeast resistance to antifungal agents, through the activation of the calcineurin 
pathway. My studies therefore identify Tra1 as a novel potential therapeutic target for 
fungal infections. 
7.2 Assessing fluorescent proteins and the impact on their 
fusion partners 
The development of GFP (2008 Nobel Prize in Chemistry jointly to Osamu Shimomura, 
Martin Chalfie, and Roger Y. Tsien) and other FPs make a powerful tool in nowadays’ 
scientific field. In modern biological researches, a great number of findings were 
achieved with the help of FPs to visualize protein localization and trafficking, protein-
protein interactions, and organelle metabolic functions (Kremers et al., 2011; 
Wiedenmann et al., 2009). There are now numerous FP options available. However, 
because of the different nature of FPs, whether a given FP is appropriate can vary from 
experiment to experiment. My study is a good example and showed that tagging 
expanded polyQ with different fluorescent proteins can alter its toxicity and aggregation 
(Jiang et al., 2017). Many factors can affect the expression of FPs and one needs to take 
them all into consideration when designing a protein fusion. These include N versus C-
terminal fusion, FP maturation and photostability, environmental conditions, codon 
optimization, and oligomerization (Costantini et al., 2015; Huang et al., 2014; Palmer and 
Freeman, 2004; Snapp, 2009). Due to the lack of rapid and quantitative methods to 
evaluate FPs, especially their impact on fusion partners, testing newly synthesized FPs 
and choosing the correct FPs for specific experiments has always been challenging. 
Most quantitative comparisons between different FPs have been made in vitro, which do 
not necessarily reflect their behavior in living cells. Cranfill et al. characterized more than 
40 FPs based on their visible spectrum, photostability, and monomeric nature to look for 
the best performing FPs. The light absorbance and fluorescence quantum yield of purified 
FPs were measured to determine the brightness. Photobleaching rates were measured by 
embedding FPs in polyacrylamide or microdroplets using laser scanning microscopy 
(Patterson and Piston, 2000; Piston et al., 1999). The monomeric quality was quantified 
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using the OSER assay (Costantini et al., 2012). Using the monomeric FP is critical for 
correct folding and maintaining the structure of fusion targets. The OSER assay is based 
on the ability of oligomerized membrane protein fluorescent fusions to transform the 
branching tubules network ER into a whorls-like organized smooth ER (OSER) structure 
(Snapp et al., 2003). Tagging FPs to ER-targeted transmembrane domain of cytochrome 
p450 to form the CytERM-FP and quantify the OSER structures can represent the FP 
oligomeric status in vivo. Compared to the traditional in vitro assays to assess the 
oligomeric tendency of FPs through ultracentrifugation or gel filtration methods, the 
OSER assay allows scientists to study FP behavior in living cells. Furthermore, another 
study expressed FPs in transgenic C.elegans embryos to assess their performance in a 
multicellular animal model (Heppert et al., 2016). However, both of the in vivo methods 
are not high throughput. 
In Chapter 2 and 3 of my thesis, I demonstrated an ideal tool to study FP brightness, 
photostability and specifically the impact on their fusion partners using the yeast polyQ 
model. Different FPs alter the toxicity and aggregation of mutant Htt. Thus, this model 
can be used to characterize new FPs and evaluate the effects on their targeted proteins.  
With the advantage of using yeast as a model, this method provides researchers with a 
rapid and high throughput tool to screen for newly synthesized FPs or potential mutations 
of classic FPs that may improve their performance. Therefore, the polyQ assay is a good 
complement to existing methods to test the next generation FPs. Furthermore, the method 
can also be used to test other genetically encoded tags. 
7.3 Correlation between aggregation and    
neurodegeneration 
Aggregation is a hallmark of a series of neurodegenerative disorders including AD, PD, 
and HD; however, its role in toxicity is debatable. It is proposed that the non-soluble 
large aggregates directly contribute to disease pathology of neurodegeneration 
(Donaldson et al., 2003; McCampbell et al., 2000). However, more evidence is showing 
that these amyloid-like aggregates may actually be cytoprotective (Todd and Lim, 2013). 
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In HD, inclusion bodies (IBs) accumulate in the striatum, cerebral cortex, cerebellum, 
and the spinal cord. The formation of IBs is found before neuron cell death and correlates 
with severe behavioral symptoms in HD transgenic mice model (Davies et al., 1997). 
Although the function of normal Htt is not fully understood, it has been found to be 
critical for clathrin-mediated endocytosis, apoptosis, and vesicle transport (Harjes and 
Wanker, 2003). Therefore, misfolded Htt may disrupt essential cellular functions by 
impairing the functions of the wild-type allele. Due to the nature of the polyQ 
oligomers/IBs, expanded polyQ may sequester other proteins. A transcriptional regulator 
CBP was found to be incorporated into the IBs in an HD cell line (McCampbell et al., 
2000). Furthermore, sequestration of essential ubiquitin binding proteins into the 
aggregates was also found in other polyQ diseases, e.g. Spinocerebellar Ataxia 
(Donaldson et al., 2003). Thus, the recruitment of other proteins may cause cellular 
dysfunctions and lead to neurotoxicity. However, this sequestration is not observed in all 
different HD models (Yu et al., 2002). Moreover, the impairment of the proteasome can 
occur before IBs formation (Mitra et al., 2009). Several studies showed that there is no 
correlation between aggregations and toxicity. An HD mouse model expressing human 
Htt 120Q displayed no significant neuronal degeneration, although IBs were observed in 
the striatum and cortex (Slow et al., 2005). Interestingly, a longitudinal survival analysis 
by following long-time survival of the same living neurons in HD demonstrated that 
neuronal cell death highly correlates with diffuse Htt (Arrasate and Finkbeiner, 2012; 
Miller et al., 2010). The accumulation of IBs reduced diffuse Htt expression and the risk 
of striatal neuronal death. The results suggested that the aggregation may be actually 
protective against neuron cell death. In addition, Takahashi et al. also reported that the 
cytotoxicity is caused by soluble oligomers but not IBs (Takahashi et al., 2008).  
The toxicity also seems dependent on the localization of mutant Htt. Tissue culture cells 
have been found to take up chemically synthesized polyQ peptides. IBs were observed 
mainly in the cytoplasm and do not affect cell viability. Adding a nucleolus localization 
signal on the other hand, significantly induce cell death in the PC-12 cell line (Yang et al., 
2002). Indeed, nuclear aggregation is quite rare in HD patient striatal neurons (Gutekunst 
et al., 1999; Kuemmerle et al., 1999), further suggesting that polyQ aggregates may not 
be a predictor of neuronal cell death. The kinetics of aggregation formation may also 
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affect its toxicity. A time-lapse microscopy analysis showed that cells that formed 
delayed IBs formation survived longer than those forming IBs quickly (Gong et al., 2008). 
Several studies also supported the idea that aggregations are epiphenomena or protective 
in PD and AD, representing a compensating mechanism to cellular stress to promote cell 
survival (Espay et al., 2019; Wan and Chung, 2012). Accepting the hypothesis that 
aggregation is protective, new therapeutic targets other than preventing aggregation and 
activating misfolded protein degradation pathways are investigated for HD and other 
misfolded protein diseases. A chemical compound library screen identified a compound 
B2 to be protective against HD and PD in mammalian cell line by promoting IBs 
formation however reduce cytotoxicity (Baldo et al., 2012). 
The yeast model of HD provides researchers with a practical tool to study the connection 
between aggregation and toxicity. Even though polyQ affects Tra1/SAGA functions, it 
did not sequester Tra1 into the aggregates, indicating that sequestration into aggregates is 
not the only mechanism that contributes to the cellular toxicity. Furthermore, we 
observed that compared to other FPs, cells expressing 72Q-moxBFP displayed the 
strongest growth defect (Figure 2.5). Interestingly, these cells seem to form fewer 
aggregates although further quantitation is required. Therefore, further studies focusing 
on the relationship between aggregation and toxicity as well as other specific factors that 
may coordinate polyQ toxicity and aggregation morphology, for example flanking 
sequences outside of the polyQ region (Dehay and Bertolotti, 2006; Duennwald et al., 
2006), is crucial for identifying new targets for HD therapy. 
7.4 TORC1 signaling in Huntington’s disease     
The highly conserved TORC1 signaling controls many cellular processes that regulate 
cell growth and proliferation, including transcription, stress responses, cell cycle, and 
importantly, autophagy (Kamada et al., 2010). TORC1 is a negative regulator of 
autophagy, which is critical for degrading protein aggregates (Ravikumar et al., 2002). 
Thus, one could quickly think that TORC1 should be inhibited in HD therapy. By 
contrast, conflicting views argue that TORC1 activation can be beneficial in HD because 
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it promotes cellular functions that have been found to be impaired by polyQ expansion 
(Ferrarelli, 2015). 
The clearance of misfolded protein aggregates is crucial for HD therapy. Multiple studies 
showed that autophagy plays a vital role in degrading aggregate-prone proteins 
(Ravikumar et al., 2002; Roscic et al., 2011; Webb et al., 2003). Ravikumar et al. (2004) 
reported that inhibiting autophagy leads to increased aggregation and cell death in the 
COS-7 cell line expressing mutant Htt. Treatment of mTOR inhibitor rapamycin, which 
activates autophagy, had opposite effects. Furthermore, another study demonstrated that 
mTORC1 is sequestered into mutant Htt aggregates in an HD cell model, transgenic mice, 
and patient brain samples (Ravikumar et al., 2004). The recruitment impairs mTOR 
kinase activity and induces autophagy. They observed increased aggregation formation 
and cell death in COS-7 cell line carrying polyQ expansion when mTOR signaling is 
enhanced by overexpressing the upstream regulator Rheb (Manning and Cantley, 2003). 
The authors hypothesized that inhibiting mTOR has protective effects in HD. Using a fly 
model of HD, they showed slower neurodegeneration when treated with rapamycin. 
Furthermore, when treated with a rapamycin analog CCI-799, Ross/Borchelt mice 
expressing Htt N-terminal fragment with 82Q showed fewer aggregates in the striatum 
and performed better in behavioral tests (Ravikumar et al., 2004). However, rapamycin 
treatment leads to significant weight loss and reduced brain mass. It also does not 
improve the lifespan of HD mice, which makes the potential of rapamycin analog in HD 
treatment questionable.  
Lee and colleagues hold the opposite opinion (Lee et al., 2015). When they activated 
mTORC1 through overexpression of Rheb (Ras homolog enriched in the brain) or Rhes 
(Ras homolog enriched in the striatum) in HD mice striatal neurons, they observed 
protective effects. mTORC1 activation promoted mitochondrial function, increased 
cholesterol synthesis, attenuated striatal atrophy, and improved HD mice disease 
phenotypes. Notably, they observed increased levels of autophagy markers LC3-II and 
Beclin-1 when mTORC1 is activated. Several studies have shown that autophagy can 
happen through mTORC1-independent pathways (Gordon et al., 1993; Petiot et al., 2000; 
Sarkar, 2013). Furthermore, mTOR reactivation can regulate lysosome formation under 
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starvation (Yu et al., 2010). Therefore, mTOR-independent or mTOR-promoted 
autophagy may be contributing to proteostasis during polyQ expansion. Targeting 
mTOR-independent autophagy pathways have shown benefits to HD in cell lines, fly, and 
zebrafish models (Sarkar et al., 2009; Williams et al., 2008). 
The role of mTOR in HD can also be tissue specific. mTOR activation is higher in 
skeletal muscles than in the brain in the transgenic R6/2 mice model of HD (She et al., 
2011) and is believed to contribute to muscle atrophy. These results may explain the 
behavior improvement see in the animal following treatment of rapamycin. Furthermore, 
inhibiting mTORC1 has shown protective effects against other neurodegenerative 
diseases such as Fragile X syndrome and ALS (Bhattacharya et al., 2012; Saxena et al., 
2013). 
The regulation of TORC1 in mammals is complicated. Suppressing or hyperactivating 
TORC1 can cause strong side effects (Li et al., 2014). The well-studied S. cerevisiae 
allows researchers to investigate the role of TORC1 in polyQ toxicity and identify 
downstream proteins that can be therapeutic targets for HD. Our data suggested that 
functional TORC1 is critical in HD. TORC1 inhibition and activation both lead to 
increased sensitivity to polyQ toxicity (Figure 4.6). TORC1 hyperactivation suppressed 
the upregulation of TRA1 during polyQ expansion, which may partly explain the growth 
defect. It is vital to investigate downstream mechanisms of the TORC1 signaling pathway 
that is crucial for HD and identify specific therapeutic targets.  
7.5 HD model organisms 
Other than the yeast model of HD used in my thesis, there are different model organisms 
developed to study HD pathology including worms, fruit flies, rodents, and larger 
mammals such as monkeys and pigs (Pouladi et al., 2013). Each model has its advantages 
and limitations. Thus, the combination of diverse HD models is meaningful for the 
research field to investigate fundamental cellular mechanisms together with neuronal 
functions and behavioral phenotypes resulting from polyQ expansions. The following 
section is extracted from Jiang, Chadwick, and Lajoie (2016). 
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Researchers have studied HD in worms; they are a useful invertebrate model of neuronal 
dysfunction and death because of their conserved basic neuronal functions compared to 
vertebrates and their simple neuroanatomy. The Hart’s group developed a C. elegans HD 
model specifically expressing Q150 in sensory neurons induced by an osm-10 promoter 
(Faber et al., 1999). There are other worm models mimicking HD, as well. One uses a 
mec-3 promoter expressing 57-residue fragment of Htt followed by GFP (Parker et al., 
2001) and another study expressed expanded polyQ in the C. elegans body wall muscle 
cells (Satyal et al., 2000). Despite lacking a homolog to the human Htt, worms provide 
researchers a good tool to study cellular events in HD, especially in neuronal cells. Fruit 
flies are also an excellent system to study HD because the Htt gene is conserved with 
mammals (Sipione and Cattaneo, 2001). Expressing Htt exon1 in photoreceptor neurons 
in the compound eye in Drosophila was achieved via the UAS-GAL4 system (Jackson et 
al., 1998; Kim et al., 2004). This small model organism allows rapid genetic 
manipulation and, as it is the case with the Huntingtin protein, it expresses a large number 
of genes with a homologue to the human proteome (Wangler et al., 2015). As with many 
other human diseases, rodents are commonly-used models in investigating the basis of 
HD. The R6/1 and R6/2 transgenic mouse model expressing Htt exon1 designed by 
Mangiarini and colleagues shows many HD symptoms, including chorea, involuntary 
stereotypic movements, tremor, and loss of muscle strength (Mangiarini et al., 1996). 
Another model expresses a cDNA encoding the N-terminal fragment of the Htt protein 
with 82Q, which also show severe Huntington’s disease phenotypes (Schilling et al., 
1999). The Hayden laboratory also created a yeast artificial chromosome (YAC) 
transgenic mice expressing the full-length HTT gene with 18Q, 46Q or 72Q. YAC mice 
expressing the 72Q HTT gene (YAC72) show a selective degeneration of medium spiny 
neurons associated with N-terminal Htt translation to the nucleus (Hodgson et al., 1999). 
Another way to express mHtt in mice is through knocking in a human HTT exon1 into the 
endogenous mouse Huntington’s disease gene homolog (Hdh) (Trettel et al., 2000; 
Wheeler et al., 2000). These mice always show a milder phenotype compared to 
transgenic models. For example, in the mutant HdhQ50 and HdhQ111, where mutant Htt is 
expressed under the endogenous mouse HTT gene promoter, an age-dependent Htt 
nuclear relocalization and inclusion bodies were observed after six months.  However, 
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these mice did not show a severe movement disorder (White et al., 1997). Although over 
20 different rodent HD models have been created over the years, each has its own 
advantages and disadvantages. The transgenic models may just mimic the disease 
symptoms rather than the age-dependent onset of HD, but the knock-in models do not 
mimic the human symptoms because the Hdh gene in mice differs from HTT in humans. 
Thus, the choice of a specific model should be made with caution (Jiang et al., 2016; 
Pouladi et al., 2013).    
The major advantage of the yeast model is the ease of genome editing and large-scale 
screening which allows researchers to focus on specific signaling pathways in cells 
expressing mutant Htt expansion and identify potential modifiers and suppressors of 
polyQ toxicity. The findings in yeast can be verified in higher eukaryotic models and 
guide the future therapeutic studies in clinic. The majority of HD yeast studies focus on 
rescuing growth defect during fermentative metabolism. A genome-wide overexpression 
screen identified that suppressors for polyQ toxicity are mainly glutamine- and 
asparagine-rich prion-like proteins (Kayatekin et al., 2014). However, there are a lot of 
questions left to be answered. Future studies can investigate the mechanisms by which 
polyQ affects mitochondria respiration in yeast, how cells cope with polyQ toxicity at 
early time points, and the role of chromatin remodeling and transcriptional regulation 
during polyQ expansions. 
7.6 Tra1/ TRRAP as a novel target for human diseases 
In my thesis, I demonstrated that Tra1 is a major regulator of the cellular stress responses 
to protein misfolding, which indicates the possibility to target Tra1 or its mammalian 
ortholog TRRAP in the treatment of HD and fungal infections. Dysregulation of 
Tra1/TRRAP and dysfunctions in histone acetylation has been found in other stress-
related human diseases, especially in cancer.  
The protein TRRAP was initially identified through its interaction with the oncoprotein c-
Myc by affinity purification (McMahon et al., 1998). In addition, the group also 
identified the binding of TRRAP to E2F transcription factors in controlling the cell cycle. 
The constitutive activation of E2F is considered an important event in oncogenesis 
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(Johnson and Schneider-Broussard, 1998). More studies have implicated the role of 
TRRAP in cancer development in recent years. TRRAP is a coactivator of an important 
tumor suppressor p53 (Barlev et al., 2001). However, it has also been found to promote 
mutant p53 accumulation in cancer cells by regulating p53 degradation machinery 
(Jethwa et al., 2018). Furthermore, TRRAP is the target of viral oncoprotein E1A. The 
adenovirus E1A directly binds to TRRAP/GCN5 and dysregulates transcription 
activation (Lang and Hearing, 2003). Additionally, TRRAP Ser722Phe mutation is 
frequently observed in melanoma (Wei et al., 2011). Patients with high expression of 
TRRAP exhibit lower survival rates in ovarian cancer according to cBio Cancer 
Genomics Portal (Cerami et al., 2012). Importantly, TRRAP is essential for cell survival 
and TRRAP knockout causes embryonic lethality (Herceg et al., 2003). Conditional 
knock out or knock down techniques allow researchers to study the role of TRRAP 
during cancer development. TRRAP knockdown was found to attenuate brain tumor 
formation in a mouse model (Wurdak et al., 2010). Another study using a high 
throughput shRNA library screen also reported that TRRAP was required for 
glioblastoma stem-like cells and TRRAP expression was increased in the gliomas 
(Wurdak et al., 2010). However, a microarray analysis of breast cancer tissue showed a 
negative correlation between TRRAP and patient survival (Wang et al., 2016). The 
evidence suggests that its role may vary in different types of cancer. Moreover, histone 
deacetylase inhibitors (HDACi) have been studied as potential cancer therapeutics due to 
their potential to compensate for the attenuation of histone acetylation observed in cancer 
development (Li and Seto, 2016). While some HDACi have been approved for clinical 
trials, these therapies still have serious limitations including side effects and low efficacy 
(Dell’Aversana et al., 2012). Therefore, targeting specific regulators of histone 
acetylation could be a better solution for cancer treatment. 
All the evidence suggests that TRRAP is an essential modifier of various diseases and 
could be a therapeutic target. The yeast models allow scientists to investigate the basic 
functions of the highly conserved homolog Tra1 and reveal the mechanisms of Tra1 
regulation during diseases. Previous studies and ours have implicated Tra1 in cellular 
stress responses. Future studies should focus on understanding the mechanisms by which 
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Tra1 regulates stress response pathways and how to control Tra1 activity in stress-related 
disease therapy. 
7.7 The potential of Tra1/TRRAP in drug development 
Tra1 and its mammalian homolog TRRAP is essential for cell survival during stresses. 
We have explored the critical role of Tra1 in HD and antifungal resistance. Thus, drugs 
and small molecules that regulate Tra1 function can be investigated in disease therapies. 
Although missing the catalytic residues, this PIKK family member has the similar 
substrate binding cleft between the N- and C-lobes comparing to TOR, ATM, and ATR 
(Díaz-Santín et al., 2017; Sharov et al., 2017), which makes it an ideal druggable target. 
Currently, there is no drug targeting Tra1/TRRAP available. 
Many PI3K inhibitors and small molecules have been designed to target the PI3K domain 
of PIKK proteins, which benefits various disease in model organisms and even clinical 
trials. As introduced previously, mTOR inhibitors showed protective effects against HD 
(Ravikumar et al., 2004). A PI3K inhibitor LY294002 inhibits PI3K activity by 
competitive inhibition of ATP binding, attenuated molecular hallmarks of AD (Aoyagi et 
al., 2010). PI3K inhibitors have also been used in cancer therapy. Through suppression of 
PI3K p110α catalytic subunit, BYL719 inhibited cancer cell proliferation both in vitro 
and in vivo (Keam et al., 2015). It has shown beneficial effects in breast cancer patients 
(Mayer et al., 2017). Furthermore, our data suggested that yeast cells carrying tra1Q3 
mutation were more sensitive to antifungal drugs, indicating that yeast Tra1 can be a 
potential therapeutic target for fungal infections. Sequence alignment data showed that 
the PI3K domain of Tra1 homologs in different species is not 100% identical (Berg et al., 
2018). Thus, it is possible to target specific amino acids in fungal Tra1 without 
interfering the host cells and thus significantly reduce side effects.   
The specific function of Tra1 PI3K has not been fully described. Studies showed that the 
PI3K domain is crucial for Tra1 stability and nuclear localization (Berg et al., 2018). The 
authors also observed reduced incorporation with the HAT complexes and increased 
sensitivity to cell stress when three arginine residues proximal to the PI3K binding cleft 
are mutated (tra1Q3). These results suggested an important role of the PI3K domain in 
regulating Tra1 function. Even though lacking ATP binding motifs, structural studies 
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suggested that the substrate-binding pocket of Tra1 PI3K is still able to interact with 
small molecules (Mutiu et al., 2007). The function of Tra1/TRRAP, primarily its PI3K 
domain needs further investigations. No small molecule ligands or RNAs have been 
identified to interact with the Tra1 PI3K domain. Our data showed that tra1Q3 cells fail to 
activate the HSR and the calcineurin pathway, indicating that the PI3K domain may be 
implicated in its binding to other transcription factors and target gene promoters. 
Understanding the critical role of the Tra1 PI3K domain will provide insights into the 
transcriptional regulation of cellular stress responses and guide the development of drugs 
and small molecules that target Tra1 for the treatment of human diseases. 
7.8 Limitations of the research  
There are some limitations to this study. The yeast model of HD we use expresses only 
the Httex1 fragment instead of the full length Htt, which may not fully represent the 
cellular functions and mechanisms of the disease-causing protein. Previous studies in 
mice models of HD have shown that, although disease progressions happen earlier, mice 
expressing mutant Httex1 develop similar phenotypes compared to full length Htt knock in 
mice (Woodman et al., 2007). The evidence supports the continued employment of the 
more efficient Httex1 to investigate the basic cellular mechanisms of HD in different 
model organisms. Moreover, the proline-rich region and protein tags can affect polyQ 
toxicity and aggregation morphology in yeast, which limits the use of the model to 
understand the aggregation formation in nuerons (Dehay and Bertolotti, 2006; 
Duennwald et al., 2006; Jiang et al., 2017). However, this result develops ideas that 
flanking sequences outside of the polyQ region can affect polyQ toxicity thus could be 
potential therapeutic targets for HD. In addition, the polyQ toxicity in yeast depends on 
cellular prion status that may result from yeast specific mechanisms (Jiang et al., 2017; 
Meriin et al., 2002; Ripaud et al., 2014). Overall, the findings in this thesis can be tested 
in mammalian cell models.  
In chapter 6, we demonstrate the role of Tra1 in antifungal resistance. The preliminary 
experiments were performed in the non-pathological yeast S. cerevisiae. Therefore, the 
results need to be verified in infectious fungi for further studies. We will evaluate the 
235 
 
functions of Tra1 and its potential as a target for antifungal treatment in the pathogenic 
yeast C. albicans in collaboration with Dr. Rebecca Shapiro (University of Guelph). 
7.9 Significance of the research  
Dysregulation of cellular stress responses is a hallmark of several human diseases, such 
as neurodegenerative disorders and fungal infections and antifungal resistance. An ideal 
model to study misfolded protein caused cellular stress is HD. By optimizing the yeast 
model of HD with modern FPs, my research supports the view that flanking sequences 
can alter polyQ toxicity and aggregation formation. We also provided a high throughput 
platform to rapidly assess the impact of FPs on their fusion partners. Moreover, the active 
stress responses in fungi promote cell survival and contribute to antifungal resistance. A 
key process of cellular stress responses is the transcriptional activation of stress-induced 
genes, which is regulated by transcription factors as well as co-activators. The highly 
conserved transcription co-activator Tra1 within the SAGA and NuA4 HAT complexes is 
linked to cellular stress responses. However, the roles of Tra1 and mechanisms on how it 
regulates cellular stress response pathways remains obscure. Therefore, it is crucial to 
investigate the specific regulatory roles of Tra1 and connections to disease pathology. 
Using S. cerevisiae, my studies target the regulation of Tra1 on the HSR, the CWI 
pathway, and the calcineurin signaling during polyQ expansions and antifungal treatment. 
First, we identified a novel connection between TORC1/Sfp1 pathway regulated cell 
growth and histone acetylation controlled by Tra1/SAGA during misfolded protein stress. 
Next, we showed that impaired HSR in HD can be traced back to a cell wall defect, 
which may all regulated by Tra1. By showing the critical role in the calcineurin pathway, 
we reported that Tra1 is vital for yeast survival against antifungal drugs.  
My thesis will provide new insights into the novel transcriptional mechanisms of cellular 
stress responses that promote cell survival as well as the underlying cellular mechanisms 
of HD and antifungal resistance. Understanding the specific functions of Tra1 within the 
HAT complexes will help uncover the secrets of transcriptional defects and dysregulation 
of cellular stress responses observed in HD and other human diseases. Furthermore, my 
study reveals a novel potential therapeutic target for the research of stress-related 
disorders generally.  
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Appendices 
Appendix A: Effect of Fluorescent Proteins on Fusion 
Partners Using Polyglutamine Toxicity Assays in Yeast 
The appendix describes protocols to assess the effects of FPs on the aggregation and 
toxicity of misfolded polyQ expansions for the rapid evaluation of a newly 
uncharacterized FP in the context of fluorescent reporters. The protocol was published in 
the Journal of Visualized Experiments. Reference: Jiang, Y., Di Gregorio, S., Albakri, M. 
B., Duennwald, M. L., Lajoie, P. Effect of Fluorescent Proteins on Fusion Partners Using 
Polyglutamine Toxicity Assays in Yeast. J. Vis. Exp. (141), e58748, doi:10.3791/58748 
(2018). 
Abstract 
For the investigation of protein localization and trafficking using live cell imaging, 
researchers often rely on fusing their protein of interest to a fluorescent reporter. The 
constantly evolving list of genetically encoded fluorescent proteins (FPs) presents users 
with several alternatives when it comes to fluorescent fusion design. Each FP has specific 
optical and biophysical properties that can affect the biochemical, cellular, and functional 
properties of the resulting fluorescent fusions. For instance, several FPs tend to form 
nonspecific oligomers that are susceptible to impede on the function of the fusion partner. 
Unfortunately, only a few methods exist to test the impact of FPs on the behavior of the 
fluorescent reporter. Here, we describe a simple method that enables the rapid assessment 
of the impact of FPs using polyglutamine (polyQ) toxicity assays in the budding yeast 
Saccharomyces cerevisiae. PolyQ-expanded huntingtin proteins are associated with the 
onset of Huntington’s disease (HD), where the expanded huntingtin aggregates into toxic 
oligomers and inclusion bodies. The aggregation and toxicity of polyQ expansions in 
yeast are highly dependent on the sequences flanking the polyQ region, including the 
presence of fluorescent tags, thus providing an ideal experimental platform to study the 
impact of FPs on the behavior of their fusion partner.  
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Introduction 
Since the initial characterization of the green fluorescent protein (GFP) from Aequorea 
Victoria (Chalfie et al., 1994), a wide palette of genetically encoded FPs have been 
developed, allowing cell biologists to simultaneously localize and track multiple cellular 
events/proteins in living cells (Shcherbakova et al., 2012; Thorn, 2017). FPs are derived 
from multiple organisms, from jellyfish to coral, and therefore, display specific 
biophysical properties that divert extensively beyond their respective fluorescent 
spectrum. These properties include brightness, photostability, and a tendency to 
oligomerize among others (Snapp, 2009; Thorn, 2017). Selecting monomeric FPs is an 
important aspect in the selection of a suitable tag when designing a fluorescent reporter, 
in order to minimize inappropriate interactions and alterations of the fusion partner’s 
function and maximize the reporter efficiency for a given cellular compartment 
(Costantini and Snapp, 2013; Costantini et al., 2015; Snapp, 2009). While GFP has, over 
time, been evolved to minimize the effect of adding the fluorescent tag to the fusion 
partner (Costantini et al., 2015; Yang et al., 1996; Zacharias et al., 2002), how new FP 
variants perform compared to GFP remains difficult to assess.  
Few methods exist to characterize the behavior of FPs. Most of them involve testing 
biophysical properties of FPs using biochemical approaches, such as ultracentrifugation 
and gel filtration protocols (Baird et al., 2000; Laue and Stafford, 1999; Pédelacq et al., 
2002; Pédelacq et al., 2006). Such methods have the caveat of using purified FPs in 
solution, offering little insight into their behavior in intact cells. The development of the 
organized smooth endoplasmic reticulum (OSER) assay offers a quantifiable assessment 
of FPs’ tendency to oligomerize in living cells (Costantini et al., 2012) by testing the 
ability of overexpressed FPs to reorganize endoplasmic reticulum tubules into OSER 
whorls (Snapp et al., 2003). This technique can successfully detect changes between 
monomeric and oligomeric variants of GFP and other FPs. However, it relies mostly on 
overexpression in transiently transfected cells, and the quantitation and image analysis 
can be time-consuming unless the technique is adopted as an automated data collection 
and analysis workflow.  
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In order to complement these approaches, we established an assay that takes advantage of 
the effect of fluorescent tags on the toxicity and aggregation of polyQ expansions in yeast 
(Duennwald et al., 2006a; Jiang et al., 2017). The expansion of the polyQ stretch with 
more than 36 repeats within the first exon of the gene encoding the huntingtin protein 
(Htt) is associated with Huntington’s disease (Gusella and MacDonald, 2006; Penney et 
al., 1997). The expression of expanded Httex1 in yeast results in a strong aggregation of 
the misfolded Htt protein coupled to a severe growth defect. Interestingly, these 
phenotypes are strongly influenced by the sequences flanking the polyQ stretch, 
including FPs (Duennwald et al., 2006a; Jiang et al., 2017). It was rationalized that the 
different properties of FPs can differentially affect polyQ toxicity in yeast. Indeed, 
compared to GFP-like FPs, red fluorescent proteins and their evolved forms have shown 
a reduced toxicity and aggregation (Jiang et al., 2017). This manuscript provides a 
detailed protocol to assess the effect of the next generation of FPs on polyQ toxicity and 
aggregation in yeast. This assay allows for a rapid and potentially high-content analysis 
of FP variants that can be used in parallel with previously characterized techniques for 
the optimal characterization of new FPs and can assess how they perform compared to 
GFP.  
Protocol  
1. Generation of New Fluorescently Tagged Httex1 Reporters for an Expression in 
Yeast  
Note: This section has been modified from the protocol by Jiang et al. and Albakri et al. 
(Albakri et al., 2018; Jiang et al., 2017). 
1.1. Design primers to amplify the sequence encoding the fluorescent protein or 
interest by PCR. The forward primer should include a leader sequence to assist 
the restriction enzyme during digestion (GATC), followed by a SpeI restriction 
site (ACTAGT) and 20 bases downstream of the ATG (excluding ATG) of the 
fluorescent protein gene of interest. The reverse primer should include the leader 
sequence (GATC), followed by a SalI restriction site (GTCGAC) and the reverse 
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complement of 20 bases upstream of the stop codon of the FP sequence 
(including stop). 
1.2. Using the primers designed in step 1.1, perform the PCR reaction using a 
thermocycler with the following settings: heat to 95 °C for 1 min and cycle at 
95 °C for 30 s, 60 °C for 30 s, and 72 °C for 2 min per kB of PCR product. 
Performing 18 cycles is ample. 
1.3. Run the PCR reaction on an agarose gel (0.5% in Tris-acetate-EDTA). There 
should a single band corresponding to the expected product size. Isolate the 
fragment using a gel purification kit.  
1.4. The protocol employs an Httex1 vector carrying 25 (nontoxic) and 72 (HD-
associated, displaying a strong aggregation) polyQ repeats. Digest both the PCR 
fragments and the vector with SpeI and SalI restriction enzymes for 3 h at 37 °C.  
1.5. Purify the digested vector by running it on an agarose gel as in step 1.3. 
1.6. Purify the digested PCR fragment using a PCR purification kit.  
1.7. Ligate the resulting digested PCR fragment and p415-GAL1-FLAG-25/72QpolyQ 
plasmids1 using T4 ligase (1 h at room temperature). Use a 10 µL reaction (1 µL 
of T4 enzyme, 1 µL of 10X buffer, 6 µL of PCR fragment, and 2 µL of vector). 
1.8. Transform 2 µL of the ligation reaction into 50 µL of Escherichia coli-competent 
cells and incubate them on ice for 30 min. Then, heat-shock the cells at 42 °C for 
30 s. Add 1 mL of SOC outgrowth media and incubate at 37 °C for 1 h in a 
shaker. Plate 200 µL of the reaction on an LB-agar plate containing 100 µg/mL 
ampicillin. Incubate the plate at 37 °C overnight. 
1.9. Select three individual bacterial colonies, grow them overnight in 3 mL of LB-
broth containing 100 µg/mL ampicillin at 37 °C in a shaker and extract the 
plasmid DNA using a plasmid purification kit. 
1.10. Check the plasmid by digesting 500 ng of DNA using SpeI and SalI restriction 
enzymes for 1 h at 37 °C and run the reaction on an agarose gel (0.5% in Tris-
acetate-EDTA). There should be two bands at the right sizes of the vector (~7 kb) 
and the insert (size varies according to the gene of interest). Then, verify the 
plasmid by sequencing.  
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1.11. Transform the p415-GAL1-FLAG-polyQ-FP plasmids into the yeast strain 
W303 following a standard yeast transformation protocol.  
2. Spotting Assay 
2.1. Streak the yeast clones carrying 25Q/72Q tagged with the FP of interest on an 
agar plate containing yeast selection media (synthetic complete-SC without 
leucine) with glucose as the carbon source. At the same time, also streak 
25Q/72Q-ymsfGFP to serve as a positive control. 
 Note: 25Q/72Q constructs that do not contain a fluorescent tag are not toxic and can 
serve as negative control.  
2.2. Incubate the plates at 30 °C for 2 - 3 d.  
2.3. Select up to three single colonies from the plate. 
2.4. Inoculate 5 mL of SC supplemented with 2% glucose as the carbon source. 
2.5. Pellet 200 µL of each overnight culture and wash it 3x with sterile distilled water. 
2.6. Resuspend the cells in SC media containing 2% galactose as the carbon source to 
induce the expression of polyQ fusions. Incubate the galactose media overnight 
at 30 °C in a tube rotator. As a control, repeat this step by using glucose-
containing media.  
2.7. The next morning, equalize the cell densities to optical density at 600 nm (OD600) 
of 0.2 in 100 µL of SC media in a sterile 96-well plate. 
2.8. Prepare four fivefold dilutions of each sample with sterile water by pipetting 20 
µL of the sample from the previous well into 80 µL of media in the next well. 
2.9. Use a yeast pinning tool to spot the cells onto selective plates (containing glucose 
or galactose) and incubate at 30 °C for 2 d. 
2.10. Image the plates with an image documentation device. 
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3. Quantification of Cell Growth in Liquid Culture 
3.1. Prepare the cell cultures, following steps 2.1 - 2.5 of this protocol. 
3.2. Measure the OD600 using a spectrophotometer. 
3.3. Dilute the cells to an OD600 of 0.1 in 300 µL of media in a 96-well plate. 
3.4. Run each sample in triplicate. 
3.5. Incubate the plate in a plate reader/incubator with shaking capabilities. Set the 
number of samples, the temperature at 30 °C, the absorbance at 600 nm, the 
length of the experiments to 24 h, and the measurement intervals to 15 min, and 
select the continuous shaking mode. 
3.6. Create the growth curve and quantify the area under the curve using scientific 
graphing software. The GraphPad Prism 7 is recommended. Paste the data into an 
XY table with three replicate values. The growth curve will be shown under the 
Graphs folder at the left side. To quantify the area under the curve, select 
Analyze at the top left and click Area under curve in XY analyses. 
4. Fluorescence Microscopy 
4.1. Prepare the cell cultures, following steps 2.1 - 2.5 of this protocol. 
4.2. Dilute the cells 10x in growth media and transfer 200 µL of each sample to 8-
well imaging chambers. 
4.3. Image the cells using a confocal microscope equipped with a 63X Plan 
Aprochromoat objective (1.4 NA) at room temperature.  
Note: The usage of a confocal microscope is optional. A standard wide-field fluorescent 
microscope can also be employed. 
4.4. Adjust the pinhole and laser power for optimal image acquisition. Since the 72Q 
aggregates are much brighter than the diffuse 25Q signal, it is often required to 
use a different acquisition setting between the different plasmids in order to avoid 
saturation of the fluorescent signal.  
4.5. Process the images using ImageJ(Schindelin et al., 2015) or another image-
processing software. At this step, the percentage of cells that display aggregate 
can be calculated manually is desired.  
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5. Dot Blot 
Note: In this protocol, dot blot is used to examine the protein expression levels. Prepare 
the cell cultures, following steps 2.1 - 2.5 of this protocol. 
5.1. Generate protein lysates using glass beads in lysis buffer (100 mM Tris, pH 7.5; 
200 mM NaCl; 1 mM EDTA; 5% glycerol, 1 mM dithiothreitol [DTT]). Add 
protease inhibitors, 4 mM phenylmethylsulfonyl fluoride (PSMF) and protease 
inhibitor cocktail, directly before use. Pellet 5 mL of the overnight culture and 
resuspend it in 200 µL of glass beads and 200 µL of lysis buffer. Vortex 30 s for 
12 rounds. Centrifuge at 12,000 x g at 4 °C for 10 min and collect the supernatant. 
5.2. Spot an equal amount of total proteins on a nitrocellulose membrane using a 
microfiltration apparatus. Prewet the membrane with PBS and assemble the 
apparatus. Connect to a vacuum source and make sure the screws are tightened. 
Turn on the vacuum and let the sample filter through the membrane by gravity. 
5.3. Block the membrane in PBS- 0.05% Tween/5% fat-free milk. 
5.4. Incubate the membrane with primary anti-FLAG antibody overnight at 4 °C. The 
monoclonal anti-FLAG M1 is recommended. 
5.5. Wash the membrane 3x for 10 min each with PSB- 0.05% Tween. 
5.6. Incubate the membrane with a fluorescently labeled secondary antibody (anti-
mouse IgG) for 1 h at room temperature in PBS- 0.05% Tween/5% fat-free milk. 
5.7. Wash membrane 3x 10 min with PSB- 0.05% Tween. 
5.8. Image-blot using an immunoblot documentation system. 
Representative results  
FPs have different biophysical properties, including their tendency to oligomerize, that 
can affect the behavior of their fusion partners in the context of fluorescent reporters. 
This protocol describes a simple method where multiple FPs can be fused to toxic polyQ 
expansions. Since polyQ toxicity is highly dependent on the sequences flanking the 
polyQ stretch (Duennwald et al., 2006a), this assay allows a rapid and direct comparison 
of fluorescent polyQ fusion reporters (Figure 1). A non-HD-associated polyQ length 
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(25Q) is used as a negative control and does not display significant toxicity or 
aggregation (Duennwald, 2013; Duennwald et al., 2006a; Duennwald et al., 2006b; Jiang 
et al., 2017). 72Q is employed to obtain the HD-like phenotypes, including strong growth 
inhibition and polyQ aggregation. Importantly, the Httex1 coding sequence employed lack 
the proline-rich domain that follows the polyQ stretch. In the presence of the proline-rich 
domain, Httex1 is not toxic in yeast (Duennwald et al., 2006a). In this assay, an Httex1 
fused to a yeast-optimized monomeric variant of superfolder GFP (Pédelacq et al., 2006) 
(ymsfGFP) (Jiang et al., 2017) is used as a positive control as previously described (Jiang 
et al., 2017). The constructs also contain a FLAG epitope tag at the N-terminus of Httex1. 
This allows detection of the different fusions with the same antibody (anti-FLAG) for 
biochemical analysis. As a proof-of-principle, 72Q Httex1 fused to yeast-optimized 
TagBFP (yomTagBFP) (Lee et al., 2013) does not result in slow growth measured by 
either spot assays on agar plates or growth in liquid media (Figure 2), indicating that the 
nature of the fluorescent tag can indeed impede polyQ expansion behavior in cells.  
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Figure 1: Workflow diagram for the analysis of the effect of fluorescent protein 
tag on the aggregation and toxicity of polyQ expansion proteins in yeast.  
First, FPs are cloned into yeast expression vectors encoding a galactose-inducible 
version of FLAG-tagged Httex1 harboring either 25Q (nontoxic) or 72Q (HD-
associated, aggregating and toxic) repeats. Clones are selected and verified by 
sequencing and, subsequently, transformed in yeast. Following the induction of 
polyQ fusion expression by incubation in galactose-containing media, either spotting 
assays on agar plates or growth liquid media can assess the polyQ toxicity. PolyQ 
aggregation is analyzed by fluorescence microscopy. A relative expression of the 
different constructs is assessed using dot blot.  
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Figure 2: Representative growth assay results following the expression of 
Httex1 fluorescent fusions in yeast.  
Yeast expressing either 25Q or 72Q Httex1 fused to ymsfGFP or yomTagBFP was 
cultured in glucose (control) or galactose media (polyQ-induced) overnight and 
either (A) spotted on agar plates or (B) incubated further in liquid media to assess 
growth under the different conditions. While 72Q-ymsfGFP induces a significant 
growth defect, 72Q-yomTagBFP displays a growth phenotype similar to the 
nontoxic 25Q counterparts.  
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Aggregation of the fluorescent polyQ fusions can be assessed using fluorescence 
microscopy. 72Q-ymsGFP displays significant aggregation compared to 25Q. However, 
the 72-yomTagBFP fluorescent signal remains diffused throughout the cytoplasm (Figure 
3). In most of the cases, it is not recommended to use the same image acquisition settings 
(laser power, exposure time) to acquire both 25Q and 72Q images. The aggregates in the 
72Q-expressing cells are much brighter than the diffused 25Q signal. Therefore, under 
imaging conditions used to acquire 72Q images, the diffused 25Q signal may appear very 
weak or not be visible at all. Appropriate acquisition settings should also be applied to 
minimize the saturation during the imaging of the 72Q-expressing cells.  
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Figure 3: Representative fluorescent images of Httex1 fluorescent fusions in 
yeast.  
Yeast expressing either 25Q or 72Q Httex1 fused to ymsfGFP or yomTagBFP was 
cultured in glucose (control) or galactose media (polyQ-induced) overnight and 
imaged with a confocal microscope. While the 72Q-ymsfGFP expression results in 
a strong polyQ protein aggregation, 72Q-yomTagBFP displays a diffused 
cytoplasmic signal similar to the nontoxic 25Q counterparts. 
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Expression levels of the various polyQ fusions could affect toxicity. Detergent-insoluble 
amyloids, such as polyQ aggregates, are notoriously difficult to study biochemically and 
are not suitable for an analysis by standerd SDS-PAGE. Therefore, dot blots can be 
performed to assess protein levels. The inclusion of the FLAG tag at the amino terminus 
end of Httex1 allows detection of all the fluorescent fusions simultaneously, despite the 
presence of FPs (Figure 4). Alternatively, semi-denaturing detergent agarose gel 
electrophoresis (SDD-AGE) can be performed to assess the formation of polyQ 
oligomers (Jiang et al., 2017). A detailed protocol and video are available in Halfmann 
and Lindquist (Halfmann and Lindquist, 2008).  
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Figure 4: Representative dot blot analysis of Httex1 fluorescent fusion 
expression in yeast. Yeast expressing 25Q, 46Q, 72Q, or 103Q Httex1 fused to CFP 
was cultured in galactose media (polyQ-induced) overnight and processed for dot 
blot analysis. Fivefold dilutions of the cell lysates are shown.  
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Discussion 
In this article, various assays to measure the aggregation of Httex1 polyQ expansions and 
their effect on yeast growth were employed as a model to study how different fluorescent 
proteins alter their fusion partners in the context of fluorescent reporters. Using a GFP 
variant (ymsfGFP) as a positive control, we showed that this detects significant changes 
in polyQ toxicity and aggregation between different fluorescent tags and allows for a 
direct and rapid comparison of the polyQ-FP fusion performance against GFP-tagged 
constructs (Albakri et al., 2018; Jiang et al., 2017). 
While the present protocol focuses on fluorescent proteins, various parts of the protocol 
could be readily adapted to test the effects of other protein tags. In addition, the present 
protocol employs low-copy yeast centromeric vectors that can vary in terms of copy 
numbers (generally one to two copies) present in cells (Sikorski and Hieter, 1989). Using 
integrative vectors to ensure a uniform expression across experimental conditions could 
circumvent this problem. While this protocol has been optimized for use in the W303 
background, other S. cerevisiae strains can be employed. However, susceptibility to 
polyQ toxicity should be determined using the ymsfGFP-tagged vectors prior to 
designing new constructs. In certain cases, it may be appropriate to employ high-copy 
(2µ) vectors to generate a significant growth defect. It is also suggested to test multiple 
isolates following the yeast transformation with polyQ vectors to avoid selecting 
spontaneous suppressors showing a reduced polyQ toxicity. Of note, the W303 yeast 
strain (Thomas and Rothstein, 1989) is usually used as it is more sensitive to polyQ 
toxicity than other S288C derivatives, such as BY4741/BY4742 (Brachmann et al., 1998), 
thus allowing for a wider range of growth phenotypes. Importantly, strains employed for 
this assay need to carry the Rnq1 prion protein since rnq1Δ cells do not display polyQ 
toxicity and aggregation (Meriin et al., 2002). It is also important to use Httex1 constructs 
carrying the amino-terminal FLAG tag and lacking the proline-rich domain. Other 
variations of the fusion design may alter toxic phenotypes (Duennwald et al., 2006a). 
Finally, the induction of the polyQ fusion expression in galactose-containing media is a 
critical step of the protocol (Duennwald, 2013). When transferring cells from glucose- to 
galactose-containing media, it is important to wash the cells at least three times with 
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sterile water to eliminate all traces of glucose that could contribute to repressing the 
induction of the Gal1 promoter (Mumberg et al., 1995). When performing spotting assays, 
culturing the cells overnight in galactose media to induce the expression of the fusion can 
exacerbate the toxic phenotype of the 72Q fusion and help discriminate changes in 
growth across different fusions (Jiang et al., 2017).  
As a limitation, previous studies did not observe differential effects between a 
nonmonomeric version of CFP (a GFP derivative) and ymsfGFP (Jiang et al., 2017). 
Thus, at least for GFP variants, this assay may not be sensitive enough to discriminate 
between monomeric and oligomeric variants, highlighting the need to complement the 
polyQ toxicity assays with other standard methods, such as the OSER assay (Costantini et 
al., 2012) and biochemical analysis (Baird et al., 2000; Laue and Stafford, 1999; Pédelacq 
et al., 2002; Pédelacq et al., 2006) that can directly assess oligomerization. Also, it should 
be noted that FPs can behave differently in yeast compared to in vitro assays or their 
expression in other organisms (Lee et al., 2013).  
Collectively, these methods allow researchers to rapidly characterize new FPs and 
measure their effect on their fusion partner. In the future, this protocol will enable the 
quick screening of new derivatives of previously characterized FPs to identify mutants 
that behave similarly to GFP variants, which are still the gold standard measure for FP 
reporters. While this protocol focuses on fluorescent proteins, it can easily be adapted to 
screen for the effects of other genetically encoded tags, such as SNAP-tag (Keppler et al., 
2003) and SunTag (Tanenbaum et al., 2014).  
In conclusion, this protocol provides a rapid and easily scalable assay to enable further 
characterization of the new generation of FPs and other genetically encoded tags to guide 
research in fusion protein design. 
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